
<html lang="en"     class="pb-page"  data-request-id="176e8dd0-c7c2-4cfc-8465-bfd580d817ea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b00927"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket" /></meta><meta name="dc.Creator" content="Christian  Lerner" /></meta><meta name="dc.Creator" content="Roland  Jakob-Roetne" /></meta><meta name="dc.Creator" content="Bernd  Buettelmann" /></meta><meta name="dc.Creator" content="Andreas  Ehler" /></meta><meta name="dc.Creator" content="Markus  Rudolph" /></meta><meta name="dc.Creator" content="Rosa María  Rodríguez Sarmiento" /></meta><meta name="dc.Description" content="A fragment screening approach designed to target specifically the S-adenosyl-l-methionine pocket of catechol O-methyl transferase allowed the identification of structurally related fragments of hig..." /></meta><meta name="Description" content="A fragment screening approach designed to target specifically the S-adenosyl-l-methionine pocket of catechol O-methyl transferase allowed the identification of structurally related fragments of hig..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 14, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00927" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00927" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00927" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00927" /></link>
        
    
    

<title>Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00927" /></meta><meta property="og:title" content="Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0015.jpeg" /></meta><meta property="og:description" content="A fragment screening approach designed to target specifically the S-adenosyl-l-methionine pocket of catechol O-methyl transferase allowed the identification of structurally related fragments of high ligand efficiency and with activity on the described orthogonal assays. By use of a reliable enzymatic assay together with X-ray crystallography as guidance, a series of fragment modifications revealed an SAR and, after several expansions, potent lead compounds could be obtained. For the first time nonphenolic and small low nanomolar potent, SAM competitive COMT inhibitors are reported. These compounds represent a novel series of potent COMT inhibitors that might be further optimized to new drugs useful for the treatment of Parkinson’s disease, as adjuncts in levodopa based therapy, or for the treatment of schizophrenia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00927"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00927">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-8/abseba.2021.7.issue-8/20210809/abseba.2021.7.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-15/accacs.2021.11.issue-15/20210806/accacs.2021.11.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-31/ascecg.2021.9.issue-31/20210809/ascecg.2021.9.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-8/bomaf6.2021.22.issue-8/20210809/bomaf6.2021.22.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-29/cgeabj.2021.99.issue-29/20210809-01/cgeabj.2021.99.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-15/enfuem.2021.35.issue-15/20210805/enfuem.2021.35.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-15/joceah.2021.86.issue-15/20210806/joceah.2021.86.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-30/jpcafh.2021.125.issue-30/20210805/jpcafh.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-30/jpcbfk.2021.125.issue-30/20210805/jpcbfk.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-30/jpccck.2021.125.issue-30/20210805/jpccck.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-30/jpclcd.2021.12.issue-30/20210805/jpclcd.2021.12.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-8/jprobs.2021.20.issue-8/20210806/jprobs.2021.20.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-15/orlef7.2021.23.issue-15/20210806/orlef7.2021.23.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-15/orgnd7.2021.40.issue-15/20210809/orgnd7.2021.40.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00927&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00927&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00927&amp;href=/doi/10.1021/acs.jmedchem.6b00927" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10163-10175</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00900" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01122" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.7b00613"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design of Potent and Druglike Nonphenolic Inhibitors for Catechol <i>O</i>-Methyltransferase Derived from a Fragment Screening Approach Targeting the <i>S</i>-Adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine Pocket</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Lerner">Christian Lerner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Jakob-Roetne">Roland Jakob-Roetne</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernd++Buettelmann">Bernd Buettelmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Ehler">Andreas Ehler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Rudolph">Markus Rudolph</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosa+Mar%C3%ADa++Rodr%C3%ADguez+Sarmiento">Rosa María Rodríguez Sarmiento</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#5f2d302c3e00323e2d363e712d303b2d36382a3a25002c3e2d32363a312b301f2d303c373a713c3032"><span class="__cf_email__" data-cfemail="bdcfd2cedce2d0dccfd4dc93cfd2d9cfd4dac8d8c7e2cedccfd0d4d8d3c9d2fdcfd2ded5d893ded2d0">[email protected]</span></a>. Phone: (+41) 61-688-3585.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00927&amp;href=/doi/10.1021%2Facs.jmedchem.6b00927" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10163–10175</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 29, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 June 2016</li><li><span class="item_label"><b>Published</b> online</span>14 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 November 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00927" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00927</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10163%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristian%2BLerner%252C%2BRoland%2BJakob-Roetne%252C%2BBernd%2BBuettelmann%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D22%26contentID%3Dacs.jmedchem.6b00927%26title%3DDesign%2Bof%2BPotent%2Band%2BDruglike%2BNonphenolic%2BInhibitors%2Bfor%2BCatechol%2BO-Methyltransferase%2BDerived%2Bfrom%2Ba%2BFragment%2BScreening%2BApproach%2BTargeting%2Bthe%2BS-Adenosyl-l-methionine%2BPocket%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10175%26publicationDate%3DNovember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00927"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2491</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00927" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Lerner&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Jakob-Roetne&quot;},{&quot;first_name&quot;:&quot;Bernd&quot;,&quot;last_name&quot;:&quot;Buettelmann&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Ehler&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Rudolph&quot;},{&quot;first_name&quot;:&quot;Rosa&quot;,&quot;last_name&quot;:&quot;María Rodríguez Sarmiento&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;10163-10175&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00927&quot;},&quot;abstract&quot;:&quot;A fragment screening approach designed to target specifically the S-adenosyl-l-methionine pocket of catechol O-methyl transferase allowed the identification of structurally related fragments of high ligand efficiency and with activity on the described orthogonal assays. By use of a reliable enzymatic assay together with X-ray crystallography as guidance, a series of fragment modifications revealed an SAR and, after several expansions, potent lead compounds could be obtained. For the first time nonphenolic and small low nanomolar potent, SAM competitive COMT inhibitors are reported. These compounds represent a novel series of potent COMT inhibitors that might be further optimized to new drugs useful for the treatment of Parkinson’s disease, as adjuncts in levodopa based therapy, or for the treatment of schizophrenia.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00927&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00927" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00927&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00927" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00927&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00927" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00927&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00927&amp;href=/doi/10.1021/acs.jmedchem.6b00927" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00927" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00927" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00927%26sid%3Dliteratum%253Aachs%26pmid%3D27685665%26genre%3Darticle%26aulast%3DLerner%26date%3D2016%26atitle%3DDesign%2Bof%2BPotent%2Band%2BDruglike%2BNonphenolic%2BInhibitors%2Bfor%2BCatechol%2BO-Methyltransferase%2BDerived%2Bfrom%2Ba%2BFragment%2BScreening%2BApproach%2BTargeting%2Bthe%2BS-Adenosyl-l-methionine%2BPocket%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D22%26spage%3D10163%26epage%3D10175%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/jmcmar.2016.59.issue-22/20161123/jmcmar.2016.59.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A fragment screening approach designed to target specifically the <i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine pocket of catechol <i>O</i>-methyl transferase allowed the identification of structurally related fragments of high ligand efficiency and with activity on the described orthogonal assays. By use of a reliable enzymatic assay together with X-ray crystallography as guidance, a series of fragment modifications revealed an SAR and, after several expansions, potent lead compounds could be obtained. For the first time nonphenolic and small low nanomolar potent, SAM competitive COMT inhibitors are reported. These compounds represent a novel series of potent COMT inhibitors that might be further optimized to new drugs useful for the treatment of Parkinson’s disease, as adjuncts in levodopa based therapy, or for the treatment of schizophrenia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The enzyme catechol <i>O</i>-methyltransferase (COMT) catalyzes the Mg<sup>2+</sup> dependent methyl transfer from its cofactor <i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine (SAM) to one of the hydroxyl groups of endogenous catechols and neurotransmitters such as dopamine and noradrenaline, resulting in termination of their biological activity. In the brain, COMT-dependent dopamine degradation is of high relevance in regions with low expression of the presynaptic dopamine transporter (DAT), in particular in the prefrontal cortex. For this reason COMT inhibition offers a unique opportunity to influence pathologies characterized by low dopamine levels in the prefrontal area such as cognitive impairment associated with schizophrenia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Most known COMT inhibitors are nitrocatechol based compounds, such as tolcapone and entacapone (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) which are successfully used as adjuncts to the L-Dopa/based treatment of Parkinson’s Disease.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> They are highly metabolized and mainly peripherally acting, protecting L-Dopa from methylation and deactivation mostly in the liver.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> While entacapone is almost exclusively peripherally acting, there is evidence for central effects with tolcapone, despite the limited brain penetration (brain to plasma ratio up to 0.01).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Reported COMT inhibitors. (B) Interactions for bisubstrate inhibitors binding to SAM and Mg<sup>2+</sup> pockets.<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Bisubstrate and hydroxypyridone based COMT inhibitors (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) have also been described.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> They do not require the presence of a nitro group; however like the catechols, they have chelating motives of phenolic nature binding to the Mg<sup>2+</sup> site. Such phenolic compounds are prone to high metabolic clearance, notably glucuronidation and sulfatation causing low oral bioavailability.<a onclick="showRef(event, 'ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref7">(3, 7)</a> In addition, their acidity and high polarity make it challenging to develop them as centrally acting drugs. Accordingly, to date, the focus has been on peripheral COMT inhibition,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> while evidence for an important role of COMT in schizophrenia is accumulating.</div><div class="NLM_p">We want to report the identification of structurally differentiated COMT inhibitors targeting exclusively the SAM pocket instead of the Mg<sup>2+</sup> site with its strict limitations for binding.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Ideally, the adenosine replacing motive should be of low molecular weight, with an acceptable polarity reflected in an adequate number of H-bond donors (typically HBD < 3), with fewer groups able to function as HBA (<7) and with a suitable lipophilicity for CNS penetration (clogP, best between 1 and 4),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> in contrast to previous examples targeting the SAM pocket.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">In the recent past, fragment-based drug discovery was successfully applied to the generation of hits or chemical tools for drug targets. A critical challenge is to further elaborate the fragment hits to potent leads with balanced properties<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with particular examples such as Zelboraf, which could be further developed into a marketed drug.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Fragment hits typically show very low affinity to the targets, so sensitivity of the screening assay and confirmation of binding by orthogonal methods are required.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We performed a fragment screening for COMT targeting the SAM pocket. We used a library consisting of 6000 compounds with molecular weights below 250 Da, up to three hydrogen bond donors, up to three hydrogen bond acceptors, and calculated log <i>P</i> (clogP) of ≤3, in compliance with the rule of three.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Affinity screening was first based on surface plasmon resonance (SPR).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Binding of the fragments to wild type human COMT apoprotein was measured at a single concentration of 200 μM, in the absence of SAM and Mg<sup>2+</sup> to exclude chelators.</div><div class="NLM_p">Results obtained with this protocol were compared with the binding to six enzyme mutants harboring variations in the SAM binding domain (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This counterscreen ensured the specificity of the interaction with the desired cofactor pocket.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selection of specific mutants on the adenosine binding pocket. Amino acids in bold (Glu90, Ser119, and His142) were mutated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon selection of 600 fragments based on affinity and site specificity, hit confirmation was performed with a 10-point SPR dose–response measurement.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> For 200 confirmed binders identified, one-dimensional (1D) <sup>1</sup>H NMR spin lock variation of Carr–Purcell–Meiboom–Gill (CPMG)<a onclick="showRef(event, 'ref14 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref17">(14, 17)</a> ligand detected method was performed by measuring the NMR spectra of the compound without/with hCOMT protein and observing line broadening due to fragment binding to the slow tumbling hCOMT and the differences in relaxation. Binding of fragments confirmed by 1D <sup>1</sup>H NMR was further characterized by two-dimensional (2D) <sup>1</sup>H NMR target detect experiments method performed with <sup>15</sup>N labeled hCOMT protein by use of heteronuclear single-quantum coherence (<sup>1</sup>H/<sup>15</sup>N HSQC) NMR with chemical shifts mapping, where fragment-induced chemical shift differences of <sup>1</sup>H/<sup>15</sup>N cross peaks of hCOMT amide backbones involved in binding are observed.<a onclick="showRef(event, 'ref14 cit17a ref18'); return false;" href="javascript:void(0);" class="ref ref14 cit17a ref18">(14, 17a, 18)</a> Additionally, all 600 fragments were tested in a functional enzymatic assay<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to determine the IC<sub>50</sub> values for COMT inhibition. Very few fragments showed significant binding in the cofactor pocket combined with a weak enzymatic inhibition, and only four fragments were active in all assays. Following this screening/validation cascade we identified three pyrazole derivatives as fragment hits (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) with high ligand efficiencies (LE).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It is worth noting that we found similar starting points to the ones recently reported, in particular fragment <b>1</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This supports our findings, and it is not surprising since, unlike the high-throughput screening libraries, fragment libraries typically contain commercially available molecules selected with similar property criteria.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected Fragment Screening Hits: Binding, Functional, and Ligand Efficiency Data</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fragment hit</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>2′</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SPR KD (μM)</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LE</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">0.36</td></tr></tbody></table></div></div><div class="NLM_p">In order to avoid interspecies differences in our hit to lead optimization process, we performed cocrystallization efforts with humanized rat COMT as this surrogate crystallizes better than human COMT and yields data relevant to human.<a onclick="showRef(event, 'cit5c'); return false;" href="javascript:void(0);" class="ref cit5c">(5c)</a> The crystal structure of humanized rat COMT in complex with fragment <b>2</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k03">5k03</a>) confirmed its binding in the SAM pocket (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of the crystal structures of rat COMT<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (orange) in complex with <i>S</i>-adenosylmethionine (SAM, yellow), dinitrocatechol (DNC, yellow), magnesium (Mg<sup>2+</sup>), and humanized rat COMT (gray) bound to fragment <b>2</b> (green). Met91 of the rat COMT is mutated in the humanized protein to Ile91.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most striking is the H-bond (290 pm) between the backbone NH of Ser119 and the nitrogen of the imidazopyridine from <b>2</b>. It corresponds to the H-bond interaction of Ser119 to the N-1 of adenine in the classical SAM binding mode. The pyrazole occupies the ribose binding region and the NH serves as H-bond donor (280 pm) to the carboxylate of Glu90, mimicking the interaction of the hydroxyl groups of the ribose in SAM which are normally the partners for the Glu90 carboxylate. There is a novel element in the binding of <b>2</b> to the adenosine pocket which is not present in the SAM bound structure, the H-bond (310 pm) between the backbone NH of Ile91 and the unprotonated N-1 of the pyrazole moiety. Additionally, the imidazopyridine ring forms a sandwich-like interaction with the aliphatic side chain of Ile91 on one side and with the benzylic CH<sub>2</sub> of Trp143 on the other side. The benzylic CH<sub>2</sub> of His142 interacts with both the pyrazole ring and the imidazopyridine. Finally, the pyrazole also interacts with the aromatic ring of Tyr68 in an edge-to-face interaction. From a comparison of the X-ray structures with SAM and fragment <b>2</b>, the side chains of Trp143 and to a lesser extend of Arg146 move to offer space to the pyridine ring. Also, the previously mentioned Tyr68 flips over to close the methionine channel indicating significant flexibility.</div><div class="NLM_p">Fragment expansion using interactive substructure searches and similarity searches within the Roche compound library, followed by chemical synthesis, led to the identification of a series of thiazole analogs (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) with affinities in the micromolar range.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values Obtained from the Enzymatic Assay for Representative First Fragment Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0013.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center">compd</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>7</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>9</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>(μM)</td><td class="colsep0 rowsep0" align="left">21 ± 3</td><td class="colsep0 rowsep0" align="left">16 ± 2</td><td class="colsep0 rowsep0" align="left">>625</td><td class="colsep0 rowsep0" align="left">24 ± 2</td><td class="colsep0 rowsep0" align="left">>625</td><td class="colsep0 rowsep0" align="left">11 ± 2.5</td><td class="colsep0 rowsep0" align="left">>425</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub>: half maximal inhibitory concentration in enzymatic functional assay. IC<sub>50</sub> values are the average of two to four independent measurements ± standard deviation.</p></div></div></div><div class="NLM_p">A formal exchange of the corresponding pyrazole ring in the original fragment <b>1</b> (IC<sub>50</sub> = 69 μM) by an identically substituted thiazole <b>3</b> (IC<sub>50</sub> = 21 μM) led to a 3-fold increase in affinity. In general, the thiazolylpyrazoles were slightly more potent. Another group significantly affecting affinity is the 4-methyl substitution at the thiazole ring. 4-Methyl substituted <b>6</b> (IC<sub>50</sub> = 24 μM) compares favorably with its unsubstituted analog <b>7</b> (>625 μM). Indeed, 4-methyl seems to be optimal, illustrated by <b>4</b> (16 μM) and <b>5</b> (>625 μM). At position 2 of the thiazole ring, only a 2-tolyl substituted compound <b>8</b> was similarly potent as its 2-methyl analog <b>4</b>. Other alkyl or aryl substituents with improved potency at this position could not be identified (data not shown). The more sterically demanding benzylic derivative <b>9</b> was inactive.</div><div class="NLM_p">To better understand the affinity differences, we examined the crystal structure of compound <b>8</b> in complex with humanized rat COMT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k05">5k05</a>) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of humanized rat COMT with fragment <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure shows that the nitrogen atom of the thiazole ring is involved in hydrogen bonding to the backbone NH (280 pm) of Ser119. The pyrazole ring, as described for compound <b>2</b>, occupies the ribose binding region, and both nitrogen atoms form hydrogen bonds to Glu90 (270 pm) and the backbone NH of Ile91 (310 pm).</div><div class="NLM_p">For compound <b>8</b>, the flexible Trp143 is now in close contact to the thiazole, binding edge-to-face to its sulfur. Extensions at position 2 in the thiazole ring are at the surface of the enzyme pointing to the solvent. Larger substituents could even reach out through the surface of the enzyme into the surrounding water. This may partially explain why no significant gain in affinity is observed with addition of aromatic rings comparing compound <b>4</b> with <b>6</b>, <b>8</b> and the lost of activity for compound <b>9</b> in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><div class="NLM_p">A methyl group at position 4 in the thiazole (<b>4</b>, <b>6</b>, <b>8</b>) fits perfectly into a small pocket deep in the binding site (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). A larger substituent such as cyclopropyl (<b>5</b>) is already too big to accommodate, while a hydrogen (<b>7</b>) leaves an unoccupied cavity.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of humanized rat COMT with fragment <b>8</b>, oriented in order to show the small pocket at position 4 in the thiazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the cocrystal structures of <b>2</b> and <b>8</b> (<a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) indicate that there is limited space due to the flipped conformation of Tyr68 compared to the SAM-bound state, considering the observed flexibility, we decided to explore substituent effects at position 3′ (R<sub>2</sub>) of the pyrazole while keeping constant the 5-(1<i>H</i>-pyrazol-5-yl)-2,4-dimethylthiazole motif of compound <b>4</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> with key representatives).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values and Physicochemical Parameters To Assess Brain Penetration for 3′-Substituted Derivatives (R<sub>2</sub>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#tbl2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">clogP <a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i> <a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">130 ± 20</td><td class="colsep0 rowsep0" align="char" char=".">37.0</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">34 ± 5</td><td class="colsep0 rowsep0" align="char" char=".">37.1</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">8 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">37.1</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">36.9</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">20 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">37.1</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">45.5</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3.2 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">37.0</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">1.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">53.9</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18S</b></td><td class="colsep0 rowsep0" align="left">1.1 ± 0.001</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18R</b></td><td class="colsep0 rowsep0" align="left">0.7 ± 0.05</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">21 ± 3</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">1.1 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">35.8</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.21 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">36.8</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.86 ± 0.16</td><td class="colsep0 rowsep0" align="char" char=".">45.9</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">0.47 ± 0.14</td><td class="colsep0 rowsep0" align="char" char=".">45.8</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.075 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">45.6</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2fn1"><div class="footnote" id="tbl2fn1"><sup>a</sup><p class="last">Compounds in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> have the following: MW < 350 Da; hydrogen bond donors (HBD), 1 (NHs + OHs); hydrogen bond acceptors (HBA), 2–3 (Ns + Os).</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">PSA: polar surface area (for CNS penetration of <60–70 Å<sup>2</sup>).</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">clogP = calculated logarithm of the partition coefficient,</p></div><div class="footnote" id="t3fn3"><sup>d</sup><p class="last">log <i>D</i> = logarithm of the octanol–water distribution coefficient at pH 7.4.</p></div></div></div><div class="NLM_p">Exploring substituent effects at position 3′ (R<sub>2</sub>) on <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, we observed that direct attachment of a sterically demanding phenyl ring at the pyrazole, compound <b>10</b>, led to a strong decrease in potency. Variation on the length of a slim linker revealed a key trend for potency improvement (compounds <b>11</b>–<b>13</b>), with 2 μM binding affinity for the shortest benzylic compound <b>13</b>. However, the lack of a phenyl ring attached to the linker (alkyl compound <b>14</b> compared with <b>13</b>) reduced potency.</div><div class="NLM_p">Further modifications were performed to understand the binding requirements at the (R<sub>2</sub>) side of the molecule for the benzylic compounds.</div><div class="NLM_p">We observed a tendency for potency increase with higher electron densities at the phenyl ring and in particular with a small alkoxy group (<b>15</b>) in para position. In this regard, alternatives with lower electron density such as a pyridine or chloro substituted rings have IC<sub>50</sub> values of >3 μM, (data not shown). Increase of size at the benzylic aromatic ring does not contribute to potency improvement (<b>16</b>); however heterocyclic biaryls such as a methylpyrazole <b>17</b> are tolerated and show similar potency to the alkoxy derivative <b>15</b>. Significant changes in potency were achieved with different substitutions at the benzylic position (<b>18</b>–<b>21</b>). Introducing a methyl substituent leads to submicromolar potency (<b>18</b>) while for example an ethyl group is already too large (<b>19</b>). For the monosubstitution at the benzylic side, the <i>R</i> enantiomers are consistently more potent by about 2-fold (e.g., <b>23</b> vs <b>22</b>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Bridging of the dimethyl (<b>20</b>) to a cyclopropyl group (<b>21</b>) leads to a further gain in affinity. By combination of the cyclopropyl at the benzylic position with an optimally substituted aromatic ring, potencies below 100 nM are obtained for the first time (<b>24</b>). Pyrazolo-pyrazole analogs follow a similar increase in potency as the thiazolo-pyrazoles with introduction of the benzyl and cyclopropyl functions and are less potent.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We were able to obtain a crystal structure of the most active compound (<b>24</b>) cocrystallized with humanized rat COMT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0l">5k0l</a>) to clarify key interactions (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Crystal structure of humanized rat COMT with inhibitor <b>24</b>: hydrogen bonds (black) and hydrophobic interactions (blue) indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The thiazolo-pyrazole H-bond pattern is confirmed to be as described for the previous compounds. Trp143 is in close contact to the thiazole sulfur atom (330 pm) and the methoxybenzene ring (350 pm). The methoxybenzene ring additionally interacts with the side chain of Met40 and is thus in a sandwich constellation.</div><div class="NLM_p">These interactions rationalize the importance of the aromatic ring as observed in the comparison of compounds <b>13</b> with <b>14</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Importantly, the side chain of Tyr68 moves out to create space for the binding of the cyclopropylene linker. The two cyclopropyl carbon atoms make three vdW interactions with the side chain of Tyr68.</div><div class="NLM_p">Although the binding potencies for the monomethyl analogs are not of big difference, we observed that the <i>R</i> enantiomers show about 2-fold higher potencies than the <i>S</i> enantiomers. The difference in potency becomes larger when comparing the weakest <i>S</i>-methyl enantiomers (e.g., <b>22</b> with IC<sub>50</sub> = 0.86 μM) with the cyclopropyl derivative <b>24</b> (IC<sub>50</sub> = 0.075 μM) or the <b>18</b><i>S</i><b>-</b>methyl enantiomer <b>18S</b> (IC<sub>50</sub> = 1.1 μM) with the cyclopropyl <b>21</b> (0.21 μM). There is also a 5-fold reduction in potency from the cyclopropyl derivative <b>21</b> to the dimethyl analog <b>20</b> (IC<sub>50</sub> = 1.1 μM) which binds with similar potency compared to the weakest <b>18S</b> enantiomer. Interestingly, superpositions for the most rigid cyclopropyl (<b>24</b> in green), the dimethyl (<b>20</b> in yellow), and the <i>R</i> and <i>S</i> monomethyl enantiomers (racemic <b>18</b> in blue and <b>22+23</b> racemic mixture in orange) reveal different conformational trends for the most differentiated compounds (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). The dimethyl substitution is sterically more demanding than cyclopropyl and seems to fit less well into the pocket. This dimethyl substitution could also affect the preferred torsional angle of the aryl group leading to different and probably worse interactions of the terminal phenyl. These less favorable interactions for the terminal aromatic ring are also observed for the weakest <i>S</i> enantiomers (see superpositions of the crystal structures on <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Furthermore, for the dimethyl and for the <i>R</i>/<i>S</i> monomethyl analogs at the benzylic side, the number of vdW interactions with the Tyr68 (indicated on <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) is reduced with respect to the best fitting two-carbon interactions on the cyclopropyl analog.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Superposition of the crystal structures of humanized rat COMT with inhibitors reported in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>: <b>22+23</b> (both in orange, cocrystallized as racemate PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0f">5k0f</a>), <b>18</b> (blue, cocrystallized as racemate, however one enantiomer (<b>18R</b>) observed in the electron density, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0b">5k0b</a>), <b>20</b> (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0c">5k0c</a>), and <b>24</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k01">5k01</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The role of key amino acids (in particular Ty68) in the enzymatic methyl transfer reaction catalyzed by COMT has recently been analyzed in great detail.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic strategy to obtain compounds <b>10</b>–<b>16</b> is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Deprotonation of ketone <b>25</b> using NaH followed by addition of the corresponding ester gave the diketone intermediates <b>26a</b>–<b>g</b> as a mixture of tautomers. Attempts to use acid chlorides instead of esters in this transformation gave no product or very poor yields. Final compounds <b>10</b>–<b>16</b> were obtained by condensation of intermediates <b>26a</b>–<b>g</b> with hydrazine hydrate in ethanol with catalytic HCl.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>10</b>–<b>16</b> Described in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, 0 °C, 15 min, then R<sub>2</sub>CO<sub>2</sub>Et, 0–100 °C, 1–3 h, 56–65%; (ii) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH/25% aq HCl (80:1), 60 °C, overnight 60–90%.</p></p></figure><div class="NLM_p">Suzuki coupling with a suitable bromophenyl substituted intermediate <b>28</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) prepared similarly as compounds <b>10</b>–<b>16</b> allowed the preparation of bicyclic analogs such as compound <b>17</b>.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>17</b> in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, 0 °C, 30 min, then <b>27</b>, 0–100 °C, 1 h, 63%; (ii) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH/25% aq HCl (80:1), 60 °C, 3 h, 99%; (iii) <b>29</b>, Cs<sub>2</sub>CO<sub>3</sub>, (PPh<sub>3</sub>)<sub>4</sub>Pd, dioxane, H<sub>2</sub>O (4:1), 165 °C, microwave, 20 min, 51%.</p></p></figure><div class="NLM_p">For the preparation of the substituted methylene bridged benzylic derivatives (<b>18</b>–<b>24</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) the addition to the deprotonated methyl ketone <b>25</b> required aldehydes <b>32a</b>–<b>f</b> and very low temperatures (−78 °C) in order to obtain acceptable yields. Deprotonation was best performed using a lithium base. The corresponding starting aldehydes <b>32a</b>–<b>f</b> (many of them commercially available) were obtained by reduction of available acids <b>30a</b>–<b>f</b> to alcohols <b>31a</b>–<b>f</b>, followed by oxidation using Dess–Martin periodinane. Oxidation of the β-hydroxy ketone intermediates <b>33a</b>–<b>f</b> to diketones <b>34a</b>–<b>f</b> was also performed with Dess–Martin periodinane. Reaction of intermediates <b>34a</b>–<b>f</b> with hydrazine gave the final compounds <b>18</b>–<b>24</b> with the central pyrazole ring in one unique tautomeric form in DMSO, as corroborated by NOESY-NMR with some observed NOEs between the NH of the imidazole and the benzylic CH or CH<sub>2</sub>. Enantiomers such as <b>22</b> and <b>23</b> were initially obtained from racemic precursor by chromatographic separation using a chiral column.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>18</b>–<b>24</b> Described in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiAlH<sub>4</sub>, THF, 0–20 °C, 70–98%; (ii) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 10 h, 70–83%; (iii) <b>25</b>, LiN(SiMe<sub>3</sub>)<sub>2</sub>, THF, −78 °C, 0.5 h; then <b>32</b>, 3 h, −78 °C, 60–99%; (iv) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 5 h, 61–88%; (v) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH/25% aq HCl (80:1), 60 °C, 4 h, 61–92%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This study illustrates the successful application of a fragment-based approach followed by fragment optimization to obtain for the first time potent and novel inhibitors that bind to the SAM pocket of COMT and do not require a catechol or phenol-like motif for high potency. These compounds behave as competitive inhibitors of SAM.</div><div class="NLM_p">In the reported lead optimization process, a challenging fragment derivatization was performed by observing key binding pocket characteristics, described in a stepwise manner with the important use of X-ray crystallography. Key interactions are described such as hydrogen bonding between the Ser118 backbone NH and the thiazole or the pyrazole nitrogen for the thiazolo-pyrazole and pyrazolo-pyrazole subseries, as well as interactions of the central pyrazole with Glu90 and with the backbone NH of Ile91. A small lipophilic pocket was identified occupied ideally with a 4-methyl substituent in the thiazole ring, which has an edge-to-face contact with Trp143.</div><div class="NLM_p">Flexibility of the enzyme was confirmed, as previously described,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> for several amino acids such as the Trp143 side chain movement. In addition, we provide insights for a relevant movement and interactions of Tyr68 that open a novel pocket, offering best contacts with a cyclopropylene linker at a benzylic position. This allows the aromatic ring to fit best into the pocket created by Trp143 and Met40 with some preferential substitution patterns.</div><div class="NLM_p last">The designed potent lead compounds have CNS druglike properties. Taken together, the reported study and observations represent an advance toward the rational design of CNS drug like and potent nonphenolic COMT inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> COMT Enzyme Inhibition Assay</h3><div class="NLM_p">The principle of the assay relies on methylation of a 4-nitrocatechol-Alexa Fluor 488 substrate. After transfer of the methyl group from <i>S</i>-adenosylmethionine (SAM) to the substrate, an increase of fluorescence intensity is observed because the methylation disturbs the intramolecular static quenching of Alexa Fluor 488. This increase of fluorescence intensity can be followed in a kinetic measurement. An inhibitor compound of COMT decreases the slope.</div><div class="NLM_p">In detail, 10 μL of recombinant hCOMT (expressed in <i>E. coli</i>) diluted to 80 nM in assay buffer was pipetted into a 384-well microtiter plate (black with flat clear bottom, nonbinding surface treated polystyrene, Corning reference 3655). 2 μL of compound dilution in 100% DMSO was then added to the enzyme solution, and the plate was shaken with 1500 rpm for 1 min. After adding 20 μL of a mixture of 320 nM 4-nitrocatechol-Alexa488 (produced in house) and 800 nM SAM (Sigma-Aldrich A2804) in assay buffer, the plate was shaken for 5 min at 1500 rpm. The plate was then transferred into a microtiter plate reader, and the fluorescence was measured every 60 s for 180 times at an excitation wavelength of 475 nm and an emission wavelength of 535 nm. The slope was then calculated from the linear range of the kinetic. The assay buffer used was 40 mM phosphate buffer at pH 7.6 containing 2.88 mM MgCl<sub>2</sub>, 0.9 mM DTT, and 0.25 mM CaCl<sub>2</sub>.</div><div class="NLM_p last">The patented COMT enzyme inhibition assay is a very sensitive homogeneous assay, suitable for screening large numbers of compounds for their COMT modulating activity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It provides a robust readout, with IC<sub>50</sub> values determined by the average of two to four independent repeat measurements. The average coefficient of variation (%CV) of the IC<sub>50</sub> values is 15%.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Enzyme Cloning, Expression, and Purification</h3><div class="NLM_p">The synthetically made gene for human, soluble COMT encoding the sequence from M51 to P271 (UniProt code <a href="https://P21964" class="ext-link">P21964</a>) was purchased from GenScript Corp. (NJ, USA) and subcloned in pET32a. The recombinant protein was expressed in BL21 (DE3) cells. The cDNA encoding for rat COMT was PCR cloned into the <i>E. coli</i> expression vector pDS56/RBSII. The construct was encoded for the soluble part of rat COMT from M44 to S264 (UniProt code <a href="https://22734" class="ext-link">22734</a>). Recombinant rCOMT was produced in <i>E. coli</i> W3110[pREP4]. In our numbering, M51 for human and M44 for rat of the soluble COMT enzymes, was set as first amino acids in the alignment of the sequences. Cell lysis was made in 50 mM Tris/HCL, pH 7.6, containing 10 mM 2-mercaptoethanol, inhibitor cOmplete (Roche Applied Science), lysozyme, DNase, and RNase. After one passage through the cell disruptor at 700 bar the solution was centrifuged (20 min, 30 000<i>g</i>, 4 °C). The supernatant was collected and ammonium sulfate added to 55% saturation. The protein pellet obtained after centrifugation at 30 000<i>g</i> was dissolved in 20 mM Bis-Tris/HCl, pH 6.2, containing 10 mM DTT and 1 mM MgCl<sub>2</sub>, dialyzed against the same buffer, and then again centrifuged. The clear supernatant was applied on a Superdex S-75 column (100 cm × 2.6 cm). Enzyme containing fractions were pooled and further purified on a HiTrap Q FF (5 mL) column in the same Bis-Tris buffer. The protein was eluted in the course of a linear NaCl gradient. Finally, the protein was again applied on a Superdex S-75 column (60 cm × 1.6 cm) in 50 mM Tris/HCl, pH 7.5, 50 mM NaCl, 10 mM DTT, 2 mM MgCl<sub>2</sub>. As shown by SDS–PAGE and HPLC, >98% pure protein was obtained. The purified protein was monomeric as detected by analytical ultracentrifugation and active in a specific enzyme assay.</div><div class="NLM_p last">Protein engineering by site directed mutagenesis, according to the Statagene QuikChange mutagenesis method, was applied to mutate specific amino acids in the active site of the enzyme. In order to block the <i>S</i>-adenosyl-methionine pocket, bulky amino acids like tryptophane, arginine, and lysine were chosen. In fact the mutations E90R, E90W, S119W, H142R, H142 K, H142W were made. Using the same mutagenesis strategy, a “humanized” rat protein was made. Thereby the methionine M91 in the so-called methionine pocket of the wild type rat enzyme was mutated to isoleucin as it is found in the wild type human enzyme. All mutant proteins could be expressed and purified as described above for the wild type enzymes.</div></div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound Synthesis and Characterization. Chemistry. General</h3><div class="NLM_p last">All compounds from <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> are described below. Reactions were carried out under argon atmosphere. Unless otherwise stated, the reactions were stopped when the starting material was fully consumed according to thin layer chromatography (TLC). The solvent was then removed, and the residue was purified by column chromatography. Unless otherwise mentioned, all reagents and chemicals were obtained from commercial suppliers and used without further purification. The purity of final compounds as measured by HPLC was at least above 95%. Column chromatography was carried out either using cartridges packed with silica gel (Isolute columns, Telos flash columns) or on glass columns on silica gel 60 (32–60 mesh, 60 Å) with the eluent mixtures given for the corresponding procedures. LC high resolution spectra were recorded with a Agilent LC system consisting of Agilent 1290 high pressure system, a CTC PAL autosampler, and a Agilent 6520 QTOF. The separation was achieved on a Zorbax Eclipse Plus C18 1.7 μm, 2.1 mm × 50 mm column at 55 °C; A = 0.01% formic acid in water; B = 0.01% formic acid in acetonitrile at flow 1 mL/min, gradient 0 min 5% B, 0.3 min 5% B, 4.5 min 99% B, 5 min 99% B. The NMR spectra were measured on a Bruker 600 MHz machine in a 5 mm TCI cryoprobe at 298 K. TMS was used for referencing. Chemical shifts are reported relative to the solvent in ppm as reference. Coupling constants (<i>J</i>) are given in Hz. The resonance multiplicity is described as s (singlet), d (doublet), t (triplet), q (quadruplet), m (multiplet), and br (broad). <sup>1</sup>H NMR is reported for the major tautomer.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 1-(2,4-Dimethylthiazol-5-yl)-3-phenylpropane-1,3-dione (<b>10</b>, Intermediate <b>26a</b>)</h3><div class="NLM_p last">Sodium hydride (60%, 186 mg, 7.73 mmol) was suspended in THF (20 mL). At 0 °C a solution of 1-(2,4-dimethylthiazol-5-yl)ethanone <b>25</b> (CAS 38205-60-6, 600 mg, 3.87 mmol) in THF (4 mL) was added dropwise. The reaction mixture was allowed to warm to room temperature and stirred for 15 min. A solution of ethyl benzoate (1.16 g, 1.11 mL, 7.73 mmol) in THF (4 mL) was added dropwise at 0 °C. After 5 min at 0 °C the mixture was stirred at 100 °C for 2 h and then cooled to 0 °C. A saturated aqueous solution of ammonium chloride (25 mL) was added. Extraction with water/ethyl acetate and chromatography (silica, 0–50% EtOAc in heptane) yielded 602 mg (60% yield) of <b>26a</b> (CAS 1467020-71-8) as a yellow solid. <i>R</i><sub><i>f</i></sub> = 0.46 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 16.53 (s, 1H), 7.91 (dd, <i>J</i> = 8.2, 1.1 Hz, 2H), 7.53–7.57 (m, 1H), 7.47–7.50 (m, 2H), 6.47 (s, 1H), 2.78 (s, 3H), 2.72 (s, 3H) (compound present only as enol-form); LC–HRMS, <i>m</i>/<i>z</i> = 260.0746 [(M + H)<sup>+</sup> calculated for C<sub>14</sub>H<sub>13</sub>NO<sub>2</sub>S = 260.074; Diff = 0.60 mD].</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2,4-Dimethyl-5-(5-phenyl-1<i>H</i>-pyrazol-3-yl)thiazole (<b>10</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)-3-phenylpropane-1,3-dione (<b>26a</b>) (300 mg, 1.16 mmol) was combined with ethanol (15 mL). Hydrazine monohydrate (99.5 mg, 98 μL, 1.27 mmol) and hydrochloric acid (25%, 75.0 μL) were added. The solution was stirred at 60 °C overnight. For compounds <b>11</b>–<b>17</b> with sterically less demanding linkers, the reaction was typically finished after 2–3 h. The reaction mixture was basified with saturated aqueous sodium bicarbonate and concentrated. Chromatography (silica, 0–5% MeOH in dichloromethane) and trituration with diethyl ether/pentane gave compound <b>10</b> as off-white solid (105 mg, 36% yield). <i>R</i><sub><i>f</i></sub> = 0.43 (dichloromethane/methanol 9:1); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.46 (br s, 1H), 7.82 (br d, <i>J</i> = 6.6 Hz, 2H), 7.47 (br d, <i>J</i> = 6.3 Hz, 2H), 7.38 (br d, <i>J</i> = 6.5 Hz, 1H), 6.94 (s, 1H), 2.60 (br s, 3H), 2.53 (br s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 256.0909 [(M + H)<sup>+</sup> calculated for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>S = 256.0903; Diff = 0.60 mD].</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1-(2,4-Dimethylthiazol-5-yl)-6-phenylhexane-1,3-dione (<b>11</b>, Intermediate <b>26b</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (150 mg, 966 μmol), NaH (60% in mineral oil, 46.4 mg, 1.16 mmol), and ethyl 4-phenylbutanoate (372 mg, 1.93 mmol) were used to synthesize <b>26b</b> following the procedure described for the preparation of <b>26a</b>. Compound <b>26b</b> (40.0 mg, 13% yield) was obtained as a yellow oil. <i>R</i><sub><i>f</i></sub> = 0.54 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 15.95 (s, 1H), 7.31–7.27 (m, 2H), 7.23–7.15 (m, 1H), 7.21–7.17 (m, 2H), 5.77 (s, 1H), 2.70 (s, 3H), 2.69 (s, 3 H), 2.71–2.68 (m, 2H), 2.37 (t, <i>J</i> = 7.6 Hz, 2H), 2.00 (quin, <i>J</i> = 7.6 Hz, 2 H) (9:1 tautomeric mixture of enol and diketone); LC–HRMS, <i>m</i>/<i>z</i> = 302.1206 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>NO<sub>2</sub>S = 302.1209; Diff = −0.30 mD].</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2,4-Dimethyl-5-[5-(3-phenylpropyl)-1<i>H</i>-pyrazol-3-yl]thiazole (<b>11</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)-6-phenylhexane-1,3-dione <b>26b</b> (170 mg, 564 μmol), hydrazine monohydrate (48.5 mg, 47 μL, 620 μmol), and hydrochloric acid (25%, 10 μL) were used to synthesize <b>11</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>11</b> (115 mg, 68% yield) was obtained as an off-white solid. <i>R</i><sub><i>f</i></sub> = 0.21 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 11.46–7.9 (br s, 1H), 7.32–7.28 (m, 2H), 7.23–7.19 (m, 1H), 7.20–7.17 (m, 2H), 6.23 (s, 1H), 2.73–2.69 (m, 2H), 2.72–2.68 (m, 2H), 2.67 (s, 3H), 2.55 (s, 3H), 2.03 (quin, <i>J</i> = 7.6 Hz, 2H); LC–HRMS, <i>m</i>/<i>z</i> = 298.138 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>S = 298.1373; Diff = 0.70 mD].</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1-(2,4-Dimethylthiazol-5-yl)-5-phenylpentane-1,3-dione (<b>12</b>, Intermediate <b>26c</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (100 mg, 0.644 mmol), NaH (60% in mineral oil, 31 mg, 0.77 mmol), and ethyl 3-phenylpropanoate (230 mg, 0.774 mmol) were used to synthesize <b>26c</b> following a similar procedure as described for the preparation of <b>26a</b>. In this case 1-(2,4-dimethylthiazol-5-yl)ethanone and NaH were stirred at 0 °C for 30 min in THF (0.5 mL) before adding the ester. After chromatography (silica gel, 0–20% EtOAc/heptane), compound <b>26c</b> (185 mg, 57% yield) was obtained as a light yellow oil. <i>R</i><sub><i>f</i></sub> = 0.39 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 15.93 (br s, 1H), 7.32–7.28 (m, 2H), 7.27–7.17 (m, 3H), 5.73 (s, 1H), 3.01–2.97 (m, 2H), 2.68 (s, 3H), 2.66 (s, 3H), 2.69–2.65 (m, 2H); LC–HRMS, <i>m</i>/<i>z</i> = 288.1066 [(M + H)<sup>+</sup> calculated for C<sub>16</sub>H<sub>17</sub>NO<sub>2</sub>S = 288.1058; Diff = 1.30 mD].</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,4-Dimethyl-5-(5-phenethyl-2<i>H</i>-pyrazol-3-yl)thiazole (<b>12</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)-5-phenylpentane-1,3-dione <b>26c</b> (40 mg, 0.14 mmol), hydrazine monohydrate (7.7 mg, 7.6 μL, 0.150 mmol), and hydrochloric acid (25%, 10 μL) were used to synthesize <b>12</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>12</b> (36 mg, 91% yield) was obtained as a light brown solid. <i>R</i><sub><i>f</i></sub> = 0.13 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 7.34–7.28 (m, 2H), 7.25–7.22 (m, 1H), 7.21–7.17 (m, 2H), 6.20 (s, 1H), 3.07–2.90 (m, 4H), 2.66 (s, 3H), 2.53 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 284.1233 [(M + H)<sup>+</sup> calculated for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>S = 284.1216; Diff = 1.70 mD].</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-(2,4-Dimethylthiazol-5-yl)-4-phenylbutane-1,3-dione (<b>13</b>, Intermediate <b>26d</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (50 mg, 0.32 mmol), NaH (60% in mineral oil, 26 mg, 0.64 mmol), and ethyl 2-phenylacetate (10.6 mg, 0.64 mmol) were used to synthesize <b>26d</b> following the procedure described for the preparation of <b>26c</b>. Compound <b>26d</b> (49 mg, 56% yield) was obtained as a white powder. <i>R</i><sub><i>f</i></sub> = 0.49 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 7.36–7.34 (m, 2H), 7.31–7.27 (m, 3H), 5.72 (s, 1H), 3.66 (s, 2H), 2.67 (s, 3H), 2.61 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 274.0893 [(M + H)<sup>+</sup> calculated for C<sub>15</sub>H<sub>15</sub>NO<sub>2</sub>S = 274.0896; Diff = −0.30 mD].</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2,4-Dimethyl-5-(5-benzyl-2<i>H</i>-pyrazol-3-yl)thiazole (<b>13</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)-4-phenylbutane-1,3-dione <b>26d</b> (100 mg, 0.37 mmol), hydrazine monohydrate (20 mg, 20 μL, 407 μmol), and hydrochloric acid (25%, 10 μL) were used to synthesize <b>13</b> following the procedure described for the preparation of <b>10</b>. The crude product was purified by trituration with diethyl ether to afford <b>13</b> as an off white solid (50 mg, 51% yield). <i>R</i><sub><i>f</i></sub> = 0.19 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 7.36–7.32 (m, 2H), 7.28 (d, <i>J</i> = 7.3 Hz, 1H), 7.26–7.23 (m, 2H), 6.25 (s, 1H), 4.05 (s, 2H), 2.66 (s, 3H), 2.53 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 270.1070 [(M + H)<sup>+</sup> calculated for C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>S = 270.1060; Diff = 1.00 mD].</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(2,4-Dimethylthiazol-5-yl)pentane-1,3-dione (<b>14</b>, Intermediate <b>26e</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (100 mg, 0.32 mmol), NaH (60% in mineral oil, 52 mg, 1.3 mmol), and ethyl proprionate (132 mg, 1.29 mmol) were used to synthesize <b>26e</b> following the procedure described for the preparation of <b>26c</b>. Compound <b>26e</b> (80 mg, 59% yield) was obtained as a light yellow oil. <i>R</i><sub><i>f</i></sub> = 0.51 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 5.79 (s, 1H), 2.70 (s, 3H), 2.69 (s, 3H), 2.39 (q, <i>J</i> = 7.6 Hz, 2H), 1.19 (t, <i>J</i> = 7.6 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 212.0745 [(M + H)<sup>+</sup> calculated for C<sub>10</sub>H<sub>13</sub>NO<sub>2</sub>S = 212.074; Diff = 0.50 mD].</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2,4-Dimethyl-5-(5-ethyl-2<i>H</i>-pyrazol-3-yl)thiazole (<b>14</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)pentane-1,3-dione <b>26e</b> (30 mg, 0.38 mmol), hydrazine monohydrate (21 mg, 21 μL, 408 μmol), and hydrochloric acid (25%, 10 μL) were used to synthesize <b>14</b> following the procedure described for the preparation of <b>10</b>. The crude product was purified by trituration with diethyl ether to afford <b>14</b> as an off white solid (27 mg, 92% yield). <i>R</i><sub><i>f</i></sub> = 0.16 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 6.23 (s, 1H), 2.72 (q, <i>J</i> = 7.7 Hz, 2H), 2.67 (s, 3H), 2.56 (s, 3H), 1.32 (t, <i>J</i> = 7.7 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 208.0924 [(M + H)<sup>+</sup> calculated for C<sub>10</sub>H<sub>13</sub>N<sub>3</sub>S = 208.0903; Diff = 2.10 mD].</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-(4-methoxyphenyl)butane-1,3-dione (<b>15</b>, Intermediate <b>26f</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (200 mg, 1.29 mmol), NaH (60% in mineral oil, 103 mg, 2.58 mmol), and ethyl 2-(4-methoxyphenyl)acetate (501 mg, 0.456 mL) were used to synthesize <b>26f</b> following the procedure described for the preparation of <b>26c</b>. Compound <b>26f</b> (202 mg, 52% yield) was obtained as a white solid. <i>R</i><sub><i>f</i></sub> = 0.51 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) (enol tautomer) δ ppm 15.84 (br s, 1H), 7.19 (br d, <i>J</i> = 8.7 Hz, 2H), 6.88 (d, <i>J</i> = 8.7 Hz, 2H), 5.71 (s, 1H), 3.81 (s, 2H), 3.60 (s, 2H), 2.67 (s, 4H), 2.62 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 304.1019 [(M + H)<sup>+</sup> calculated for C<sub>16</sub>H<sub>17</sub>NO<sub>3</sub>S = 304.1002; Diff = 1.70 mD].</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-[5-[(4-Methoxyphenyl)methyl]-1<i>H</i>-pyrazol-3-yl]-2,4-dimethylthiazole (<b>15</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)-4-(4-methoxyphenyl)butane-1,3-dione (200 mg, 659 μmol), <b>26f</b>, hydrazine monohydrate (36.3 mg, 35 μL, 725 μmol), and HCl 25% (26 μL) were used to synthesize <b>15</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>15</b> (159 mg, 81% yield) was obtained as a white solid. <i>R</i><sub><i>f</i></sub> = 0.343 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 7.17–7.16 (m, 2H); 6.88–6.87 (m, 2H), 6.23 (s, 1H), 3.99 (s, 2H), 3.81 (s, 3H), 2.66 (s, 3H), 2.53 (s, 3H); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.39 (br s, 1H, NH imidazole); 7.19 (d, <i>J</i> = 8.66, 2H), 6.87 (d, <i>J</i> = 8.66, 2H), 6.22 (s, 1H), 3.91 (s, 2H), 3.72 (s, 3H), 2.56 (s, 3H), 2.42 (s, 3H). NOESY (600 MHz, DMSO-<i>d</i><sub>6</sub>): Interaction between δ 13.39 (br s, 1H, NH) and 3.91 (s, 2H, CH<sub>2</sub>) indicating the imidazole tautomer is the one indicated. LC–HRMS, <i>m</i>/<i>z</i> = 300.1176 [(M + H)<sup>+</sup> calculated for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>OS = 300.1165; Diff = 1.10 mD].</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-(Biphenyl-4-yl)-1-(2,4-dimethyl-1,3-thiazol-5-yl)butane-1,3-dione (<b>16</b>, Intermediate <b>26g</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone 25,(100 mg, 0.644 mmol, 87 μL), NaH (60% in mineral oil, 51.5 mg, 1.29 mmol), and ethyl biphenyl-4-ylacetate (CAS number 14062-23-8) (310 mg, 1.29 mmol) were used to synthesize <b>26g</b> following the procedure described for the preparation of <b>26c</b>. Compound <b>26g</b> (137 mg, 61% yield) was obtained as a white solid. <i>R</i><sub><i>f</i></sub> = 0.61 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 15.86 (br s, 1H, OH enol), 7.52–7.63 (m, 5H), 7.40–7.49 (m, 2H), 7.36 (br d, <i>J</i> = 8.1 Hz, 2H), 5.78 (s, 1H), 3.70 (s, 2H), 2.67 (s, 3H), 2.63 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 350.121 [(M + H)<sup>+</sup> calculated for C<sub>21</sub>H<sub>19</sub>NO<sub>2</sub>S = 350.1209; Diff = 0.10 mD].</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-[5-(Biphenyl-4-ylmethyl)-1<i>H</i>-pyrazol-3-yl]-2,4-dimethyl-1,3-thiazole (<b>16</b>)</h3><div class="NLM_p last">4-(Biphenyl-4-yl)-1-(2,4-dimethyl-1,3-thiazol-5-yl)butane-1,3-dione <b>26g</b> (116 mg, 332 μmol), hydrazine monohydrate (18.3 mg, 18 μL, 365 μmol) in ethanol (1.3 mL), and HCl 25% (13 μL) were used to synthesize <b>16</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>16</b> (81.4 mg, 71% yield) was obtained as a light yellow solid. <i>R</i><sub><i>f</i></sub> = 0.16 (pentane/EtOAc 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.61–7.55 (m, 4H), 7.46–7.41 (m, 2H), 7.37–7.34 (m, 1H), 7.32 (br d, <i>J</i> = 8.4 Hz, 2H), 6.29 (s, 1H), 4.10 (br s, 2H), 2.67 (s, 3H), 2.55 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 346.1378 [(M + H)<sup>+</sup> calculated for C<sub>21</sub>H<sub>19</sub>N<sub>3</sub>S = 346.1373; Diff = 0.50 mD].</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-(4-Bromophenyl)-1-(2,4-dimethyl-1,3-thiazol-5-yl)butane-1,3-dione (<b>17</b>, Intermediate <b>26h</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (200 mg, 1.29 mmol, 174 μL), sodium hydride (60% in mineral oil, 103 mg, 2.58 mmol), and ethyl (4-bromophenyl)acetate (626 mg, 2.58 mmol) were used to synthesize <b>26h</b> following the procedure described for the preparation of <b>26c</b>. Compound <b>26h</b> was obtained as a light yellow solid (283.8 mg, 63% yield). <i>R</i><sub><i>f</i></sub> = 0.54 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 15.82 (br s, 1H, OH enol), 7.43–7.51 (m, 2H), 7.16 (br d, <i>J</i> = 8.5 Hz, 2H), 5.71 (s, 1H), 3.61 (s, 2H), 2.68 (s, 3H), 2.64 (s, 3H); GC–EI-MS: <i>m</i>/<i>z</i> = 351 (M<sup>•+</sup>; calculated for C<sub>15</sub>H<sub>14</sub>BrNO<sub>2</sub>S <i>m</i>/<i>z</i> = 351)</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-[5-(4-Bromobenzyl)-1<i>H</i>-pyrazol-3-yl]-2,4-dimethyl-1,3-thiazole (<b>17</b>, Intermediate <b>28</b>)</h3><div class="NLM_p last">4-(4-Bromophenyl)-1-(2,4-dimethyl-1,3-thiazol-5-yl)butane-1,3-dione <b>26h</b> (200 mg, 568 μmol), hydrazine monohydrate (31.3 mg, 31 μL, 625 μmol) in ethanol (2.3 mL), and HCl 25% (23 μL) were used to synthesize <b>28</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>28</b> (195.2 mg, 99% yield) was obtained as a light yellow solid. <i>R<sub>f</sub></i> = 0.12 (EtOAc/heptane 1:1), <i>R</i><sub><i>f</i></sub> = 0.385 (EtOAc); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.86 (br s, 1H, NH), 7.51 (d, <i>J</i> = 8.26 Hz, 2H), 7.24 (br d, <i>J</i> = 8.4 Hz, 2H), 6.27 (br s, 1H), 3.97 (s, 2H, CH<sub>2</sub>), 2.56 (s, 3H), 2.43 (s, 3H). NOESY (600 MHz, DMSO-<i>d</i><sub>6</sub>): Interaction between δ 12.86 (br s, 1H, NH), and 3.97 (s, 2H, CH<sub>2</sub>) indicating the imidazole tautomer is the one indicated. LC–HRMS, <i>m</i>/<i>z</i> = 348.0168 [(M + H)<sup>+</sup> calculated for C<sub>15</sub>H<sub>14</sub>BrN<sub>3</sub>S = 348.0165; Diff = 0.30 mD].</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2,4-Dimethyl-5-{5-[4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl]-1<i>H</i>-pyrazol-3-yl}-1,3-thiazole (<b>17</b>)</h3><div class="NLM_p last">5-[5-(4-Bromobenzyl)-1<i>H</i>-pyrazol-3-yl]-2,4-dimethyl-1,3-thiazole <b>28</b> (180 mg, 517 μmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (129 mg, 620 μmol), Cs<sub>2</sub>CO<sub>3</sub> (674 mg, 2.07 mmol), and tetrakis(triphenylphosphine)palladium (0) (59.7 mg, 51.7 μmol) were combined in dioxane (2.2 mL) and water (550 μL). The vial was capped, and the mixture was heated in a microwave oven at 165 °C. After 20 min reaction was poured into a saturated sodium bicarbonate solution (50 mL) and extracted with dichloromethane (3 × 50 mL). The organic layers were dried over MgSO<sub>4</sub> and concentrated. The residue was purified by column chromatography (silica gel, 0–100% EtOAc in heptane) to afford 92.3 mg of <b>17</b> (51% yield) as a light yellow solid. <i>R</i><sub><i>f</i></sub> = 0.17 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.74 (s, 1H), 7.60 (s, 1H), 7.45–7.42 (m, 2H), 7.26–7.22 (m, 2H), 6.26 (s, 1H), 4.05 (s, 2H), 3.95 (s, 3H), 2.66 (s, 3H), 2.54 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 350.1442 [(M + H)<sup>+</sup> calculated for C<sub>19</sub>H<sub>19</sub>N<sub>5</sub>S = 350.1434; Diff = 0.80 mD].</div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-phenylpentan-1-one (<b>18</b>, Intermediate <b>33a</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (500 mg, 3.22 mmol) was dissolved in THF (3 mL). The reaction mixture was cooled down to −78 °C, and lithium bis(trimethylsilyl)amide in THF (3.54 mL, 3.54 mmol) was added. After stirring for 30 min at 0 °C, the reaction was cooled again to −78 °C and 2-phenylpropanal <b>32a</b> (CAS registry number 93-53-8) (562 mg, 561 μL, 4.19 mmol), dissolved in THF (3 mL), was slowly added. The mixture was stirred for 3 h at −78 °C until TLC indicated the reaction was finished. The reaction was stopped by adding 15 mL of H<sub>2</sub>O at −78 °C and extracted with DCM at room temp. The organic layers were dried over MgSO<sub>4</sub> and concentrated. The crude material was purified by column chromatography (silica gel, 0–80% EtOAc in heptane) to afford 571 mg (61% yield) of desired intermediate <b>33a</b> as an oil. <i>R</i><sub><i>f</i></sub> = 0.28 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.31–7.26 (m, 3H), 7.26–7.21 (m, 2H), 7.21–7.16 (m, 1H), 4.07–4.04 (m, 1H), 2.75–2.70 (m, 2H), 2.61 (s, 3H), 2.54 (s, 3H), 1.25 (s, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 290.1224 [(M + H)<sup>+</sup> calculated for C<sub>16</sub>H<sub>19</sub>NO<sub>2</sub>S = 290.1209; Diff = 1.50 mD].</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-phenylpentane-1,3-dione (<b>18</b>, Intermediate <b>34a</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)-3-hydroxy-4-phenylpentan-1-one <b>33a</b> (212 mg, 0.733 mmol) and Dess–Martin periodinane (15% in DCM, 2.07 g, 0.733 mmol) were combined at 0 °C with DCM (8 mL). The reaction mixture was stirred for 5 h at rt, diluted with 25 mL of saturated solution of NaHCO<sub>3</sub>, and extracted with DCM (3 × 30 mL). The organic layers were dried over MgSO<sub>4</sub> and concentrated. The crude material was purified by column chromatography (silica gel, 0–100% EtOAc in heptane) to afford 186.3 mg (88% yield) of <b>34a</b> as a light yellow viscous liquid. <i>R</i><sub><i>f</i></sub> = 0.40 (EtOAc/heptane 1:1); <i>R</i><sub><i>f</i></sub> = 0.59 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 15.83 (br s, 1H), 7.38–7.27 (m, 5H), 5.74 (s, 1H), 3.72 (q, <i>J</i> = 7.2 Hz, 1H), 2.66 (s, 3H), 2.59 (s, 3H), 1.55 (d, <i>J</i> = 7.2 Hz, 3H); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 16.00 (br s, 1H, OH), 7.37–7.34 (m, 3H), 7.31–7.24 (m, 2H), 6.00 (s, 1H), 3.9–3.95 (m, 1H), 2.64 (s, 3H), 2.54 (s, 3H), 1.46 (d, <i>J</i> = 7.2 Hz, 3H); GC–EI-MS <i>m</i>/<i>z</i> = 287.1 (M<sup><b>•</b>+</sup>; calculated for C<sub>16</sub>H<sub>17</sub>NO<sub>2</sub>S <i>m</i>/<i>z</i> = 287.1).</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2,4-Dimethyl-5-[5-(1-phenylethyl)-1<i>H</i>-pyrazol-3-yl]-1,3-thiazole (<b>18</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-phenylpentane-1,3-dione <b>34a</b> (162 mg, 564 μmol), hydrazine monohydrate (31 mg, 31 μL, 620 μmol) in ethanol (2.2 mL), and HCl 25% (23 μL) were used to synthesize <b>18</b> following the procedure described for the preparation of <b>10</b>. Compound <b>18</b> (100.2 mg, 63% yield) was obtained as an off-white solid. <i>R</i><sub><i>f</i></sub> = 0.41 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.38–7.32 (m, 2H), 7.28–7.24 (m, 3H), 6.30 (s, 1H), 4.19 (q, <i>J</i> = 7.2 Hz, 1H), 2.67 (s, 3H), 2.56 (s, 3H), 1.68 (d, <i>J</i> = 7.2 Hz, 3H); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (br s, 1H, NH), 7.33–7.28 (m, 4H), 7.22–7.20 (m, 1H), 6.30 (d, <i>J</i> = 1.9 Hz, 1H), 4.22 (q, <i>J</i> = 7.2 Hz, 1H), 2.56 (s, 3H), 2.45 (s, 3H), 1.60 (d, <i>J</i> = 7.2 Hz, 3H); NOESY (600 MHz, DMSO-<i>d</i><sub>6</sub>); NOE between 12.82 (br s, 1H, NH) and 4.22 (q, <i>J</i> = 7.2 Hz, 1H); LC–HRMS, <i>m</i>/<i>z</i> = 284.1216 [(M + H)<sup>+</sup> calculated for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>S = 284.1216; Diff = 0.00 mD]. The racemic mixture <b>18R/S</b> was separated using a chiral column (Chiralpack AD, 10% EtOH/heptane); the retention time for enantiomer A with [α]<sup>20</sup><sub>D</sub> (<i>c</i> 1 CHCl<sub>3</sub>) = +71.347 (100% ee) was 8.58 min; for enantiomer B with [α]<sup>20</sup><sub>D</sub> (<i>c</i> 1 CHCl<sub>3</sub>) = −69.747 (99% ee), the retention time was 9.7 min. In the enzymatic assay, IC<sub>50</sub>= 1.12 μM for enantiomer A (<b>18S</b>) and IC<sub>50</sub>= 0.70 μM for enantiomer B (<b>18R</b>). The absolute configuration was determined by enantioselective synthesis, preparing enantiomer A using chiral <i>S</i>-(+)-2-phenylpropanal and comparing optical rotations from final compounds ([α]<sup>20</sup><sub>D</sub> (<i>c</i> 1 CHCl<sub>3</sub>) = +73.79 for the prepared chiral <i>S</i> enantiomer) and also by co-injections in chiral HPLC.</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Phenylbutan-1-ol (<b>19</b>, Intermediate <b>31b</b>)</h3><div class="NLM_p last"><b>31b</b> was prepared by reduction of 2-phenylbutanoic acid <b>30b</b> (500 mg, 3.05 mmol) in THF (5.5 mL) using LiAlH<sub>4</sub> 1 M in THF (6.09 mL, 6.09 mmol) and stirring 1 h at 0 °C. Quenching the reaction with a saturated NH<sub>4</sub>Cl aqueous solution and extraction using EtOAc afforded, after concentration of the organic phase, 457 mg of alcohol <b>31b</b> (98% yield) that was used as a crude in the next reaction.</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Phenylbutanal (<b>19</b>, Intermediate <b>32b</b>)</h3><div class="NLM_p last"><b>32b</b> (CAS registry number 2439-43-2) was prepared from 2-phenylbutan-1-ol <b>31b</b> (445 mg, 2.96 mmol) using Dess–Martin periodinane (15% in DCM, 8.3 g, 2.96 mmol) in dichloromethane (15.5 mL) and stirring for 6 h at room temperature. The reaction was poured into 50 mL of saturated NaHCO<sub>3</sub> and extracted with dichloromethane. The organic layers were dried over MgSO<sub>4</sub> and concentrated. The crude material was purified by column chromatography (silica gel, 0–50% EtOAc in heptane) to afford 202 mg (50% yield) of the desired aldehyde <b>32b</b>. <i>R</i><sub><i>f</i></sub> = 0.53 (EtOAc/heptane 1:2); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.7 (s, 1H), 7.4–7.2 (m, 5H), 3.44–3.38 (m, 1H), 2.19–2.05 (dt, <i>J</i> = 14.3, 7.0 Hz, 1H), 1.84–1.69 (dt, <i>J</i> = 14.0, 7.1 Hz, 1H), 0.91 (br t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-phenylhexan-1-one (<b>19</b>, Intermediate <b>33b</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (153 mg, 133 μL, 986 μmol), lithium bis(trimethylsilyl)amide in THF (1.08 mL, 1.08 mmol), and 2-phenylbutanal (190 mg, 1.28 mmol) <b>32b</b> were used to synthesize <b>33b</b> following the procedure described for the preparation of <b>33a</b>. Compound <b>33b</b> (239 mg, 60% yield) was obtained as an oil. <i>R</i><sub><i>f</i></sub> = 0.24 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.32–7.29 (m, 2H), 7.24–7.14 (m, 3H), 4.32–4.2 (m, 1H), 3.34 (d, <i>J</i> = 4.1 Hz, 1H), 2.67 (m, 2H), 2.64 (s, 3H), 2,57 (s, 3H), 2.57–2.64 (m, 1H), 2.22–2.20 (m, 1H), 1.63–1.61 (m, 1H), 0.76 (t, <i>J</i> = 7.4 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 304.1378 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>21</sub>NO<sub>2</sub>S = 304.1366; Diff = 1.20 mD].</div></div><div id="sec5_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-phenylhexane-1,3-dione (<b>19</b>, Intermediate <b>34b</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-phenylhexan-1-one <b>33b</b> (100 mg, 0.330 mmol) and Dess–Martin periodinane (15% weight in DCM) (1.03 g, 0.363 mmol) were used to synthesize <b>34b</b> following the procedure described for the preparation of <b>34a</b>. Compound <b>34b</b> (76 mg, 76% yield) was obtained as a viscous liquid. <i>R</i><sub><i>f</i></sub> = 0.53 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) (major tautomer) δ 15.98 (s, 1H), 7.35–7.30 (m, 5H), 5.79 (s, 1H), 3.40 (t, <i>J</i> = 7.7 Hz, 1H), 2.67 (s, 3H), 2.62 (s, 3H), 2.17–2.13 (m, 1H), 1.87–1.89 (m, 1H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 302.1223 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>NO<sub>2</sub>S = 302.1209; Diff = 1.40 mD].</div></div><div id="sec5_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(2,4-Dimethyl-5-[5-(1-phenylpropyl)-1<i>H</i>-pyrazol-3-yl]-1,3-thiazole (<b>19</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-phenylhexane-1,3-dione <b>34b</b> (33 mg, 109 μmol), hydrazine monohydrate (6 mg, 36 μL, 120 μmol), and HCl 25% (5 μL) were used to synthesize <b>19</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>19</b> (28.3 mg, 87% yield) was obtained as an off-white solid. <i>R</i><sub><i>f</i></sub> = 0.39 (EtOAc); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (br s, 1H), 7.31 (m, 4H), 7.22–7.19 (m, 1H), 6.35 (s, 1H), 3.91 (br t, <i>J</i> = 7.51 Hz, 1H), 2.56 (s, 3H), 2.45 (s, 3H), 2.12–2.05 (m, 1H), 1.99–1.93 (m, 1H), 0.83 (t, <i>J</i> = 7.30 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 298.1385 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>S = 298.1383; Diff = 0.20 mD]. The racemic mixture <b>19R/S</b> was separated using a chiral column (Chiralpak AD, 15% EtOH/heptane). The retention time for enantiomer A (<b>19S</b>) was 8.22 min with [α]<sup>20</sup><sub>D</sub> (<i>c</i> 0.99 CHCl<sub>3</sub>) = +74.69 (100% ee); for enantiomer B (<b>19R</b> enantiomer) with [α]<sup>20</sup><sub>D</sub> (<i>c</i> 1 CHCl<sub>3</sub>) = −69.6 (96% ee), the retention time was 9.07 min. On the enzymatic assay, IC<sub>50</sub>= 28 μM for the <b>19S</b> enantiomer and IC<sub>50</sub> = 16 μM for the <b>19R</b> enantiomer. The absolute configuration was determined by enantioselective synthesis using <i>S</i>-(+)-2-phenylbutanal.</div></div><div id="sec5_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Methyl-2-phenylpropanal (<b>20</b>, Intermediate <b>32c</b>)</h3><div class="NLM_p last">2-Methyl-2-phenylpropan-ol <b>31c</b> (300 mg, 1.99 mmol) and Dess–Martin periodinane (15% in DCM) (5.62 g, 1.99 mmol) were used to synthesize <b>32c</b> following the procedure described for the preparation of <b>32b</b>. Compound <b>32c</b> (296 mg, 45% yield) was obtained as a light yellow oil. NMR was the same as described in literature (CAS registry number 3805-10-5).</div></div><div id="sec5_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-methyl-4-phenylpentan-1-one (<b>20</b>, Intermediate <b>33c</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (91.8 mg, 79.8 μL, 592 μmol), lithium bis(trimethylsilyl)amide in THF (0.651 mL, 651 μmol), and 2-methyl-2-phenylpropanal <b>32c</b> (114 mg, 769 μmol) were used to synthesize <b>33c</b> following the procedure described for the preparation of <b>33a</b>. Compound <b>33c</b> (103 mg, 57% yield) was obtained as a colorless oil. <i>R</i><sub><i>f</i></sub> = 0.25 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.42–7.39 (br d, <i>J</i> = 7.9 Hz, 2H), 7.34 (br t, <i>J</i> = 7.9 Hz, 2H), 7.24–7.20 (m, 1H), 4.31–4.33 (br dd, <i>J</i> = 5.8, 3 Hz, 1H), 2.87 (d, <i>J</i> = 3.3 Hz, 1H), 2.64–2.65 (m, 1H) inside 2.65 (s, 3H), 2,60 (s, 3H), 1.42 (s, 3H), 1.39 (s, 3H) ; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.39–7.38 (br d, <i>J</i> = 7.6 Hz, 2H), 7.32–7–29 (br t, <i>J</i> = 7.6 Hz, 2H), 7.20–7.17 (m, 1H), 5.03 (d, <i>J</i> = 5.8 Hz, 1 H, O<u class="uu">H</u>), 4.08–4.03 (m, 1H), 2.63–2.59 (m, 1H) inside 2.60 (s, 3H), 2,50 (s, 3H), 2.36–2.39 (dd, <i>J</i> = 15,2, 2.1 Hz 1H), 1.27 (s, 6H); LC–HRMS, <i>m</i>/<i>z</i> = 304.1369 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>21</sub>NO<sub>2</sub>S = 304.1366; Diff = 0.30 mD].</div></div><div id="sec5_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-methyl-4-phenylpentane-1,3-dione (<b>20</b>, Intermediate <b>34c</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-methyl-4-phenylpentan-1-one <b>33c</b> (84 mg, 0.277 mmol) and Dess–Martin periodinane (15% in DCM) (861 mg, 0.305 mmol) were used to synthesize <b>34c</b> following the procedure described for the preparation of <b>34a</b>. Compound <b>34c</b> (65 mg, 78% yield) was obtained as a viscous liquid. <i>R</i><sub><i>f</i></sub> = 0.44 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) (major tautomer) δ 15.93 (s, 1H, OH), 7.36–7.26 (m, 5H), 5.65 (s, 1H), 2.65 (s, 3H), 2.52 (s, 3H), 1.59 (s, 6H); LC–HRMS, <i>m</i>/<i>z</i> = 302.1198 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>NO<sub>2</sub>S = 302.1209; Diff = −1.10 mD].</div></div><div id="sec5_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2,4-Dimethyl-5-[5-(2-phenylpropan-2-yl)-1<i>H</i>-pyrazol-3-yl]-1,3-thiazole (<b>20</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-methyl-4-phenylpentane-1,3-dione <b>34c</b> (62 mg, 205 μmol), hydrazine hydrate (13 mg, 266 μmol), and HCl 25% (5 μL) were used to synthesize <b>20</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>20</b> (56 mg, 92% yield) was obtained as an off white solid. <i>R</i><sub><i>f</i></sub> = 0.35 (EtOAc); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.33–7.29 (m, 4H), 7.22–7.19 (m, 1H), 6.32 (s, 1H), 2.67 (s, 3H), 2.57 (s, 3H), 1.74 (s, 6H); LC–HRMS, <i>m</i>/<i>z</i> = 298.1385 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>S = 298.1373; Diff = 1.00 mD].</div></div><div id="sec5_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-3-(1-phenylcyclopropyl)propan-1-one (<b>21</b>, Intermediate <b>33d</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (100 mg, 87 μL, 644 μmol), lithium bis(trimethylsilyl)amide in THF (0.709 mL, 709 μmol), and 1-phenylcyclopropanecarbaldehyde (188 mg, 1.29 mmol) <b>32d</b> (CAS registry number 21744-88-7) were used to synthesize <b>33d</b> following the procedure described for the preparation of <b>33a</b>. Compound <b>33d</b> (130 mg, 67% yield) was obtained as a colorless oil. <i>R</i><sub><i>f</i></sub> = 0.54 (EtOAc), 0.31 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.40–7.38 (br d, <i>J</i> = 8.2 Hz, 2H), 7.30–7.33 (br t, <i>J</i> = 7.66 Hz, 2H), 7.29–7.25 (m, 1H), 3.87 (dd, <i>J</i> =  9.6, 2.2 Hz, 1H), 3.01–3.09 (br s, 1H), 2.99 (dd, <i>J</i> = 17, 2.4 Hz, 1H), 2.74 (dd, <i>J</i> = 16.9, 9.6 Hz, 1H), 2.66 (s, 3H), 2.62 (s, 3H), 0.91–0.82 (m, 4H); LC–HRMS, <i>m</i>/<i>z</i> = 302.1218 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>NO<sub>2</sub>S = 302.1209; Diff = 0.90 mD].</div></div><div id="sec5_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-(1-phenylcyclopropyl)propane-1,3-dione (<b>21</b>, Intermediate <b>34d</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-3-(1-phenylcyclopropyl)propan-1-one <b>33d</b> (81 mg, 0.269 mmol) and Dess–Martin periodinane (15% in DCM) (760 mg, 0.269 mmol) were used to synthesize <b>34d</b> following the procedure described for the preparation of <b>34a</b>. Compound <b>34d</b> (81 mg, 70.5% yield) was obtained as a viscous liquid. <i>R</i><sub><i>f</i></sub> = 0.54 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) (major tautomer in enol form) δ 16.38 (br s, 1H), 7.40–7.34 (m, 5H), 5.44 (s, 1H), 2.61 (s, 3H), 2.37 (s, 3H), 1.78 (q, <i>J</i> = 3.7 Hz, 2H), 1.31 (q, <i>J</i> = 3.7 Hz, 2H); LC–HRMS, <i>m</i>/<i>z</i> = 300.1054 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>17</sub>NO<sub>2</sub>S = 300.1053; Diff = 0.10 mD].</div></div><div id="sec5_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2,4-Dimethyl-5-[5-(1-phenylcyclopropyl)-1<i>H</i>-pyrazol-3-yl]-1,3-thiazole (<b>21</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-(1-phenylcyclopropyl)propane-1,3-dione <b>34d</b> (61.3 mg, 205 μmol), hydrazine hydrate (13 mg, 266 μmol), and HCl 25% (5 μL) were used to synthesize <b>21</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>21</b> (50 mg, 83% yield) was obtained as an off white solid. <i>R</i><sub><i>f</i></sub> = 0.33 (EtOAc); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.85 (s, 1H), 7.32–7.20 (m, 5H), 6.21 (s, 1H), 2.56 (s, 3H), 2.42 (s, 3H), 1.36–1.28 (m, 4H); LC–HRMS, <i>m</i>/<i>z</i> = 296.1226 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>S = 296.1216; Diff = 1.00 mD].</div></div><div id="sec5_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>rac</i>)-1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-(4-methoxyphenyl)pentan-1-one (<b>22</b> and <b>23</b>, Intermediate <b>33e</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone (100 mg, 644 μmol), lithium bis(trimethylsilyl)amide, and 2-(4-methoxyphenyl)propanal <b>32e</b> (CAS registry number 5405-83-4) (111 mg, 676 μmol) were used to synthesize <b>33e</b> following the procedure described for the preparation of <b>33a</b>. Compound <b>33e</b> (146 mg, 71% yield) was obtained as a liquid. <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/heptane 1:1). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.12 (br d, <i>J</i> = 9 Hz, 2H), 6.85 (br d, <i>J</i> = 8.8 Hz, 2H), 4.17 (dt, <i>J</i> = 8.4, 2.7 Hz, 1H), 3.79 (s, 3H), 3.19 (br s, 1H), 2.79–2.71 (m, 3H), 2.65 (s, 3H), 2.61 (s, 3H), 1.38 (d, <i>J</i> = 7 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 320.1317 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>21</sub>NO<sub>3</sub>S = 320.1315; Diff = 0.20 mD].</div></div><div id="sec5_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>rac</i>)-1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-(4-methoxyphenyl)pentane-1,3-dione (<b>22</b> and <b>23</b>, Intermediate <b>34e</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-4-(4-methoxyphenyl)pentan-1-one <b>33e</b> (140 mg, 0.438 mmol) and Dess–Martin periodinane (15% in DCM) (1.28 g, 0.460 mmol) were used to synthesize <b>34e</b> following the procedure described for the preparation of <b>34a</b>. Compound <b>34e</b> (85 mg, 61% yield) was obtained as a light yellow viscous liquid. <i>R</i><sub><i>f</i></sub> = 0.36 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) (major tautomer in enol form) δ 15.9 (br s, 1H, OH), 7.22 (br d, <i>J</i> = 9 Hz, 2H), 6.88 (br d, <i>J</i> = 8.8 Hz, 2H), 5.73 (s, 1H), 3.8 (s, 3H), 3.67 (q, <i>J</i> = 7.2, 1H), 2.66 (s, 3H), 2.61 (s, 3H), 1.52 (d, <i>J</i> = 7.2 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 318.1159 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>NO<sub>3</sub>S = 318.1159; Diff = 0.00 mD].</div></div><div id="sec5_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>rac</i>)-5-{5-[1-(4-Methoxyphenyl)ethyl]-1<i>H</i>-pyrazol-3-yl}-2,4-dimethyl-1,3-thiazole (<b>22+23</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-(4-methoxyphenyl)pentane-1,3-dione <b>34e</b> (79 mg, 249 μmol), hydrazine monohydrate (13.7 mg, 13.3 μL, 274 μmol), and HCl 25% (10 μL) were used to synthesize the racemic mixture of <b>22</b> and <b>23</b> following the procedure described for the preparation of <b>10</b>. After chromatography, the racemic compound <b>22+23</b> (78 mg, 74% yield) was obtained as an off-white solid. <i>R</i><sub><i>f</i></sub> = 0.1 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.16–7.14 (br d, <i>J</i> = 8.4 Hz, 2H), 6.89–6.87 (br d, <i>J</i> = 8.4 Hz, 2H), 6.28 (s, 1H), 4.14 (q, <i>J</i> = 7.2 Hz, 1H), 3.8 (s, 3H), 2.66 (s, 3H), 2.55 (s, 3H), 1.66 (d, <i>J</i> = 7.2 Hz, 3H); LC–HRMS, <i>m</i>/<i>z</i> = 314.134 [(M + H)<sup>+</sup> calculated for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>OS = 314.1322; Diff = 1.80 mD].</div></div><div id="sec5_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-{5-[(1<i>S</i>)-1-(4-Methoxyphenyl)ethyl]-1<i>H</i>-pyrazol-3-yl}-2,4-dimethyl-1,3-thiazole (<b>22</b>) and 5-{5-[(1<i>R</i>)-1-(4-Methoxyphenyl)ethyl]-1<i>H</i>-pyrazol-3-yl}-2,4-dimethyl-1,3-thiazole (<b>23</b>)</h3><div class="NLM_p last">The racemic compound (<b>22+23</b>) was separated using a chiral column (Reprosil Chiral NR, 10% EtOH in heptane). The retention time for enantiomer A (compound <b>23</b> on <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) was 14.37 min with IC<sub>50</sub> = 0.47 μM and assigned as 5-{5-[(1<i>R</i>)-1-(4-methoxyphenyl)ethyl]-1<i>H</i>-pyrazol-3-yl}-2,4-dimethyl-1,3-thiazole) with [α]<sup>20</sup><sub>D</sub> (<i>c</i> 1 CHCl<sub>3</sub>) = −66.7 (100% ee). The retention time for enantiomer B (compound <b>22</b> on <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) was 15.65 min with IC<sub>50</sub> = 0.86 μM and assigned as 5-{5-[(1<i>S</i>)-1-(4-methoxyphenyl)ethyl]-1<i>H</i>-pyrazol-3-yl}-2,4-dimethyl-1,3-thiazole) with [α]<sup>20</sup><sub>D</sub> (<i>c</i> 1 CHCl<sub>3</sub>) = +60.41 (93% ee). The absolute configuration of the enantiomers was assigned via X-ray crystallography and by enantioselective synthesis using chiral aldehyde.</div></div><div id="sec5_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-(4-Methoxyphenyl)cyclopropanecarbaldehyde (<b>24</b>, Intermediate <b>32f</b>)</h3><div class="NLM_p last">(1-(4-Methoxyphenyl)cyclopropyl)methanol <b>31f</b> (500 mg, 2.80 mmol) and Dess–Martin periodinane (15% in DCM) (1.25g, 2.04 mmol) were used to synthesize <b>32f</b> following the procedure described for the preparation of <b>32b</b>. Compound <b>32f</b> (494 mg, 83% yield) was obtained as a light yellow oil. NMR was the same as described in literature (CAS registry number 34603-55-9).</div></div><div id="sec5_3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-3-[1-(4-methoxyphenyl)cyclopropyl]propan-1-one (<b>24</b>, Intermediate <b>33f</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone <b>25</b> (150 mg, 966 μmol), lithium bis(trimethylsilyl)amide in THF (1.06 mL, 1.06 mmol), and 1-(4-methoxyphenyl)cyclopropanecarbaldehyde <b>32f</b> were used to synthesize <b>33f</b> following the procedure described for the preparation of <b>33a</b>. Compound <b>33f</b> (319 mg, 99% yield) was obtained as a yellowish oil. <i>R</i><sub><i>f</i></sub> = 0.19 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.32 (m, 2H), 6.85 (d, <i>J</i> =  8.8 Hz, 2H), 3.82–3.77 (m, 4H), 3.01–2.96 (m, 1H), 2.97 (br s, 1H), 2.73 (dd, 16.9, 9.6 Hz, 1H), 2.67 (s, 3H), 2.63 (s, 3H), 1.00–0.96 (m, 1H), 0.86–0.82 (m, 2H), 0.82–0.79 (m, 1H); LC–HRMS, <i>m</i>/<i>z</i> = 332.131 [(M + H)<sup>+</sup> calculated for C<sub>18</sub>H<sub>21</sub>NO<sub>3</sub>S = 332.1313; Diff = −0.30 mD].</div></div><div id="sec5_3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]propane-1,3-dione (<b>24</b>, Intermediate <b>34f</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-hydroxy-3-[1-(4-methoxyphenyl)cyclopropyl]propan-1-one <b>33f</b> (150 mg, 0.45 mmol) and Dess–Martin periodinane (15% weight in DCM) (1.27 g, 0.45 mmol) were used to synthesize <b>34f</b> following the procedure described for the preparation of <b>34a</b>. Compound <b>34f</b> (91 mg, 61% yield) was obtained as an oil. <i>R</i><sub><i>f</i></sub> = 0.38 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 16.43 (br s, 1H, OH), 7.31 (br d, <i>J</i> =  9 Hz, 2H), 6.90 (br d, <i>J</i> =  8.8 Hz, 2H), 5.48 (s, 1H), 3.84 (s, 3H), 2.62 (s, 3H), 2.42 (s, 3H), 1.76–1.74 (m, 2H), 1.27–1.25 (m, 2H); LC–HRMS, <i>m</i>/<i>z</i> = 330.1161 [(M + H)<sup>+</sup> calculated for C<sub>18</sub>H<sub>19</sub>NO<sub>3</sub>S = 330.1159; Diff = 0.20 mD].</div></div><div id="sec5_3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-{5-[1-(4-Methoxyphenyl)cyclopropyl]-1<i>H</i>-pyrazol-3-yl}-2,4-dimethyl-1,3-thiazole (<b>24</b>)</h3><div class="NLM_p last">1-(2,4-Dimethyl-1,3-thiazol-5-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]propane-1,3-dione (90 mg, 273 μmol) <b>34f</b>, hydrazine monohydrate (15 mg, 15 μL, 301 μmol), and HCl 25% (10 μL) were used to synthesize <b>24</b> following the procedure described for the preparation of <b>10</b>. After chromatography, compound <b>24</b> (45 mg, 51% yield) was obtained as an off-white solid. <i>R</i><sub><i>f</i></sub> = 0.15 (EtOAc/heptane 1:1); <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.33 (d, <i>J</i> =  8.5 Hz, 2H), 6.83 (d, <i>J</i> =  8.5 Hz, 2H), 6.03 (s, 1H), 3.82 (s, 3H), 2.65 (s, 3H), 2.53 (s, 3H), 1.35–1.32 (m, 4H); LC–HRMS, <i>m</i>/<i>z</i> = 326.1334 [(M + H)<sup>+</sup> calculated for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>OS = 326.1322; Diff = 1.20 mD].</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00927">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00927" class="ext-link">10.1021/acs.jmedchem.6b00927</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for noncommercial available compounds in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, pyrazolo-pyrazole analogs, and 4-ethyl analogs, crystallization conditions, X-ray data collection, and experimental details on methods used for fragment screening (SPR, 1D/2D NMR) (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf">jm6b00927_si_001.pdf (1.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_002.csv">jm6b00927_si_002.csv (1.39 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k01">5k01</a> (compound <b>2′</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k03">5k03</a> (compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k05">5k05</a> (compound <b>8</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k09">5k09</a> (compound <b>15</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0b">5k0b</a> (compound <b>18</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0c">5k0c</a> (compound <b>20</b> in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0e">5k0e</a> (alternative X-ray of compound <b>20</b>, not shown), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0f">5k0f</a> (<b>22 + 23</b>, cocrystallized as racemate), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0l">5k0l</a> (compound <b>24</b> in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0j">5k0j</a> (alternative X-ray of compound <b>24</b>, not shown), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0n">5k0n</a> (<b>24′</b>, pyrazolo-pyrazole analog of <b>24</b> in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf" class="ext-link">Supporting Information</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00927" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosa María Rodríguez Sarmiento</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research and
Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#20524f53417f4d415249410e524f4452494755455a7f5341524d49454e544f60524f4348450e434f4d"><span class="__cf_email__" data-cfemail="e2908d9183bd8f83908b83cc908d86908b85978798bd9183908f8b878c968da2908d818a87cc818d8f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Lerner</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research and
Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Jakob-Roetne</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research and
Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernd Buettelmann</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research and
Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Ehler</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research and
Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Rudolph</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Research and
Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are employees of F. Hoffmann-La Roche AG.<br /></br></div></li></ul></div><div class="ack" id="ACK-d234e4250-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Walter Huber for Biacore assessment, Alfred Ross for NMR experiments, Caterina Bissantz for feedback on the manuscript, and Bernd Kuhn for contribution with X-ray pictures. Also thanks go to Stefan Berchtold, Samantha Brenckle, Markus Bender, and Nadine Nock for the synthesis of the compounds described, Daniel Schlatter for providing hCOMT for assays, and Doris Roth and Remo Hochstrasser for the in vitro potency assessment. The research described in the manuscript was funded by F. Hoffmann-La Roche AG.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> Abbreviations Used</h2><tr><td class="NLM_term">COMT</td><td class="NLM_def"><p class="first last">catechol <i>O</i>-methyltransferase</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosyl <span class="smallcaps smallerCapital">l</span>-methionine</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">CPMG</td><td class="NLM_def"><p class="first last">Carr–Purcell–Meiboom–Gill</p></td></tr><tr><td class="NLM_term">HSQC-NMR</td><td class="NLM_def"><p class="first last">heteronuclear single quantum coherence</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">DNC</td><td class="NLM_def"><p class="first last">dinitrocatechol</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Apud, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Treatment of Cognitive Deficits Associated with Schizophrenia, Potential Role of Catechol-<i>O</i>-Methyltransferase Inhibitors</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span><span class="refDoi"> DOI: 10.2165/00023210-200721070-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2165%2F00023210-200721070-00002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=535-557&author=J.+A.+Apudauthor=D.+R.+Weinberger&title=Treatment+of+Cognitive+Deficits+Associated+with+Schizophrenia%2C+Potential+Role+of+Catechol-O-Methyltransferase+Inhibitors&doi=10.2165%2F00023210-200721070-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.2165%2F00023210-200721070-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200721070-00002%26sid%3Dliteratum%253Aachs%26aulast%3DApud%26aufirst%3DJ.%2BA.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTreatment%2520of%2520Cognitive%2520Deficits%2520Associated%2520with%2520Schizophrenia%252C%2520Potential%2520Role%2520of%2520Catechol-O-Methyltransferase%2520Inhibitors%26jtitle%3DCNS%2520Drugs%26date%3D2007%26volume%3D21%26spage%3D535%26epage%3D557%26doi%3D10.2165%2F00023210-200721070-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Tuathaigh, C. M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desbonnet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waddington, J. L.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-Methyl Transferase as a Drug Target for Schizophrenia</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.2174/187152712800672418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2174%2F187152712800672418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22483298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFekur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=282-291&author=C.+M.+P.+O%E2%80%99Tuathaighauthor=L.+Desbonnetauthor=P.+Leeauthor=J.+L.+Waddington&title=Catechol-O-Methyl+Transferase+as+a+Drug+Target+for+Schizophrenia&doi=10.2174%2F187152712800672418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyl transferase as a drug target for schizophrenia</span></div><div class="casAuthors">O'Tuathaigh, Colm M. P.; Desbonnet, Lieve; Lee, Peter; Waddington, John L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">282-291</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Current antipsychotic drugs lack material efficacy against the neg. symptoms and cognitive deficits of schizophrenia.  There is considerable uncertainty regarding the optimal pharmacotherapeutic strategy for treating these and other aspects of psychotic illness.  The present review summarises clin., mutant, and psychopharmacol. data related to catechol-O-methyltransferase (COMT), an enzyme involved in the catabolism of catecholamine neurotransmitters, with a view to establishing the antipsychotic potential of compds. targeting the action of this enzyme.  The review examines clin. and preclin. genetic data linking COMT gene variation with risk for schizophrenia or specific symptoms or disease endophenotypes.  We then summarise data concerning the behavioral effects of COMT inhibitors.  These genetic and pharmacol. data relating to COMT as a therapeutic target have implications for the development of individualised treatments for treatment-resistant symptoms of schizophrenia, including cognitive dysfunction and, potentially, neg. symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpUrWoWYdrlrVg90H21EOLACvtfcHk0lhflWhXk4F70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFekur8%253D&md5=7e601317b307aed4862ad322f5b21aef</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2174%2F187152712800672418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152712800672418%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Tuathaigh%26aufirst%3DC.%2BM.%2BP.%26aulast%3DDesbonnet%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DWaddington%26aufirst%3DJ.%2BL.%26atitle%3DCatechol-O-Methyl%2520Transferase%2520as%2520a%2520Drug%2520Target%2520for%2520Schizophrenia%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D11%26spage%3D282%26epage%3D291%26doi%3D10.2174%2F187152712800672418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kiss, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and their Therapeutic Utility</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8692</span><span class="NLM_x">–</span> <span class="NLM_lpage">8717</span><span class="refDoi"> DOI: 10.1021/jm500572b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500572b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8692-8717&author=L.+E.+Kissauthor=P.+Soares-da-Silva&title=Medicinal+Chemistry+of+Catechol+O-Methyltransferase+%28COMT%29+Inhibitors+and+their+Therapeutic+Utility&doi=10.1021%2Fjm500572b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility</span></div><div class="casAuthors">Kiss, Laszlo E.; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8692-8717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Catechol O-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures.  COMT is a druggable biol. target for the treatment of various central and peripheral nervous system disorders, including Parkinson's disease, depression, schizophrenia, and other dopamine deficiency-related diseases.  The purpose of this perspective is fourfold: (i) to summarize the physiol. role of COMT inhibitors in central and peripheral nervous system disorders; (ii) to provide the history and perspective of the medicinal chem. behind the discovery and development of COMT inhibitors; (iii) to discuss how the physicochem. properties of recognized COMT inhibitors are understood to exert influence over their pharmacol. properties; and (iv) to evaluate the clin. benefits of the most relevant COMT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_JOcVUbOM4LVg90H21EOLACvtfcHk0lhoO88-q5RBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git7rI&md5=60ddd0ce0b752ddb1bd8898805a8935b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm500572b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500572b%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DL.%2BE.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Catechol%2520O-Methyltransferase%2520%2528COMT%2529%2520Inhibitors%2520and%2520their%2520Therapeutic%2520Utility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8692%26epage%3D8717%26doi%3D10.1021%2Fjm500572b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jorga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotteler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heizmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, R.</span><span> </span><span class="NLM_article-title">Metabolism and Excretion of Tolcapone, a Novel Inhibitor of Catechol-O-Methyltransferase</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1046/j.1365-2125.1999.00036.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1046%2Fj.1365-2125.1999.00036.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10583021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=513-520&author=K.+Jorgaauthor=B.+Fottelerauthor=P.+Heizmannauthor=R.+Gasser&title=Metabolism+and+Excretion+of+Tolcapone%2C+a+Novel+Inhibitor+of+Catechol-O-Methyltransferase&doi=10.1046%2Fj.1365-2125.1999.00036.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase</span></div><div class="casAuthors">Jorga, Karin; Fotteler, Barbel; Heizmann, Peter; Gasser, Rodolfo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-520</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The rate of excretion and routes of metab. of tolcapone, a novel inhibitor of catechol-O-methyltransferase (COMT) were studied.  Six healthy male volunteers were given 200 mg [14C]-tolcapone (approx. 50 μCi) orally.  To assess excretion balance and to identify metabolites, urine and feces were collected before administration and until radioactivity fell below 75 d min-1 ml-1 (urine) and 100 d min-1 mg-1 (feces).  Blood samples were collected frequently before and after administration to det. plasma radioactivity, to identify tolcapone metabolites and to measure plasma tolcapone and its methylated deriv. 3-O-methyltolcapone (3-OMT).  The mean proportion of the dose excreted in urine was 57.3% and in feces 40.5%.  Excretion was almost complete (more than 95%) in all participants after 9 days.  The major early metabolite present in plasma was the 3-O-β,D-glucuronide conjugate, which was detectable within 2 h after dosing.  The major late metabolite in plasma was 3-OMT.  The 3-O-β,D-glucuronide was also the most abundant metabolite in urine and feces, accounting for 27% and 33%, resp., of the total radioactivity excreted by these routes and for 26% of the original dose.  Redn. of the nitro moiety yields an amine deriv., detected in both urine and feces, with subsequent modifications, such as acetylation of the amine group and conjugation with glucuronic acid or sulfate, or both.  Oxidative reactions due to cytochrome P 450 enzymes are of small significance, as is 3-O-methylation by COMT.  Tolcapone is almost completely metabolized and excreted in urine and feces (only 0.5% of tolcapone was excreted unchanged); glucuronidation is the most important route of metab.  The relatively long duration of excretion is caused by the long half-life of 3-OMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomxbJ3foHx37Vg90H21EOLACvtfcHk0lhoO88-q5RBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D&md5=53200da79657f3560fc6de831654cd86</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.1999.00036.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.1999.00036.x%26sid%3Dliteratum%253Aachs%26aulast%3DJorga%26aufirst%3DK.%26aulast%3DFotteler%26aufirst%3DB.%26aulast%3DHeizmann%26aufirst%3DP.%26aulast%3DGasser%26aufirst%3DR.%26atitle%3DMetabolism%2520and%2520Excretion%2520of%2520Tolcapone%252C%2520a%2520Novel%2520Inhibitor%2520of%2520Catechol-O-Methyltransferase%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1999%26volume%3D48%26spage%3D513%26epage%3D520%26doi%3D10.1046%2Fj.1365-2125.1999.00036.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-Methyltransferase and its Inhibitors in Parkinson’s Disease</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2007.00020.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1111%2Fj.1527-3458.2007.00020.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=17894650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1aksrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=352-379&author=M.+J.+Bonif%C3%A1cioauthor=P.+N.+Palmaauthor=L.+Almeidaauthor=P.+Soares-da-Silva&title=Catechol-O-Methyltransferase+and+its+Inhibitors+in+Parkinson%E2%80%99s+Disease&doi=10.1111%2Fj.1527-3458.2007.00020.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase and its inhibitors in Parkinson's disease</span></div><div class="casAuthors">Bonifacio, Maria Joao; Palma, P. Nuno; Almeida, Luis; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-379</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurol. disorder characterized by the degeneration of dopaminergic neurons, with consequent redn. in striatal dopamine levels leading to characteristic motor symptoms.  The most effective treatment for this disease continues to be the dopamine replacement therapy with levodopa together with an inhibitor of arom. amino acid decarboxylase (AADC).  The efficacy of this therapy, however, decreases with time and most patients develop fluctuating responses and dyskinesias.  The last decade showed that the use of catechol-O-methyltransferase inhibitors as adjuvants to the levodopa/AADC inhibitor therapy, significantly improves the clin. benefits of this therapy.  The purpose of this article is to review the current knowledge on the enzyme catechol-O-methyltransferase (COMT) and the role of COMT inhibitors in PD as a new therapeutic approach to PD involving conversion of levodopa to dopamine at the target region in the brain and facilitation of the continuous action of this amine at the receptor sites.  A historical overview of the discovery and development of COMT inhibitors is presented with a special emphasis on nebicapone, presently under clin. development, as well as entacapone and tolcapone, which are already approved as adjuncts in the therapy of PD.  This article reviews human pharmacokinetic and pharmacodynamic properties of these drugs as well as their clin. efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXMKaksd904LVg90H21EOLACvtfcHk0lhoO88-q5RBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1aksrfF&md5=158db2bbed0a8efa49d2bd44fce59616</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2007.00020.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2007.00020.x%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DCatechol-O-Methyltransferase%2520and%2520its%2520Inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2007%26volume%3D13%26spage%3D352%26epage%3D379%26doi%3D10.1111%2Fj.1527-3458.2007.00020.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikkinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and Pharmacodynamics of Entacapone and Tolcapone after Acute and Repeated Administration: A Comparative Study in the Rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1124/jpet.102.042846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1124%2Fjpet.102.042846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=12538800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=498-506&author=M.+Forsbergauthor=M.+Lehtonenauthor=M.+Heikkinenauthor=J.+Savolainenauthor=T.+J%C3%A4rvinenauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Pharmacokinetics+and+Pharmacodynamics+of+Entacapone+and+Tolcapone+after+Acute+and+Repeated+Administration%3A+A+Comparative+Study+in+the+Rat&doi=10.1124%2Fjpet.102.042846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: A comparative study in the rat</span></div><div class="casAuthors">Forsberg, Markus; Lehtonen, Marko; Heikkinen, Minna; Savolainen, Jouko; Jarvinen, Tomi; Mannisto, Pekka T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">498-506</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Two catechol-O-methyltransferase (COMT) inhibitors, entacapone and tolcapone, were compared in the rat to elucidate the actual differences between their pharmacokinetics and pharmacodynamics after single and repeated administration.  Their inhibitory potencies were also compared in vitro.  After i.v. administration (3 mg/kg), the elimination half-life (t1/2β) of entacapone (0.8 h) was clearly shorter than that of tolcapone (2.9 h).  The striatum/serum ratio of tolcapone was 3-fold higher than that of entacapone.  After a single oral dose (10 mg/kg), both entacapone and tolcapone produced an equal maximal degree of COMT inhibition in peripheral tissues, but tolcapone inhibited striatal COMT more effectively than did entacapone.  After the 7-day treatment (10 mg/kg twice daily), COMT activity had recovered to a level of 67 to 101% of control within 8 h after the last dose of entacapone.  In tolcapone-treated animals, there was still extensive COMT inhibition present in peripheral tissues, and the degree of inhibition was higher than that attained after a single dose.  The pharmacokinetic-pharmacodynamic modeling revealed that a plateau of COMT inhibition near the maximal attainable inhibition was reached already by plasma concns. below 2000 ng/mL, both with entacapone and tolcapone.  Entacapone and tolcapone inhibited equally rat liver COMT in vitro with Ki values of 10.7 and 10.0 nM, resp.  In conclusion, tolcapone has a longer duration of action and a better brain penetration than entacapone.  The results also suggest that peripheral COMT is inhibited continuously when tolcapone is dosed at 12-h intervals, but this was not seen with entacapone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirtOEbWW5mrVg90H21EOLACvtfcHk0likF9RsorNzug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVChtA%253D%253D&md5=8221083765b1ce6aa7d02c9b58c8233b</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.042846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.042846%26sid%3Dliteratum%253Aachs%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DHeikkinen%26aufirst%3DM.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DPharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520Entacapone%2520and%2520Tolcapone%2520after%2520Acute%2520and%2520Repeated%2520Administration%253A%2520A%2520Comparative%2520Study%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D498%26epage%3D506%26doi%3D10.1124%2Fjpet.102.042846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ceravolo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-Dopa PET Evidence that Tolcapone Acts as a Central COMT Inhibitor in Parkinson’s Disease</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1002/syn.10034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fsyn.10034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=201-207&author=R.+Ceravoloauthor=P.+Picciniauthor=D.+L.+Baileyauthor=K.+M.+Jorgaauthor=H.+Brysonauthor=D.+J.+Brooks&title=18F-Dopa+PET+Evidence+that+Tolcapone+Acts+as+a+Central+COMT+Inhibitor+in+Parkinson%E2%80%99s+Disease&doi=10.1002%2Fsyn.10034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2Fsyn.10034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.10034%26sid%3Dliteratum%253Aachs%26aulast%3DCeravolo%26aufirst%3DR.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DBailey%26aufirst%3DD.%2BL.%26aulast%3DJorga%26aufirst%3DK.%2BM.%26aulast%3DBryson%26aufirst%3DH.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3D18F-Dopa%2520PET%2520Evidence%2520that%2520Tolcapone%2520Acts%2520as%2520a%2520Central%2520COMT%2520Inhibitor%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DSynapse%26date%3D2002%26volume%3D43%26spage%3D201%26epage%3D207%26doi%3D10.1002%2Fsyn.10034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-<i>O</i>-Methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4040</span><span class="NLM_x">–</span> <span class="NLM_lpage">4042</span><span class="refDoi"> DOI: 10.1002/1521-3773(20011105)40:21<4040::AID-ANIE4040>3.0.CO;2-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=4040-4042&author=C.+Lernerauthor=A.+Rufauthor=V.+Gramlichauthor=B.+Masjostauthor=G.+Z%C3%BCrcherauthor=R.+Jakob-Roetneauthor=E.+Borroniauthor=F.+Diederich&title=X-ray+Crystal+Structure+of+a+Bisubstrate+Inhibitor+Bound+to+the+Enzyme+Catechol-O-Methyltransferase%3A+A+Dramatic+Effect+of+Inhibitor+Preorganization+on+Binding+Affinity&doi=10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820011105%252940%253A21%253C4040%253A%253AAID-ANIE4040%253E3.0.CO%253B2-C%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DX-ray%2520Crystal%2520Structure%2520of%2520a%2520Bisubstrate%2520Inhibitor%2520Bound%2520to%2520the%2520Enzyme%2520Catechol-O-Methyltransferase%253A%2520A%2520Dramatic%2520Effect%2520of%2520Inhibitor%2520Preorganization%2520on%2520Binding%2520Affinity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D4040%26epage%3D4042%26doi%3D10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Bisubstrate Inhibitors of the Enzyme Catechol <i>O</i>-Methyltransferase (COMT): Efficient Inhibition Despite the Lack of a Nitro Group</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span><span class="refDoi"> DOI: 10.1002/cbic.200400084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fcbic.200400084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1270-1274&author=R.+Pauliniauthor=C.+Lernerauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+Inhibitors+of+the+Enzyme+Catechol+O-Methyltransferase+%28COMT%29%3A+Efficient+Inhibition+Despite+the+Lack+of+a+Nitro+Group&doi=10.1002%2Fcbic.200400084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200400084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200400084%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520Inhibitors%2520of%2520the%2520Enzyme%2520Catechol%2520O-Methyltransferase%2520%2528COMT%2529%253A%2520Efficient%2520Inhibition%2520Despite%2520the%2520Lack%2520of%2520a%2520Nitro%2520Group%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1270%26epage%3D1274%26doi%3D10.1002%2Fcbic.200400084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allemann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tissot, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span> </span><span class="NLM_article-title">Catechol-O-Methyltransferase in Complex with Substituted 3′-Deoxyribose Bisubstrate Inhibitors</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1107/S0907444912001138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1107%2FS0907444912001138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22349227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=253-260&author=M.+Ellermannauthor=C.+Lernerauthor=G.+Burgyauthor=A.+Ehlerauthor=C.+Bissantzauthor=R.+Jakob-Roetneauthor=R.+Pauliniauthor=O.+Allemannauthor=H.+Tissotauthor=D.+Grunsteinauthor=M.+Stihleauthor=F.+Diederichauthor=M.+G.+Rudolph&title=Catechol-O-Methyltransferase+in+Complex+with+Substituted+3%E2%80%B2-Deoxyribose+Bisubstrate+Inhibitors&doi=10.1107%2FS0907444912001138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Lerner, Christian; Burgy, Guillaume; Ehler, Andreas; Bissantz, Caterina; Jakob-Roetne, Roland; Paulini, Ralph; Allemann, Oliver; Tissot, Heloise; Gruenstein, Dan; Stihle, Martine; Diederich, Francois; Rudolph, Markus G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-260</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">High-resoln. structures of catechol-O-methyltransferase with ribose-modified inhibitors and Mg2+ identify the side chain of Glu90 as crucial for hydrogen bonding to the ribose hydroxyl groups.  Glu90 subtly aligns with the 2'-hydroxyl, but not the 3'-hydroxyl, group to increase binding affinity, explaining the obsd. activities of bisubstrate inhibitors with a 3'-desoxyribose moiety.  The biol. activity of catechol neurotransmitters such as dopamine in the synapse is modulated by transporters and enzymes.  Catechol-O-methyltransferase (COMT; EC 2.1.1.6) inactivates neurotransmitters by catalyzing the transfer of a Me group from S-adenosylmethionine to catechols in the presence of Mg2+.  This pathway also inactivates L-DOPA, the std. therapeutic for Parkinson's disease.  Depletion of catechol neurotransmitters in the prefrontal cortex has been linked to schizophrenia.  The inhibition of COMT therefore promises improvements in the treatment of these diseases.  The concept of bisubstrate inhibitors for COMT has been described previously.  Here, ribose-modified bisubstrate inhibitors were studied.  Three high-resoln. crystal structures of COMT in complex with novel ribose-modified bisubstrate inhibitors confirmed the predicted binding mode but displayed subtle alterations at the ribose-binding site.  The high affinity of the inhibitors can be convincingly rationalized from the structures, which document the possibility of removing and/or replacing the ribose 3'-hydroxyl group and provide a framework for further inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocHxOEL-zuzLVg90H21EOLACvtfcHk0liCFin9CYNVrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D&md5=2b1b40fde37e8eae240dd4a1c2c58c4f</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001138%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DAllemann%26aufirst%3DO.%26aulast%3DTissot%26aufirst%3DH.%26aulast%3DGrunstein%26aufirst%3DD.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26atitle%3DCatechol-O-Methyltransferase%2520in%2520Complex%2520with%2520Substituted%25203%25E2%2580%25B2-Deoxyribose%2520Bisubstrate%2520Inhibitors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D253%26epage%3D260%26doi%3D10.1107%2FS0907444912001138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6381</span><span class="refDoi"> DOI: 10.1002/chem.201003648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fchem.201003648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=21538606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6369-6381&author=M.+Ellermannauthor=R.+Pauliniauthor=R.+Jakob-Roetneauthor=C.+Lernerauthor=E.+Borroniauthor=D.+Rothauthor=A.+Ehlerauthor=W.+B.+Schweizerauthor=D.+Schlatterauthor=M.+G.+Rudolphauthor=F.+Diederich&title=Molecular+Recognition+at+the+Active+Site+of+Catechol-O-methyltransferase+%28COMT%29%3A+Adenine+Replacements+in+Bisubstrate+Inhibitors&doi=10.1002%2Fchem.201003648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Paulini, Ralph; Jakob-Roetne, Roland; Lerner, Christian; Borroni, Edilio; Roth, Doris; Ehler, Andreas; Schweizer, W. Bernd; Schlatter, Daniel; Rudolph, Markus G.; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6369-6381, S6369/1-S6369/95</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">L-Dopa, the std. therapeutic for Parkinson's disease, is inactivated by the enzyme catechol-O-methyltransferase (COMT).  COMT catalyzes the transfer of an activated Me group from S-adenosylmethionine (SAM) to its catechol substrates, such as L-dopa, in the presence of magnesium ions.  The mol. recognition properties of the SAM-binding site of COMT have been investigated only sparsely.  Here, we explore this site by structural alterations of the adenine moiety of bisubstrate inhibitors.  The mol. recognition of adenine is of special interest due to the great abundance and importance of this nucleobase in biol. systems.  Novel bisubstrate inhibitors with adenine replacements were developed by structure-based design and synthesized using a nucleosidation protocol introduced by Vorbrueggen and co-workers.  Key interactions of the adenine moiety with COMT were measured with a radiochem. assay.  Several bisubstrate inhibitors, most notably the adenine replacements thiopyridine, purine, N-methyladenine, and 6-methylpurine, displayed nanomolar IC50 values (median inhibitory concn.) for COMT down to 6 nM.  A series of six cocrystal structures of the bisubstrate inhibitors in ternary complexes with COMT and Mg2+ confirm our predicted binding mode of the adenine replacements.  The cocrystal structure of an inhibitor bearing no nucleobase can be regarded as an intermediate along the reaction coordinate of bisubstrate inhibitor binding to COMT.  Our studies show that solvation varies with the type of adenine replacement, whereas among the adenine derivs., the nitrogen atom at position 1 is essential for high affinity, while the exocyclic amino group is most efficiently substituted by a Me group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo1pH4WO4rXLVg90H21EOLACvtfcHk0liCFin9CYNVrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D&md5=2e3849c0801ab409dd4e41b9a5957a8b</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1002%2Fchem.201003648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201003648%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DRoth%26aufirst%3DD.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DMolecular%2520Recognition%2520at%2520the%2520Active%2520Site%2520of%2520Catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Adenine%2520Replacements%2520in%2520Bisubstrate%2520Inhibitors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D6369%26epage%3D6381%26doi%3D10.1002%2Fchem.201003648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><div class="note"><p class="first last">In vivo properties of hydroxypyridones derivatives are discussed where compounds required very high doses to reach meaningful brain exposure:</p></div><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandebo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polsky-Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhearn, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotter, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLoughlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N. A.</span><span> </span><span class="NLM_article-title">Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-<i>O</i>-Methyltransferase Inhibitors and Substrates</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1021/cn200109w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200109w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGru7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=129-140&author=R.+G.+Robinsonauthor=S.+M.+Smithauthor=S.+E.+Wolkenbergauthor=M.+Kandeboauthor=L.+Yaoauthor=C.+R.+Gibsonauthor=S.+T.+Harrisonauthor=S.+Polsky-Fisherauthor=J.+C.+Barrowauthor=P.+J.+Manleyauthor=J.+J.+Mulhearnauthor=K.+K.+Nandaauthor=J.+W.+Schubertauthor=B.+W.+Trotterauthor=Z.+Zhaoauthor=J.+M.+Sandersauthor=R.+F.+Smithauthor=D.+McLoughlinauthor=S.+Sharmaauthor=D.+L.+Hallauthor=T.+L.+Walkerauthor=J.+L.+Kershnerauthor=N.+Bhandariauthor=P.+H.+Hutsonauthor=N.+A.+Sachs&title=Characterization+of+Non-Nitrocatechol+Pan+and+Isoform+Specific+Catechol-O-Methyltransferase+Inhibitors+and+Substrates&doi=10.1021%2Fcn200109w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates</span></div><div class="casAuthors">Robinson, Ronald G.; Smith, Sean M.; Wolkenberg, Scott E.; Kandebo, Monika; Yao, Lihang; Gibson, Christopher R.; Harrison, Scott T.; Polsky-Fisher, Stacey; Barrow, James C.; Manley, Peter J.; Mulhearn, James J.; Nanda, Kausik K.; Schubert, Jeffrey W.; Trotter, B. Wesley; Zhao, Zhijian; Sanders, John M.; Smith, Robert F.; McLoughlin, Debra; Sharma, Sujata; Hall, Dawn L.; Walker, Tiffany L.; Kershner, Jennifer L.; Bhandari, Neetesh; Hutson, Pete H.; Sachs, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-140</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reduced dopamine neurotransmission in the prefrontal cortex has been implicated as causal for the neg. symptoms and cognitive deficit assocd. with schizophrenia; thus, a compd. which selectively enhances dopamine neurotransmission in the prefrontal cortex may have therapeutic potential.  Inhibition of catechol-O-methyltransferase (COMT, EC 2.1.1.6) offers a unique advantage, since this enzyme is the primary mechanism for the elimination of dopamine in cortical areas.  Since membrane bound COMT (MB-COMT) is the predominant isoform in human brain, a high throughput screen (HTS) to identify novel MB-COMT specific inhibitors was completed.  Subsequent optimization led to the identification of novel, non-nitrocatechol COMT inhibitors, some of which interact specifically with MB-COMT.  Compds. were characterized for in vitro efficacy vs. human and rat MB and sol. (S)-COMT.  Select compds. were administered to male Wistar rats, and ex vivo COMT activity, compd. levels in plasma and cerebrospinal fluid (CSF), and CSF dopamine metabolite levels were detd. as measures of preclin. efficacy.  Finally, novel non-nitrocatechol COMT inhibitors displayed less potent uncoupling of the mitochondrial membrane potential (MMP) compared to tolcapone as well as nonhepatotoxic entacapone, thus mitigating the risk of hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbigUdkIqxH7Vg90H21EOLACvtfcHk0lispCGSUseCCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGru7%252FE&md5=c36c8e4964ce90ba45fe0e1555f6748b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcn200109w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200109w%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DKandebo%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DGibson%26aufirst%3DC.%2BR.%26aulast%3DHarrison%26aufirst%3DS.%2BT.%26aulast%3DPolsky-Fisher%26aufirst%3DS.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DNanda%26aufirst%3DK.%2BK.%26aulast%3DSchubert%26aufirst%3DJ.%2BW.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DR.%2BF.%26aulast%3DMcLoughlin%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%2BL.%26aulast%3DWalker%26aufirst%3DT.%2BL.%26aulast%3DKershner%26aufirst%3DJ.%2BL.%26aulast%3DBhandari%26aufirst%3DN.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DSachs%26aufirst%3DN.%2BA.%26atitle%3DCharacterization%2520of%2520Non-Nitrocatechol%2520Pan%2520and%2520Isoform%2520Specific%2520Catechol-O-Methyltransferase%2520Inhibitors%2520and%2520Substrates%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D129%26epage%3D140%26doi%3D10.1021%2Fcn200109w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span> </span><span class="NLM_article-title">First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of Phenolics</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3655</span><span class="NLM_x">–</span> <span class="NLM_lpage">3681</span><span class="refDoi"> DOI: 10.1002/jps.22568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fjps.22568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=21484808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=3655-3681&author=B.+Wuauthor=K.+Kulkarniauthor=S.+Basuauthor=S.+Zhangauthor=M.+Hu&title=First-Pass+Metabolism+via+UDP-Glucuronosyltransferase%3A+a+Barrier+to+Oral+Bioavailability+of+Phenolics&doi=10.1002%2Fjps.22568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics</span></div><div class="casAuthors">Wu, Baojian; Kulkarni, Kaustubh; Basu, Sumit; Zhang, Shuxing; Hu, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3655-3681</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Glucuronidation mediated by UDP-glucuronosyltransferases (UGTs) is a significant metabolic pathway that facilitates efficient elimination of numerous endobiotics and xenobiotics, including phenolics.  UGT genetic deficiency and polymorphisms or inhibition of glucuronidation by concomitant use of drugs are assocd. with inherited physiol. disorders or drug-induced toxicities.  Moreover, extensive glucuronidation can be a barrier to oral bioavailability as the first-pass glucuronidation (or premature clearance by UGTs) of orally administered agents usually results in the poor oral bioavailability and lack of efficacies.  This review focused on the first-pass glucuronidation of phenolics including natural polyphenols and pharmaceuticals.  The complexity of UGT-mediated metab. of phenolics is highlighted with species-, gender-, organ- and isoform-dependent specificity, as well as functional compensation between UGT1A and 2B subfamily.  In addn., recent advances are discussed with respect to the mechanisms of enzymic actions, including the important properties such as binding pocket size and phosphorylation requirements. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 100:3655-3681, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrChVweDmYyjbVg90H21EOLACvtfcHk0lispCGSUseCCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemsrs%253D&md5=b18e570f927808112e9603b3160a02c5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fjps.22568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22568%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DKulkarni%26aufirst%3DK.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DM.%26atitle%3DFirst-Pass%2520Metabolism%2520via%2520UDP-Glucuronosyltransferase%253A%2520a%2520Barrier%2520to%2520Oral%2520Bioavailability%2520of%2520Phenolics%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D3655%26epage%3D3681%26doi%3D10.1002%2Fjps.22568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Barrow, J. C.</span><span> </span><span class="NLM_article-title">Inhibitors of Catechol-O-Methyltransferase</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.2174/187152712800672517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2174%2F187152712800672517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22483290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFekurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=324-332&author=J.+C.+Barrow&title=Inhibitors+of+Catechol-O-Methyltransferase&doi=10.2174%2F187152712800672517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of catechol-O-methyltransferase</span></div><div class="casAuthors">Barrow, James C.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">324-332</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the identification of Catechol-O-Methyltransferase (COMT) by Axelrod in 1957, many inhibitors of this enzyme have been reported.  While COMT inhibition may be beneficial in a no. of disease states, most of the effort over the years has been directed at boosting L-DOPA concns. as adjunct treatment for Parkinson's disease.  This review summarizes the major classes of COMT inhibitors, from early catechol and pyrogallol variants to bisubstrate inhibitors.  The nitrocatechol substructure has proven to be a particularly productive scaffold, resulting in two marketed drugs and several improved drug candidates working their way through clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYoGtMWsRwLVg90H21EOLACvtfcHk0lispCGSUseCCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFekurs%253D&md5=ad380403a4e60ee1ae057c3e4622319f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F187152712800672517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152712800672517%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26atitle%3DInhibitors%2520of%2520Catechol-O-Methyltransferase%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D11%26spage%3D324%26epage%3D332%26doi%3D10.2174%2F187152712800672517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Crystal Structure of Catechol <i>O</i>-Methyltransferase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1038/368354a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1038%2F368354a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=8127373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaK2cXksFaqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=354-358&author=J.+Vidgrenauthor=L.+A.+Svenssonauthor=A.+Liljas&title=Crystal+Structure+of+Catechol+O-Methyltransferase&doi=10.1038%2F368354a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of catechol O-methyltransferase</span></div><div class="casAuthors">Vidgren, Jukka; Svensson, L. Anders; Liljas, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6469</span>),
    <span class="NLM_cas:pages">354-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The at. structure of catechol O-methyltransferase (COMT, EC 2.1.1.6) was solved to 2.0 Å resoln., which provides new insights into the mechanism of the Me transfer reaction.  The co-enzyme-binding domain is strikingly similar to that of an S-adenosyl-L-methionine (AdoMet)-dependent DNA methylase, indicating that all AdoMet methylases may have a common structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEyNem_cc5_bVg90H21EOLACvtfcHk0ljbu1T5R-TtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFaqu78%253D&md5=71c7ecae5f4daddfd352d319116d4746</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F368354a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F368354a0%26sid%3Dliteratum%253Aachs%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DL.%2BA.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DCrystal%2520Structure%2520of%2520Catechol%2520O-Methyltransferase%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D354%26epage%3D358%26doi%3D10.1038%2F368354a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal Chemical Properties of Successful Central Nervous System Drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+Chemical+Properties+of+Successful+Central+Nervous+System+Drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebddvj43i6XJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520Chemical%2520Properties%2520of%2520Successful%2520Central%2520Nervous%2520System%2520Drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">Very polar inhibitors targeting the cofactor pocket, being structural SAM analogs, have been reported:</p></div><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borchardt, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. S.</span><span> </span><span class="NLM_article-title">Potential Inhibitors of S-Adenosylmethionine-Dependent Methyltransferases. 1. Modification of the Amino Acid Portion of S-Adenosylhomocysteine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1021/jm00254a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00254a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaE2MXisFKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=862-868&author=R.+T.+Borchardtauthor=Y.+S.+Wu&title=Potential+Inhibitors+of+S-Adenosylmethionine-Dependent+Methyltransferases.+1.+Modification+of+the+Amino+Acid+Portion+of+S-Adenosylhomocysteine&doi=10.1021%2Fjm00254a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Potential inhibitors of S-adenosylmethionine-dependent methyltransferases.  1.  Modification of the amino acid portion of S-adenosylhomocysteine</span></div><div class="casAuthors">Borchardt, Ronald T.; Wu, Yih Shiong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">862-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Eight analogs of S-adenosyl-L-homocysteine (L-I) [979-92-0] were prepd. by the reaction of the desired S-benzylhomocysteine deriv. with 2',3'-O-isopropylidene-5'-O-p-toluenesulfonyladenosine [5605-63-0] in Na-NH3(liq.) followed by hydrolysis, and their abilities to inhibit methyltransferase was investigated.  The terminal amino and carboxy groups and the S of the homocysteine portion of I are required for max. binding by the enzymes.  The L configuration is required to give max. inhibition, with the exception of the potent inhibition of histamine N-methyltransferase [9029-80-5] by S-adenosyl-D-homocysteine (D-I) [53276-26-9].  The relation of structure to activity and nature of the binding sites was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1wdEbKRPW37Vg90H21EOLACvtfcHk0ljbu1T5R-TtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXisFKltw%253D%253D&md5=9fa22849dceea9da74edbab1d8921d8c</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm00254a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00254a016%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26aulast%3DWu%26aufirst%3DY.%2BS.%26atitle%3DPotential%2520Inhibitors%2520of%2520S-Adenosylmethionine-Dependent%2520Methyltransferases.%25201.%2520Modification%2520of%2520the%2520Amino%2520Acid%2520Portion%2520of%2520S-Adenosylhomocysteine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1974%26volume%3D17%26spage%3D862%26epage%3D868%26doi%3D10.1021%2Fjm00254a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Borchardt, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. S.</span><span> </span><span class="NLM_article-title">Potential Inhibitors of S-Adenosylmethionine-dependent Methyltransferases. 3. Modifications of the Sugar Portion of S-Adenosylhomocysteine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1021/jm00237a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00237a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaE2MXktVShtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=300-304&author=R.+T.+Borchardtauthor=Y.+S.+Wu&title=Potential+Inhibitors+of+S-Adenosylmethionine-dependent+Methyltransferases.+3.+Modifications+of+the+Sugar+Portion+of+S-Adenosylhomocysteine&doi=10.1021%2Fjm00237a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential inhibitors of S-adenosylmethionine-dependent methyltransferases.  3.  Modifications of the sugar portion of S-adenosylhomocysteine</span></div><div class="casAuthors">Borchardt, Ronald T.; Wu, Yih Shiong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Three deoxy analogs of S-adenosyl-L-homocysteine (I) [979-92-0], prepd. by condensation of the tosylated nucleoside with S-benzyl-L-homocysteine [7689-60-3] were tested for specificity of inhibition of 4 methyltransferases.  Histamine-N-methyltransferase (EC 2.1.1.8) [9029-80-5] and hydroxyindole O-methyltransferase (EC 2.1.1.4) [9029-77-0] show strict specificity for the ribose portion of I.  Phenylethanolamine N-methyltransferase [9037-68-7] and catechol O-methyltransferase (EC 2.1.1.6) [9012-25-3] are less sensitive to changes in the ribose moiety and show inhibition by S-2'-deoxyadenosyl-L-homocysteine [55197-16-5] and S-3'-deoxyadenosyl-L-homocysteine [55197-15-4].  The relation of structure to inhibition and binding of enzymes was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaV0BbluLLc7Vg90H21EOLACvtfcHk0ljbu1T5R-TtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVShtrc%253D&md5=643ea43723970cb4539ee873a0fe58b8</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm00237a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00237a018%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26aulast%3DWu%26aufirst%3DY.%2BS.%26atitle%3DPotential%2520Inhibitors%2520of%2520S-Adenosylmethionine-dependent%2520Methyltransferases.%25203.%2520Modifications%2520of%2520the%2520Sugar%2520Portion%2520of%2520S-Adenosylhomocysteine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D300%26epage%3D304%26doi%3D10.1021%2Fjm00237a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fuller, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarajan, R.</span><span> </span><span class="NLM_article-title">Inhibition of Methyltransferases by Some New Analogs of <i>S</i>-Adenosylhomocysteine</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1983</span><span class="refDoi"> DOI: 10.1016/0006-2952(78)90018-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2F0006-2952%2878%2990018-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1978&pages=1981-1983&author=R.+W.+Fullerauthor=R.+Nagarajan&title=Inhibition+of+Methyltransferases+by+Some+New+Analogs+of+S-Adenosylhomocysteine&doi=10.1016%2F0006-2952%2878%2990018-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2878%2990018-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252878%252990018-7%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DR.%2BW.%26aulast%3DNagarajan%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Methyltransferases%2520by%2520Some%2520New%2520Analogs%2520of%2520S-Adenosylhomocysteine%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1978%26volume%3D27%26spage%3D1981%26epage%3D1983%26doi%3D10.1016%2F0006-2952%2878%2990018-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">Experiences in Fragment-Based Drug Discovery</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/j.tips.2012.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2Fj.tips.2012.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22459076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslejsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=224-232&author=C.+W.+Murrayauthor=M.+L.+Verdonkauthor=D.+C.+Rees&title=Experiences+in+Fragment-Based+Drug+Discovery&doi=10.1016%2Fj.tips.2012.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Experiences in fragment-based drug discovery</span></div><div class="casAuthors">Murray, Christopher W.; Verdonk, Marcel L.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">224-232</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) has become established in both industry and academia as an alternative approach to high-throughput screening for the generation of chem. leads for drug targets.  In FBDD, specialised detection methods are used to identify small chem. compds. (fragments) that bind to the drug target, and structural biol. is usually employed to establish their binding mode and to facilitate their optimization.  In this article, we present three recent and successful case histories in FBDD.  We then re-examine the key concepts and challenges of FBDD with particular emphasis on recent literature and our own experience from a substantial no. of FBDD applications.  Our opinion is that careful application of FBDD is living up to its promise of delivering high quality leads with good phys. properties and that in future many drug mols. will be derived from fragment-based approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUzcsuUdmx4bVg90H21EOLACvtfcHk0lgcOEH8LiU28Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslejsLs%253D&md5=c97b6b84a4afeadb87ee7d46e6d2bb91</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DExperiences%2520in%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D224%26epage%3D232%26doi%3D10.1016%2Fj.tips.2012.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzanov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolop, K.</span><span> </span><span class="NLM_article-title">Clinical Efficacy of a RAF Inhibitor Needs Broad Target Blockade in BRAF-Mutant Melanoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1038/nature09454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1038%2Fnature09454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=20823850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=596-599&author=G.+Bollagauthor=P.+Hirthauthor=J.+Tsaiauthor=J.+Zhangauthor=P.+N.+Ibrahimauthor=H.+Choauthor=W.+Spevakauthor=C.+Zhangauthor=Y.+Zhangauthor=G.+Habetsauthor=E.+A.+Burtonauthor=B.+Wongauthor=G.+Tsangauthor=B.+L.+Westauthor=B.+Powellauthor=R.+Shellooeauthor=A.+Marimuthuauthor=H.+Nguyenauthor=K.+Y.+J.+Zhangauthor=D.+R.+Artisauthor=J.+Schlessingerauthor=F.+Suauthor=B.+Higginsauthor=R.+Iyerauthor=K.+D%E2%80%99Andreaauthor=A.+Koehlerauthor=M.+Stummauthor=P.+S.+Linauthor=R.+J.+Leeauthor=J.+Grippoauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+B.+Chapmanauthor=K.+T.+Flahertyauthor=X.+Xuauthor=K.+L.+Nathansonauthor=K.+Nolop&title=Clinical+Efficacy+of+a+RAF+Inhibitor+Needs+Broad+Target+Blockade+in+BRAF-Mutant+Melanoma&doi=10.1038%2Fnature09454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span></div><div class="casAuthors">Bollag, Gideon; Hirth, Peter; Tsai, James; Zhang, Jiazhong; Ibrahim, Prabha N.; Cho, Hanna; Spevak, Wayne; Zhang, Chao; Zhang, Ying; Habets, Gaston; Burton, Elizabeth A.; Wong, Bernice; Tsang, Garson; West, Brian L.; Powell, Ben; Shellooe, Rafe; Marimuthu, Adhirai; Nguyen, Hoa; Zhang, Kam Y. J.; Artis, Dean R.; Schlessinger, Joseph; Su, Fei; Higgins, Brian; Iyer, Raman; D'Andrea, Kurt; Koehler, Astrid; Stumm, Michael; Lin, Paul S.; Lee, Richard J.; Grippo, Joseph; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; Chapman, Paul B.; Flaherty, Keith T.; Xu, Xiaowei; Nathanson, Katherine L.; Nolop, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">7315</span>),
    <span class="NLM_cas:pages">596-599</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">B-RAF is the most frequently mutated protein kinase in human cancers.  The finding that oncogenic mutations in BRAF are common in melanoma, followed by the demonstration that these tumors are dependent on the RAF/MEK/ERK pathway, offered hope that inhibition of B-RAF kinase activity could benefit melanoma patients.  Herein, we describe the structure-guided discovery of PLX4032 (RG7204), a potent inhibitor of oncogenic B-RAF kinase activity.  Preclin. expts. demonstrated that PLX4032 selectively blocked the RAF/MEK/ERK pathway in BRAF mutant cells and caused regression of BRAF mutant xenografts.  Toxicol. studies confirmed a wide safety margin consistent with the high degree of selectivity, enabling Phase 1 clin. trials using a cryst. formulation of PLX4032 (ref. 5).  In a subset of melanoma patients, pathway inhibition was monitored in paired biopsy specimens collected before treatment initiation and following 2 wk of treatment.  This anal. revealed substantial inhibition of ERK phosphorylation, yet clin. evaluation did not show tumor regressions.  At higher drug exposures afforded by a new amorphous drug formulation, greater than 80% inhibition of ERK phosphorylation in the tumors of patients correlated with clin. response.  Indeed, the Phase 1 clin. data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.  These data demonstrate that BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYwlns1EfcLVg90H21EOLACvtfcHk0lgcOEH8LiU28Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK&md5=8a26d0ab41970f39a109ddafff2f17b4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09454%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DF.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DA.%26aulast%3DStumm%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DNolop%26aufirst%3DK.%26atitle%3DClinical%2520Efficacy%2520of%2520a%2520RAF%2520Inhibitor%2520Needs%2520Broad%2520Target%2520Blockade%2520in%2520BRAF-Mutant%2520Melanoma%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D596%26epage%3D599%26doi%3D10.1038%2Fnature09454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><div class="note"><p class="first last">For a comprehensive review on fragment-based approaches see the following:</p></div><span class="NLM_contrib-group">Scott, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abell, C.</span><span> </span><span class="NLM_article-title">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4990</span><span class="NLM_x">–</span> <span class="NLM_lpage">5003</span><span class="refDoi"> DOI: 10.1021/bi3005126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3005126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4990-5003&author=D.+E.+Scottauthor=A.+G.+Coyneauthor=S.+A.+Hudsonauthor=C.+Abell&title=Fragment-Based+Approaches+in+Drug+Discovery+and+Chemical+Biology&doi=10.1021%2Fbi3005126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Scott, Duncan E.; Coyne, Anthony G.; Hudson, Sean A.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4990-5003</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based approaches to finding novel small mols. that bind to proteins are now firmly established in drug discovery and chem. biol.  Initially developed primarily in a few centers in the biotech and pharma industry, this methodol. has now been adopted widely in both the pharmaceutical industry and academia.  After the initial success with kinase targets, the versatility of this approach has now expanded to a broad range of different protein classes.  Herein we describe recent fragment-based approaches to a wide range of target types, including Hsp90, β-secretase, and allosteric sites in human immunodeficiency virus protease and fanesyl pyrophosphate synthase.  The role of fragment-based approaches in an academic research environment is also examd. with an emphasis on neglected diseases such as tuberculosis.  The development of a fragment library, the fragment screening process, and the subsequent fragment hit elaboration will be discussed using examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2ry6mWC83bVg90H21EOLACvtfcHk0lji-85GAKXIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D&md5=39a6f0f741e711fd572e24c95142f55d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3005126%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DHudson%26aufirst%3DS.%2BA.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-Based%2520Approaches%2520in%2520Drug%2520Discovery%2520and%2520Chemical%2520Biology%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D4990%26epage%3D5003%26doi%3D10.1021%2Fbi3005126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huber, W.</span><span> </span><span class="NLM_article-title">A New Strategy for Improved Secondary Screening and Lead Optimization Using High-Resolution SPR Characterization of Compound–Target Interactions</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1002/jmr.744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fjmr.744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=15997470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslGhu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=273-281&author=W.+Huber&title=A+New+Strategy+for+Improved+Secondary+Screening+and+Lead+Optimization+Using+High-Resolution+SPR+Characterization+of+Compound%E2%80%93Target+Interactions&doi=10.1002%2Fjmr.744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions</span></div><div class="casAuthors">Huber, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-281</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Biophys. label-free assays such as those based on SPR are essential tools in generating high-quality data on affinity, kinetic, mechanistic and thermodn. aspects of interactions between target proteins and potential drug candidates.  Here we show examples of the integration of SPR with bioinformatic approaches and mutation studies in the early drug discovery process.  We call this combination 'structure-based biophys. anal.'.  Binding sites are identified on target proteins using information that is either extd. from three-dimensional structural anal. (x-ray crystallog. or NMR), or derived from a pharmacore model based on known binders.  The binding site information is used for in silico screening of a large substance library (e.g. available chem. directory), providing virtual hits.  The three-dimensional structure is also used for the design of mutants where the binding site has been impaired.  The wild-type target and the impaired mutant are then immobilized on different spots of the sensor chip and the interactions of compds. with the wild-type and mutant are compared in order to identify selective binders for the binding site of the target protein.  This method can be used as a cost-effective alternative to high-throughput screening methods in cases when detailed binding site information is available.  Here, we present three examples of how this technique can be applied to provide invaluable data during different phases of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUgKw8f-3b7Vg90H21EOLACvtfcHk0lji-85GAKXIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslGhu70%253D&md5=9ab5c7fd7e733fc4d8a4b0c817f82736</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1002%2Fjmr.744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.744%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26atitle%3DA%2520New%2520Strategy%2520for%2520Improved%2520Secondary%2520Screening%2520and%2520Lead%2520Optimization%2520Using%2520High-Resolution%2520SPR%2520Characterization%2520of%2520Compound%25E2%2580%2593Target%2520Interactions%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2005%26volume%3D18%26spage%3D273%26epage%3D281%26doi%3D10.1002%2Fjmr.744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Navratilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Fragment Screening by Surface Plasmon Resonance</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1021/ml900002k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml900002k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1agtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=44-48&author=I.+Navratilovaauthor=A.+L.+Hopkins&title=Fragment+Screening+by+Surface+Plasmon+Resonance&doi=10.1021%2Fml900002k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Screening by Surface Plasmon Resonance</span></div><div class="casAuthors">Navratilova, Iva; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-48</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery is a validated approach for the discovery of drug candidates.  However, the weak affinity of fragment compds. requires highly sensitive biophys. techniques, such as NMR or x-ray crystallog., to identify hits.  Thus the advantages of screening small fragment libraries are partly offset by the high cost of biophys. analyses.  Here the authors present a method for biosensor-based fragment screening using surface plasmon resonance (SPR).  To reduce the false pos. detection rate the authors present a novel method of data anal. that incorporates multiple referencing with ligand efficiency.  By implementing all necessary steps for assay design, data anal. and interpretation, SPR-based fragment screening has potential to eliminate all nonspecific (false pos.) binders.  Therefore, given the advantages of low protein consumption, rapid assay development and kinetic and thermodn. validation of hits, SPR can be considered as a primary screening technol. for fragment-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2SPJs9bLebVg90H21EOLACvtfcHk0lji-85GAKXIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1agtbk%253D&md5=05b985a9906da33beb06c710e8c11550</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fml900002k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900002k%26sid%3Dliteratum%253Aachs%26aulast%3DNavratilova%26aufirst%3DI.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DFragment%2520Screening%2520by%2520Surface%2520Plasmon%2520Resonance%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D44%26epage%3D48%26doi%3D10.1021%2Fml900002k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Fragment Library Screening and Lead Characterization Using SPR Biosensors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1735</span><span class="refDoi"> DOI: 10.2174/156802609790102392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2174%2F156802609790102392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=19929838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFeitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1725-1735&author=U.+H.+Danielson&title=Fragment+Library+Screening+and+Lead+Characterization+Using+SPR+Biosensors&doi=10.2174%2F156802609790102392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment library screening and lead characterization using SPR biosensors</span></div><div class="casAuthors">Danielson, U. Helena</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1725-1735</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The transition from high throughput screening of collections of drug-like compds. to screening of fragment libraries via lower throughput methods with high sensitivity has revolutionized early drug discovery.  It is highlighting the need for sensitive biophys. techniques for interaction anal. rather than high throughput methods.  Biosensors with SPR detection are well suited for this novel scenario.  In less than 20 years the technique has been launched, established and become a highly informative method for a variety of applications in drug discovery.  It is no longer limited to the detection of proteins or other high mol. wt. analytes, but the detection of weakly interacting fragments is now feasible.  This paper discusses the theor. and exptl. limitations for such applications and reviews a no. of successful studies in the area of fragment-based lead discovery that have recently been published.  It can be anticipated that the evolution of this young technique will be significantly influenced by the requirements for efficient fragment-based lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPzUsOfVCNbVg90H21EOLACvtfcHk0lji-85GAKXIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFeitr0%253D&md5=a4943e5e7e1a893cad27a54febf5beb7</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.2174%2F156802609790102392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609790102392%26sid%3Dliteratum%253Aachs%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DFragment%2520Library%2520Screening%2520and%2520Lead%2520Characterization%2520Using%2520SPR%2520Biosensors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1725%26epage%3D1735%26doi%3D10.2174%2F156802609790102392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Mutations in SAM binding site used for secondary screening were Glu90-Arg, Glu90-Trp, Ser119-Trp, His142-Arg, His142-Lys, and His142-Trp.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">A one-dimensional (1D) <sup>1</sup>H NMR spin lock variation of Carr–Purcell–Meiboom–Gill (CPMG) method was used:</p></div><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Klages, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">NMR-Based Screening: A Powerful Tool in Fragment-Based Drug Discovery</span> <span class="citation_source-journal">Analyst</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1039/B709658P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1039%2FB709658P" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=692-705&author=J.+Klagesauthor=M.+Colesauthor=H.+Kessler&title=NMR-Based+Screening%3A+A+Powerful+Tool+in+Fragment-Based+Drug+Discovery&doi=10.1039%2FB709658P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1039%2FB709658P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB709658P%26sid%3Dliteratum%253Aachs%26aulast%3DKlages%26aufirst%3DJ.%26aulast%3DColes%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DNMR-Based%2520Screening%253A%2520A%2520Powerful%2520Tool%2520in%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DAnalyst%26date%3D2007%26volume%3D132%26spage%3D692%26epage%3D705%26doi%3D10.1039%2FB709658P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meiboom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, D.</span><span> </span><span class="NLM_article-title">Modified Spin-Echo Method for Measuring Nuclear Relaxation Times</span> <span class="citation_source-journal">Rev. Sci. Instrum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1063/1.1716296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1063%2F1.1716296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaF3cXosFWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1958&pages=688-691&author=S.+Meiboomauthor=D.+Gill&title=Modified+Spin-Echo+Method+for+Measuring+Nuclear+Relaxation+Times&doi=10.1063%2F1.1716296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Modified spin-echo method for measuring nuclear relaxation times</span></div><div class="casAuthors">Meiboom, S.; Gill, D.</div><div class="citationInfo"><span class="NLM_cas:title">Review of Scientific Instruments</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">688-91</span>CODEN:
                <span class="NLM_cas:coden">RSINAK</span>;
        ISSN:<span class="NLM_cas:issn">0034-6748</span>.
    </div><div class="casAbstract">The Carr-Purcell method for the measurement of long nuclear relaxation times in liquids (cf. CA 48, 8077e) has been further modified.  While the pulse sequence of the modified technique was identical to the original scheme, the necessity of a very accurate adjustment of the 180° pulses was eliminated and the reproducibility was improved.  A schematic diagram of the transmitter gate used in the app. is discussed, and the derivation and principle of the method is explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfTQfkWfruf7Vg90H21EOLACvtfcHk0liI6m25PtBF5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3cXosFWitQ%253D%253D&md5=ecf0073dea1daa97157b5e2b6b62dc73</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1063%2F1.1716296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.1716296%26sid%3Dliteratum%253Aachs%26aulast%3DMeiboom%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DD.%26atitle%3DModified%2520Spin-Echo%2520Method%2520for%2520Measuring%2520Nuclear%2520Relaxation%2520Times%26jtitle%3DRev.%2520Sci.%2520Instrum.%26date%3D1958%26volume%3D29%26spage%3D688%26epage%3D691%26doi%3D10.1063%2F1.1716296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fersht, A. R.</span><span> </span><span class="NLM_article-title">Toward the Rational Design of p53- Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2Fj.chembiol.2009.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=20142040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=46-56&author=N.+Basseauthor=J.+L.+Kaarauthor=G.+Settanniauthor=A.+C.+Joergerauthor=T.+J.+Rutherfordauthor=A.+R.+Fersht&title=Toward+the+Rational+Design+of+p53-+Stabilizing+Drugs%3A+Probing+the+Surface+of+the+Oncogenic+Y220C+Mutant&doi=10.1016%2Fj.chembiol.2009.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant</span></div><div class="casAuthors">Basse, Nicolas; Kaar, Joel L.; Settanni, Giovanni; Joerger, Andreas C.; Rutherford, Trevor J.; Fersht, Alan R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-56</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The p53 cancer mutation Y220C induces formation of a cavity on the protein's surface that can accommodate stabilizing small mols.  We combined fragment screening and mol. dynamics to assess the druggability of p53-Y220C and map ligand interaction sites within the mutational cavity.  Elucidation of the binding mode of fragment hits by crystallog. yielded a clear picture of how a drug might dock in the cavity.  Simulations that solvate the protein with isopropanol found addnl. sites that extend the druggable surface.  Moreover, structural observations and simulation revealed the dynamic landscape of the cavity, which improves our understanding of the impact of the mutation on p53 stability.  This underpins the importance of considering flexibility of the cavity in screening for optimized ligands.  Our findings provide a blueprint for the design of effective drugs that rescue p53-Y220C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJc5HAxcEvgLVg90H21EOLACvtfcHk0liI6m25PtBF5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ns70%253D&md5=9b7ada8df99710cc4f77c75e43b2e617</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DKaar%26aufirst%3DJ.%2BL.%26aulast%3DSettanni%26aufirst%3DG.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DRutherford%26aufirst%3DT.%2BJ.%26aulast%3DFersht%26aufirst%3DA.%2BR.%26atitle%3DToward%2520the%2520Rational%2520Design%2520of%2520p53-%2520Stabilizing%2520Drugs%253A%2520Probing%2520the%2520Surface%2520of%2520the%2520Oncogenic%2520Y220C%2520Mutant%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D46%26epage%3D56%26doi%3D10.1016%2Fj.chembiol.2009.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Enderle, T.; Roth, D.</span><span> </span><span class="NLM_article-title">Method for the Identification of Catechol O-Methyltransferase Modulators</span>. WO/2012/013614 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Enderle&author=D.+Roth&title=Method+for+the+Identification+of+Catechol+O-Methyltransferase+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEnderle%26aufirst%3DT.%26atitle%3DMethod%2520for%2520the%2520Identification%2520of%2520Catechol%2520O-Methyltransferase%2520Modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mortenson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span> </span><span class="NLM_article-title">Assessing the Lipophilicity of Fragments and Early Hits</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span><span class="refDoi"> DOI: 10.1007/s10822-011-9435-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1007%2Fs10822-011-9435-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=21614595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=663-667&author=P.+N.+Mortensonauthor=C.+W.+Murray&title=Assessing+the+Lipophilicity+of+Fragments+and+Early+Hits&doi=10.1007%2Fs10822-011-9435-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the lipophilicity of fragments and early hits</span></div><div class="casAuthors">Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits.  This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small.  Ligand efficiency (LE) considers both the potency and the size of the mol., and enables us to est. whether or not an initial hit is likely to be optimizable to a potent, druglike lead.  While size is a key property that needs to be controlled in a small mol. drug, there are a no. of addnl. properties that should also be considered.  Lipophilicity is amongst the most important of these addnl. properties, and here we present a new efficiency index (LLEAT) that combines lipophilicity, size and potency.  The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists.  Monitoring both LE and LLEAT should help both in the selection of more promising fragment hits, and controlling mol. wt. and lipophilicity during optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnbfcwp30BrVg90H21EOLACvtfcHk0liI6m25PtBF5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL&md5=e6d68046d3d20bd2ea088ce218451c25</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9435-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9435-z%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DAssessing%2520the%2520Lipophilicity%2520of%2520Fragments%2520and%2520Early%2520Hits%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26spage%3D663%26epage%3D667%26doi%3D10.1007%2Fs10822-011-9435-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lanier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellery, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosbeary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadotani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saikatendu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hixon, M. S.</span><span> </span><span class="NLM_article-title">A Fragment-Based Approach to Identifying <i>S</i>-Adenosyl-L-Methionine -Competitive Inhibitors of Catechol <i>O</i>-Methyl Transferase (COMT)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5459</span><span class="NLM_x">–</span> <span class="NLM_lpage">5463</span><span class="refDoi"> DOI: 10.1021/jm500475k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500475k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5459-5463&author=M.+Lanierauthor=G.+Ambrusauthor=D.+C.+Coleauthor=R.+Davenportauthor=J.+Elleryauthor=R.+Fosbearyauthor=A.+J.+Jenningsauthor=A.+Kadotaniauthor=Y.+Kamadaauthor=R.+Kamranauthor=S.-I.+Matsumotoauthor=A.+Mizukamiauthor=S.+Okuboauthor=K.+Okadaauthor=K.+Saikatenduauthor=L.+Walshauthor=H.+Wuauthor=M.+S.+Hixon&title=A+Fragment-Based+Approach+to+Identifying+S-Adenosyl-L-Methionine+-Competitive+Inhibitors+of+Catechol+O-Methyl+Transferase+%28COMT%29&doi=10.1021%2Fjm500475k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm500475k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500475k%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DAmbrus%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DEllery%26aufirst%3DJ.%26aulast%3DFosbeary%26aufirst%3DR.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKadotani%26aufirst%3DA.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DKamran%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DS.-I.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DSaikatendu%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHixon%26aufirst%3DM.%2BS.%26atitle%3DA%2520Fragment-Based%2520Approach%2520to%2520Identifying%2520S-Adenosyl-L-Methionine%2520-Competitive%2520Inhibitors%2520of%2520Catechol%2520O-Methyl%2520Transferase%2520%2528COMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5459%26epage%3D5463%26doi%3D10.1021%2Fjm500475k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">Absolute configuration was confirmed for enantiomers <b>18R</b>/<b>18S</b> and <b>19R</b>/<b>19S</b> and for <b>22</b> and <b>23</b> by enantioselective synthesis of one enantiomer using the corresponding chiral aldehydes or X-ray crystallography. We observed that the <i>R</i> enantiomers have a negative optical rotation (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf" class="ext-link">Supporting Information</a> for data on pyrazolo-pyrazole analogs of compounds <b>15</b> and <b>24</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinman, J. P.</span><span> </span><span class="NLM_article-title">Enzymatic Transfer; Role of and Active Site Residue in Generating Active Site Compaction that Correlates with Catalytic Efficiency</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">17134</span><span class="NLM_x">–</span> <span class="NLM_lpage">17137</span><span class="refDoi"> DOI: 10.1021/ja207467d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja207467d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=17134-17137&author=J.+Zhangauthor=J.+P.+Klinman&title=Enzymatic+Transfer%3B+Role+of+and+Active+Site+Residue+in+Generating+Active+Site+Compaction+that+Correlates+with+Catalytic+Efficiency&doi=10.1021%2Fja207467d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fja207467d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja207467d%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26atitle%3DEnzymatic%2520Transfer%253B%2520Role%2520of%2520and%2520Active%2520Site%2520Residue%2520in%2520Generating%2520Active%2520Site%2520Compaction%2520that%2520Correlates%2520with%2520Catalytic%2520Efficiency%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D17134%26epage%3D17137%26doi%3D10.1021%2Fja207467d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulik, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinman, J. P.</span><span> </span><span class="NLM_article-title">Mediation of Donor-Acceptor Distance in an Enzymatic Methyl Transfer Reaction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">7954</span><span class="NLM_x">–</span> <span class="NLM_lpage">7959</span><span class="refDoi"> DOI: 10.1073/pnas.1506792112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1073%2Fpnas.1506792112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=26080432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSit7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=7954-7959&author=J.+Zhangauthor=H.+J.+Kulikauthor=T.+J.+Martinezauthor=J.+P.+Klinman&title=Mediation+of+Donor-Acceptor+Distance+in+an+Enzymatic+Methyl+Transfer+Reaction&doi=10.1073%2Fpnas.1506792112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Mediation of donor-acceptor distance in an enzymatic methyl transfer reaction</span></div><div class="casAuthors">Zhang, Jianyu; Kulik, Heather J.; Martinez, Todd J.; Klinman, Judith P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7954-7959</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enzymic Me transfer, catalyzed by catechol-O-methyltransferase (COMT), is investigated using binding isotope effects (BIEs), time-resolved fluorescence lifetimes, Stokes shifts, and extended graphics processing unit (GPU)-based quantum mechanics/mol. mechanics (QM/MM) approaches.  The WT enzyme is compared with mutants at Tyr68, a conserved residue that is located behind the reactive sulfur of cofactor.  Small (>1) BIEs are obsd. for an S-adenosylmethionine (AdoMet)-binary and abortive ternary complex contg. 8-hydroxyquinoline, and contrast with previously reported inverse (<1) kinetic isotope effects (KIEs).  Extended GPU-based computational studies of a ternary complex contg. catecholate show a clear trend in ground state structures, from noncanonical bond lengths for WT toward soln. values with mutants.  Structural and dynamical differences that are sensitive to Tyr68 have also been detected using time-resolved Stokes shift measurements and mol. dynamics.  These exptl. and computational results are discussed in the context of active site compaction that requires an ionization of substrate within the enzyme ternary complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUXlL6tcX_srVg90H21EOLACvtfcHk0liYIco6cal9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSit7rL&md5=f89dc78bd1fc331ac7061eef6c69f899</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1506792112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1506792112%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKulik%26aufirst%3DH.%2BJ.%26aulast%3DMartinez%26aufirst%3DT.%2BJ.%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26atitle%3DMediation%2520of%2520Donor-Acceptor%2520Distance%2520in%2520an%2520Enzymatic%2520Methyl%2520Transfer%2520Reaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D7954%26epage%3D7959%26doi%3D10.1073%2Fpnas.1506792112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span> </span><span class="NLM_article-title">Crystal Structures of the Apo and Holo Form of Rat Catechol-<i>O</i>-Methyltransferase</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1016/j.jsb.2008.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2Fj.jsb.2008.11.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2009&pages=133-139&author=E.+Tsujiauthor=K.+Okazakiauthor=M.+Isajiauthor=K.+Takeda&title=Crystal+Structures+of+the+Apo+and+Holo+Form+of+Rat+Catechol-O-Methyltransferase&doi=10.1016%2Fj.jsb.2008.11.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2008.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2008.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DOkazaki%26aufirst%3DK.%26aulast%3DIsaji%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DK.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520Apo%2520and%2520Holo%2520Form%2520of%2520Rat%2520Catechol-O-Methyltransferase%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2009%26volume%3D165%26spage%3D133%26epage%3D139%26doi%3D10.1016%2Fj.jsb.2008.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c'],'ref16':[],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':[],'ref23':[],'ref24':['cit24a','cit24b'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Andreas
N. Baumann, Franziska Schüppel, Michael Eisold, Andrea Kreppel, Regina de Vivie-Riedle, <span class="NLM_string-name hlFld-ContribAuthor">Dorian Didier</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative Ring Contraction of Cyclobutenes: General Approach to Cyclopropylketones including Mechanistic Insights. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (9)
                                     , 4905-4921. <a href="https://doi.org/10.1021/acs.joc.8b00297" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00297%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOxidative%252BRing%252BContraction%252Bof%252BCyclobutenes%25253A%252BGeneral%252BApproach%252Bto%252BCyclopropylketones%252Bincluding%252BMechanistic%252BInsights%26aulast%3DBaumann%26aufirst%3DAndreas%2BN.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01022018%26date%3D16042018%26date%3D11042018%26volume%3D83%26issue%3D9%26spage%3D4905%26epage%3D4921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher N. Johnson, Daniel A. Erlanson, Wolfgang Jahnke, Paul N. Mortenson, <span class="NLM_string-name hlFld-ContribAuthor">David C. Rees</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2016. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1774-1784. <a href="https://doi.org/10.1021/acs.jmedchem.7b01298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2016%26aulast%3DJohnson%26aufirst%3DChristopher%2BN.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D31082017%26date%3D31102017%26volume%3D61%26issue%3D5%26spage%3D1774%26epage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sundararajan  Balasubramani</span>, <span class="hlFld-ContribAuthor ">Shuo  Lv</span>, <span class="hlFld-ContribAuthor ">Qiyang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqin  Zhou</span>, <span class="hlFld-ContribAuthor ">M.D. Saravana  Moorthy</span>, <span class="hlFld-ContribAuthor ">D.  Sathish</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Moola</span>. </span><span class="cited-content_cbyCitation_article-title">A systematic review of the O-methyltransferase gene expression. </span><span class="cited-content_cbyCitation_journal-name">Plant Gene</span><span> <strong>2021,</strong> <em>27 </em>, 100295. <a href="https://doi.org/10.1016/j.plgene.2021.100295" title="DOI URL">https://doi.org/10.1016/j.plgene.2021.100295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.plgene.2021.100295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.plgene.2021.100295%26sid%3Dliteratum%253Aachs%26jtitle%3DPlant%2520Gene%26atitle%3DA%252Bsystematic%252Breview%252Bof%252Bthe%252BO-methyltransferase%252Bgene%252Bexpression%26aulast%3DBalasubramani%26aufirst%3DSundararajan%26date%3D2021%26volume%3D27%26spage%3D100295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-35. <a href="https://doi.org/10.1002/0471266949.bmc265" title="DOI URL">https://doi.org/10.1002/0471266949.bmc265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc265%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLead%252BDiscovery%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D35%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Cruz-Vicente</span>, <span class="hlFld-ContribAuthor ">Luís A.  Passarinha</span>, <span class="hlFld-ContribAuthor ">Samuel  Silvestre</span>, <span class="hlFld-ContribAuthor ">Eugenia  Gallardo</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (8)
                                     , 2193. <a href="https://doi.org/10.3390/molecules26082193" title="DOI URL">https://doi.org/10.3390/molecules26082193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26082193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26082193%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BDevelopments%252Bin%252BNew%252BTherapeutic%252BAgents%252Bagainst%252BAlzheimer%252Band%252BParkinson%252BDiseases%25253A%252BIn-Silico%252BApproaches%26aulast%3DCruz-Vicente%26aufirst%3DPedro%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D8%26spage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang-Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Dong-Fang  Zhao</span>, <span class="hlFld-ContribAuthor ">Frank J.  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Yu-Fan  Fan</span>, <span class="hlFld-ContribAuthor ">Yang-Liu  Xia</span>, <span class="hlFld-ContribAuthor ">Guang-Bo  Ge</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Analysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 15-27. <a href="https://doi.org/10.1016/j.jpha.2020.03.012" title="DOI URL">https://doi.org/10.1016/j.jpha.2020.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpha.2020.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpha.2020.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Analysis%26atitle%3DAnalytical%252Bmethodologies%252Bfor%252Bsensing%252Bcatechol-O-methyltransferase%252Bactivity%252Band%252Btheir%252Bapplications%26aulast%3DWang%26aufirst%3DFang-Yuan%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang-Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Gui-Lin  Wei</span>, <span class="hlFld-ContribAuthor ">Yu-Fan  Fan</span>, <span class="hlFld-ContribAuthor ">Dong-Fang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Wei  Zou</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of catechol-
              O
              -methyltransferase by natural pentacyclic triterpenes: structure–activity relationships and kinetic mechanism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1079-1087. <a href="https://doi.org/10.1080/14756366.2021.1928112" title="DOI URL">https://doi.org/10.1080/14756366.2021.1928112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1928112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1928112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Bcatechol-%252BO%252B-methyltransferase%252Bby%252Bnatural%252Bpentacyclic%252Btriterpenes%25253A%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Band%252Bkinetic%252Bmechanism%26aulast%3DWang%26aufirst%3DFang-Yuan%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1079%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago Barros  Silva</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">Maria Paula  Serrão</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Liver says no: the ongoing search for safe catechol O-methyltransferase inhibitors to replace tolcapone. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (10)
                                     , 1846-1854. <a href="https://doi.org/10.1016/j.drudis.2020.07.015" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DLiver%252Bsays%252Bno%25253A%252Bthe%252Bongoing%252Bsearch%252Bfor%252Bsafe%252Bcatechol%252BO-methyltransferase%252Binhibitors%252Bto%252Breplace%252Btolcapone%26aulast%3DSilva%26aufirst%3DTiago%2BBarros%26date%3D2020%26volume%3D25%26issue%3D10%26spage%3D1846%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iasmin Ramos  da Silva</span>, <span class="hlFld-ContribAuthor ">Michelle Rocha  Parise</span>, <span class="hlFld-ContribAuthor ">Maristela  Pereira</span>, <span class="hlFld-ContribAuthor ">Roosevelt Alves  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Prospecting for new catechol-
              O
              -methyltransferase (COMT) inhibitors as a potential treatment for Parkinson’s disease: a study by molecular dynamics and structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>2 </em>, 1-20. <a href="https://doi.org/10.1080/07391102.2020.1794963" title="DOI URL">https://doi.org/10.1080/07391102.2020.1794963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1794963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1794963%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DProspecting%252Bfor%252Bnew%252Bcatechol-%252BO%252B-methyltransferase%252B%252528COMT%252529%252Binhibitors%252Bas%252Ba%252Bpotential%252Btreatment%252Bfor%252BParkinson%2525E2%252580%252599s%252Bdisease%25253A%252Ba%252Bstudy%252Bby%252Bmolecular%252Bdynamics%252Band%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3Dda%2BSilva%26aufirst%3DIasmin%2BRamos%26date%3D2020%26date%3D2020%26volume%3D2%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">M. Shahar  Yar</span>, <span class="hlFld-ContribAuthor ">Gourav  Grover</span>, <span class="hlFld-ContribAuthor ">Rajarshi  Nath</span>. </span><span class="cited-content_cbyCitation_article-title">Neurological and psychiatric management using COMT inhibitors: A review. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103418. <a href="https://doi.org/10.1016/j.bioorg.2019.103418" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103418%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNeurological%252Band%252Bpsychiatric%252Bmanagement%252Busing%252BCOMT%252Binhibitors%25253A%252BA%252Breview%26aulast%3DAkhtar%26aufirst%3DMd%2BJawaid%26date%3D2020%26volume%3D94%26spage%3D103418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Luo</span>, <span class="hlFld-ContribAuthor ">Anne Sofie L.  Hansen</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Konstantin  Schneider</span>, <span class="hlFld-ContribAuthor ">Mette  Kristensen</span>, <span class="hlFld-ContribAuthor ">Ulla  Christensen</span>, <span class="hlFld-ContribAuthor ">Hanne B.  Christensen</span>, <span class="hlFld-ContribAuthor ">Bin  Du</span>, <span class="hlFld-ContribAuthor ">Emre  Özdemir</span>, <span class="hlFld-ContribAuthor ">Adam M.  Feist</span>, <span class="hlFld-ContribAuthor ">Jay D.  Keasling</span>, <span class="hlFld-ContribAuthor ">Michael K.  Jensen</span>, <span class="hlFld-ContribAuthor ">Markus J.  Herrgård</span>, <span class="hlFld-ContribAuthor ">Bernhard O.  Palsson</span>, . </span><span class="cited-content_cbyCitation_article-title">Coupling S-adenosylmethionine–dependent methylation to growth: Design and uses. </span><span class="cited-content_cbyCitation_journal-name">PLOS Biology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (3)
                                     , e2007050. <a href="https://doi.org/10.1371/journal.pbio.2007050" title="DOI URL">https://doi.org/10.1371/journal.pbio.2007050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pbio.2007050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pbio.2007050%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Biology%26atitle%3DCoupling%252BS-adenosylmethionine%2525E2%252580%252593dependent%252Bmethylation%252Bto%252Bgrowth%25253A%252BDesign%252Band%252Buses%26aulast%3DLuo%26aufirst%3DHao%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D3%26spage%3De2007050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colm M P  O'Tuathaigh</span>, <span class="hlFld-ContribAuthor ">Paula M  Moran</span>, <span class="hlFld-ContribAuthor ">Xuechu C  Zhen</span>, <span class="hlFld-ContribAuthor ">John L  Waddington</span>. </span><span class="cited-content_cbyCitation_article-title">Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2017,</strong> <em>174 </em>
                                    (19)
                                     , 3173-3190. <a href="https://doi.org/10.1111/bph.13938" title="DOI URL">https://doi.org/10.1111/bph.13938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13938%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DTranslating%252Badvances%252Bin%252Bthe%252Bmolecular%252Bbasis%252Bof%252Bschizophrenia%252Binto%252Bnovel%252Bcognitive%252Btreatment%252Bstrategies%26aulast%3DO%2527Tuathaigh%26aufirst%3DColm%2BM%2BP%26date%3D2017%26date%3D2017%26volume%3D174%26issue%3D19%26spage%3D3173%26epage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben J.  Davis</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 371-439. <a href="https://doi.org/10.1016/bs.armc.2017.07.002" title="DOI URL">https://doi.org/10.1016/bs.armc.2017.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2017.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2017.07.002%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BLead%252BDiscovery%26aulast%3DDavis%26aufirst%3DBen%2BJ.%26date%3D2017%26spage%3D371%26epage%3D439%26pub%3DElsevier%26atitle%3DPlatform%252BTechnologies%252Bin%252BDrug%252BDiscovery%252Band%252BValidation%26date%3D2017%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Reported COMT inhibitors. (B) Interactions for bisubstrate inhibitors binding to SAM and Mg<sup>2+</sup> pockets.<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selection of specific mutants on the adenosine binding pocket. Amino acids in bold (Glu90, Ser119, and His142) were mutated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of the crystal structures of rat COMT<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (orange) in complex with <i>S</i>-adenosylmethionine (SAM, yellow), dinitrocatechol (DNC, yellow), magnesium (Mg<sup>2+</sup>), and humanized rat COMT (gray) bound to fragment <b>2</b> (green). Met91 of the rat COMT is mutated in the humanized protein to Ile91.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of humanized rat COMT with fragment <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of humanized rat COMT with fragment <b>8</b>, oriented in order to show the small pocket at position 4 in the thiazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Crystal structure of humanized rat COMT with inhibitor <b>24</b>: hydrogen bonds (black) and hydrophobic interactions (blue) indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Superposition of the crystal structures of humanized rat COMT with inhibitors reported in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>: <b>22+23</b> (both in orange, cocrystallized as racemate PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0f">5k0f</a>), <b>18</b> (blue, cocrystallized as racemate, however one enantiomer (<b>18R</b>) observed in the electron density, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0b">5k0b</a>), <b>20</b> (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0c">5k0c</a>), and <b>24</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k01">5k01</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>10</b>–<b>16</b> Described in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, 0 °C, 15 min, then R<sub>2</sub>CO<sub>2</sub>Et, 0–100 °C, 1–3 h, 56–65%; (ii) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH/25% aq HCl (80:1), 60 °C, overnight 60–90%.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>17</b> in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, 0 °C, 30 min, then <b>27</b>, 0–100 °C, 1 h, 63%; (ii) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH/25% aq HCl (80:1), 60 °C, 3 h, 99%; (iii) <b>29</b>, Cs<sub>2</sub>CO<sub>3</sub>, (PPh<sub>3</sub>)<sub>4</sub>Pd, dioxane, H<sub>2</sub>O (4:1), 165 °C, microwave, 20 min, 51%.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/medium/jm-2016-009272_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>18</b>–<b>24</b> Described in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b00927/20161118/images/large/jm-2016-009272_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00927&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiAlH<sub>4</sub>, THF, 0–20 °C, 70–98%; (ii) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 10 h, 70–83%; (iii) <b>25</b>, LiN(SiMe<sub>3</sub>)<sub>2</sub>, THF, −78 °C, 0.5 h; then <b>32</b>, 3 h, −78 °C, 60–99%; (iv) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 5 h, 61–88%; (v) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH/25% aq HCl (80:1), 60 °C, 4 h, 61–92%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Apud, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Treatment of Cognitive Deficits Associated with Schizophrenia, Potential Role of Catechol-<i>O</i>-Methyltransferase Inhibitors</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span><span class="refDoi"> DOI: 10.2165/00023210-200721070-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2165%2F00023210-200721070-00002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=535-557&author=J.+A.+Apudauthor=D.+R.+Weinberger&title=Treatment+of+Cognitive+Deficits+Associated+with+Schizophrenia%2C+Potential+Role+of+Catechol-O-Methyltransferase+Inhibitors&doi=10.2165%2F00023210-200721070-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.2165%2F00023210-200721070-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200721070-00002%26sid%3Dliteratum%253Aachs%26aulast%3DApud%26aufirst%3DJ.%2BA.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTreatment%2520of%2520Cognitive%2520Deficits%2520Associated%2520with%2520Schizophrenia%252C%2520Potential%2520Role%2520of%2520Catechol-O-Methyltransferase%2520Inhibitors%26jtitle%3DCNS%2520Drugs%26date%3D2007%26volume%3D21%26spage%3D535%26epage%3D557%26doi%3D10.2165%2F00023210-200721070-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Tuathaigh, C. M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desbonnet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waddington, J. L.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-Methyl Transferase as a Drug Target for Schizophrenia</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.2174/187152712800672418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2174%2F187152712800672418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22483298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFekur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=282-291&author=C.+M.+P.+O%E2%80%99Tuathaighauthor=L.+Desbonnetauthor=P.+Leeauthor=J.+L.+Waddington&title=Catechol-O-Methyl+Transferase+as+a+Drug+Target+for+Schizophrenia&doi=10.2174%2F187152712800672418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyl transferase as a drug target for schizophrenia</span></div><div class="casAuthors">O'Tuathaigh, Colm M. P.; Desbonnet, Lieve; Lee, Peter; Waddington, John L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">282-291</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Current antipsychotic drugs lack material efficacy against the neg. symptoms and cognitive deficits of schizophrenia.  There is considerable uncertainty regarding the optimal pharmacotherapeutic strategy for treating these and other aspects of psychotic illness.  The present review summarises clin., mutant, and psychopharmacol. data related to catechol-O-methyltransferase (COMT), an enzyme involved in the catabolism of catecholamine neurotransmitters, with a view to establishing the antipsychotic potential of compds. targeting the action of this enzyme.  The review examines clin. and preclin. genetic data linking COMT gene variation with risk for schizophrenia or specific symptoms or disease endophenotypes.  We then summarise data concerning the behavioral effects of COMT inhibitors.  These genetic and pharmacol. data relating to COMT as a therapeutic target have implications for the development of individualised treatments for treatment-resistant symptoms of schizophrenia, including cognitive dysfunction and, potentially, neg. symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpUrWoWYdrlrVg90H21EOLACvtfcHk0lgfB_bqmm3-_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFekur8%253D&md5=7e601317b307aed4862ad322f5b21aef</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2174%2F187152712800672418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152712800672418%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Tuathaigh%26aufirst%3DC.%2BM.%2BP.%26aulast%3DDesbonnet%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DWaddington%26aufirst%3DJ.%2BL.%26atitle%3DCatechol-O-Methyl%2520Transferase%2520as%2520a%2520Drug%2520Target%2520for%2520Schizophrenia%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D11%26spage%3D282%26epage%3D291%26doi%3D10.2174%2F187152712800672418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kiss, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and their Therapeutic Utility</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8692</span><span class="NLM_x">–</span> <span class="NLM_lpage">8717</span><span class="refDoi"> DOI: 10.1021/jm500572b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500572b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8692-8717&author=L.+E.+Kissauthor=P.+Soares-da-Silva&title=Medicinal+Chemistry+of+Catechol+O-Methyltransferase+%28COMT%29+Inhibitors+and+their+Therapeutic+Utility&doi=10.1021%2Fjm500572b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility</span></div><div class="casAuthors">Kiss, Laszlo E.; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8692-8717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Catechol O-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures.  COMT is a druggable biol. target for the treatment of various central and peripheral nervous system disorders, including Parkinson's disease, depression, schizophrenia, and other dopamine deficiency-related diseases.  The purpose of this perspective is fourfold: (i) to summarize the physiol. role of COMT inhibitors in central and peripheral nervous system disorders; (ii) to provide the history and perspective of the medicinal chem. behind the discovery and development of COMT inhibitors; (iii) to discuss how the physicochem. properties of recognized COMT inhibitors are understood to exert influence over their pharmacol. properties; and (iv) to evaluate the clin. benefits of the most relevant COMT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_JOcVUbOM4LVg90H21EOLACvtfcHk0lgfB_bqmm3-_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git7rI&md5=60ddd0ce0b752ddb1bd8898805a8935b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm500572b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500572b%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DL.%2BE.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Catechol%2520O-Methyltransferase%2520%2528COMT%2529%2520Inhibitors%2520and%2520their%2520Therapeutic%2520Utility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8692%26epage%3D8717%26doi%3D10.1021%2Fjm500572b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jorga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotteler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heizmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, R.</span><span> </span><span class="NLM_article-title">Metabolism and Excretion of Tolcapone, a Novel Inhibitor of Catechol-O-Methyltransferase</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1046/j.1365-2125.1999.00036.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1046%2Fj.1365-2125.1999.00036.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10583021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=513-520&author=K.+Jorgaauthor=B.+Fottelerauthor=P.+Heizmannauthor=R.+Gasser&title=Metabolism+and+Excretion+of+Tolcapone%2C+a+Novel+Inhibitor+of+Catechol-O-Methyltransferase&doi=10.1046%2Fj.1365-2125.1999.00036.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase</span></div><div class="casAuthors">Jorga, Karin; Fotteler, Barbel; Heizmann, Peter; Gasser, Rodolfo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-520</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The rate of excretion and routes of metab. of tolcapone, a novel inhibitor of catechol-O-methyltransferase (COMT) were studied.  Six healthy male volunteers were given 200 mg [14C]-tolcapone (approx. 50 μCi) orally.  To assess excretion balance and to identify metabolites, urine and feces were collected before administration and until radioactivity fell below 75 d min-1 ml-1 (urine) and 100 d min-1 mg-1 (feces).  Blood samples were collected frequently before and after administration to det. plasma radioactivity, to identify tolcapone metabolites and to measure plasma tolcapone and its methylated deriv. 3-O-methyltolcapone (3-OMT).  The mean proportion of the dose excreted in urine was 57.3% and in feces 40.5%.  Excretion was almost complete (more than 95%) in all participants after 9 days.  The major early metabolite present in plasma was the 3-O-β,D-glucuronide conjugate, which was detectable within 2 h after dosing.  The major late metabolite in plasma was 3-OMT.  The 3-O-β,D-glucuronide was also the most abundant metabolite in urine and feces, accounting for 27% and 33%, resp., of the total radioactivity excreted by these routes and for 26% of the original dose.  Redn. of the nitro moiety yields an amine deriv., detected in both urine and feces, with subsequent modifications, such as acetylation of the amine group and conjugation with glucuronic acid or sulfate, or both.  Oxidative reactions due to cytochrome P 450 enzymes are of small significance, as is 3-O-methylation by COMT.  Tolcapone is almost completely metabolized and excreted in urine and feces (only 0.5% of tolcapone was excreted unchanged); glucuronidation is the most important route of metab.  The relatively long duration of excretion is caused by the long half-life of 3-OMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomxbJ3foHx37Vg90H21EOLACvtfcHk0lgfB_bqmm3-_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D&md5=53200da79657f3560fc6de831654cd86</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.1999.00036.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.1999.00036.x%26sid%3Dliteratum%253Aachs%26aulast%3DJorga%26aufirst%3DK.%26aulast%3DFotteler%26aufirst%3DB.%26aulast%3DHeizmann%26aufirst%3DP.%26aulast%3DGasser%26aufirst%3DR.%26atitle%3DMetabolism%2520and%2520Excretion%2520of%2520Tolcapone%252C%2520a%2520Novel%2520Inhibitor%2520of%2520Catechol-O-Methyltransferase%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1999%26volume%3D48%26spage%3D513%26epage%3D520%26doi%3D10.1046%2Fj.1365-2125.1999.00036.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-Methyltransferase and its Inhibitors in Parkinson’s Disease</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2007.00020.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1111%2Fj.1527-3458.2007.00020.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=17894650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1aksrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=352-379&author=M.+J.+Bonif%C3%A1cioauthor=P.+N.+Palmaauthor=L.+Almeidaauthor=P.+Soares-da-Silva&title=Catechol-O-Methyltransferase+and+its+Inhibitors+in+Parkinson%E2%80%99s+Disease&doi=10.1111%2Fj.1527-3458.2007.00020.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase and its inhibitors in Parkinson's disease</span></div><div class="casAuthors">Bonifacio, Maria Joao; Palma, P. Nuno; Almeida, Luis; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-379</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurol. disorder characterized by the degeneration of dopaminergic neurons, with consequent redn. in striatal dopamine levels leading to characteristic motor symptoms.  The most effective treatment for this disease continues to be the dopamine replacement therapy with levodopa together with an inhibitor of arom. amino acid decarboxylase (AADC).  The efficacy of this therapy, however, decreases with time and most patients develop fluctuating responses and dyskinesias.  The last decade showed that the use of catechol-O-methyltransferase inhibitors as adjuvants to the levodopa/AADC inhibitor therapy, significantly improves the clin. benefits of this therapy.  The purpose of this article is to review the current knowledge on the enzyme catechol-O-methyltransferase (COMT) and the role of COMT inhibitors in PD as a new therapeutic approach to PD involving conversion of levodopa to dopamine at the target region in the brain and facilitation of the continuous action of this amine at the receptor sites.  A historical overview of the discovery and development of COMT inhibitors is presented with a special emphasis on nebicapone, presently under clin. development, as well as entacapone and tolcapone, which are already approved as adjuncts in the therapy of PD.  This article reviews human pharmacokinetic and pharmacodynamic properties of these drugs as well as their clin. efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXMKaksd904LVg90H21EOLACvtfcHk0ljxfqDo5TquKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1aksrfF&md5=158db2bbed0a8efa49d2bd44fce59616</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2007.00020.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2007.00020.x%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DCatechol-O-Methyltransferase%2520and%2520its%2520Inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2007%26volume%3D13%26spage%3D352%26epage%3D379%26doi%3D10.1111%2Fj.1527-3458.2007.00020.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikkinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and Pharmacodynamics of Entacapone and Tolcapone after Acute and Repeated Administration: A Comparative Study in the Rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1124/jpet.102.042846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1124%2Fjpet.102.042846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=12538800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=498-506&author=M.+Forsbergauthor=M.+Lehtonenauthor=M.+Heikkinenauthor=J.+Savolainenauthor=T.+J%C3%A4rvinenauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Pharmacokinetics+and+Pharmacodynamics+of+Entacapone+and+Tolcapone+after+Acute+and+Repeated+Administration%3A+A+Comparative+Study+in+the+Rat&doi=10.1124%2Fjpet.102.042846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: A comparative study in the rat</span></div><div class="casAuthors">Forsberg, Markus; Lehtonen, Marko; Heikkinen, Minna; Savolainen, Jouko; Jarvinen, Tomi; Mannisto, Pekka T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">498-506</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Two catechol-O-methyltransferase (COMT) inhibitors, entacapone and tolcapone, were compared in the rat to elucidate the actual differences between their pharmacokinetics and pharmacodynamics after single and repeated administration.  Their inhibitory potencies were also compared in vitro.  After i.v. administration (3 mg/kg), the elimination half-life (t1/2β) of entacapone (0.8 h) was clearly shorter than that of tolcapone (2.9 h).  The striatum/serum ratio of tolcapone was 3-fold higher than that of entacapone.  After a single oral dose (10 mg/kg), both entacapone and tolcapone produced an equal maximal degree of COMT inhibition in peripheral tissues, but tolcapone inhibited striatal COMT more effectively than did entacapone.  After the 7-day treatment (10 mg/kg twice daily), COMT activity had recovered to a level of 67 to 101% of control within 8 h after the last dose of entacapone.  In tolcapone-treated animals, there was still extensive COMT inhibition present in peripheral tissues, and the degree of inhibition was higher than that attained after a single dose.  The pharmacokinetic-pharmacodynamic modeling revealed that a plateau of COMT inhibition near the maximal attainable inhibition was reached already by plasma concns. below 2000 ng/mL, both with entacapone and tolcapone.  Entacapone and tolcapone inhibited equally rat liver COMT in vitro with Ki values of 10.7 and 10.0 nM, resp.  In conclusion, tolcapone has a longer duration of action and a better brain penetration than entacapone.  The results also suggest that peripheral COMT is inhibited continuously when tolcapone is dosed at 12-h intervals, but this was not seen with entacapone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirtOEbWW5mrVg90H21EOLACvtfcHk0ljxfqDo5TquKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVChtA%253D%253D&md5=8221083765b1ce6aa7d02c9b58c8233b</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.042846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.042846%26sid%3Dliteratum%253Aachs%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DHeikkinen%26aufirst%3DM.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DPharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520Entacapone%2520and%2520Tolcapone%2520after%2520Acute%2520and%2520Repeated%2520Administration%253A%2520A%2520Comparative%2520Study%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D498%26epage%3D506%26doi%3D10.1124%2Fjpet.102.042846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ceravolo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-Dopa PET Evidence that Tolcapone Acts as a Central COMT Inhibitor in Parkinson’s Disease</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1002/syn.10034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fsyn.10034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=201-207&author=R.+Ceravoloauthor=P.+Picciniauthor=D.+L.+Baileyauthor=K.+M.+Jorgaauthor=H.+Brysonauthor=D.+J.+Brooks&title=18F-Dopa+PET+Evidence+that+Tolcapone+Acts+as+a+Central+COMT+Inhibitor+in+Parkinson%E2%80%99s+Disease&doi=10.1002%2Fsyn.10034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2Fsyn.10034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.10034%26sid%3Dliteratum%253Aachs%26aulast%3DCeravolo%26aufirst%3DR.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DBailey%26aufirst%3DD.%2BL.%26aulast%3DJorga%26aufirst%3DK.%2BM.%26aulast%3DBryson%26aufirst%3DH.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3D18F-Dopa%2520PET%2520Evidence%2520that%2520Tolcapone%2520Acts%2520as%2520a%2520Central%2520COMT%2520Inhibitor%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DSynapse%26date%3D2002%26volume%3D43%26spage%3D201%26epage%3D207%26doi%3D10.1002%2Fsyn.10034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-<i>O</i>-Methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4040</span><span class="NLM_x">–</span> <span class="NLM_lpage">4042</span><span class="refDoi"> DOI: 10.1002/1521-3773(20011105)40:21<4040::AID-ANIE4040>3.0.CO;2-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=4040-4042&author=C.+Lernerauthor=A.+Rufauthor=V.+Gramlichauthor=B.+Masjostauthor=G.+Z%C3%BCrcherauthor=R.+Jakob-Roetneauthor=E.+Borroniauthor=F.+Diederich&title=X-ray+Crystal+Structure+of+a+Bisubstrate+Inhibitor+Bound+to+the+Enzyme+Catechol-O-Methyltransferase%3A+A+Dramatic+Effect+of+Inhibitor+Preorganization+on+Binding+Affinity&doi=10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820011105%252940%253A21%253C4040%253A%253AAID-ANIE4040%253E3.0.CO%253B2-C%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DX-ray%2520Crystal%2520Structure%2520of%2520a%2520Bisubstrate%2520Inhibitor%2520Bound%2520to%2520the%2520Enzyme%2520Catechol-O-Methyltransferase%253A%2520A%2520Dramatic%2520Effect%2520of%2520Inhibitor%2520Preorganization%2520on%2520Binding%2520Affinity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D4040%26epage%3D4042%26doi%3D10.1002%2F1521-3773%2820011105%2940%3A21%3C4040%3A%3AAID-ANIE4040%3E3.0.CO%3B2-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Bisubstrate Inhibitors of the Enzyme Catechol <i>O</i>-Methyltransferase (COMT): Efficient Inhibition Despite the Lack of a Nitro Group</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span><span class="refDoi"> DOI: 10.1002/cbic.200400084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fcbic.200400084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1270-1274&author=R.+Pauliniauthor=C.+Lernerauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+Inhibitors+of+the+Enzyme+Catechol+O-Methyltransferase+%28COMT%29%3A+Efficient+Inhibition+Despite+the+Lack+of+a+Nitro+Group&doi=10.1002%2Fcbic.200400084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200400084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200400084%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520Inhibitors%2520of%2520the%2520Enzyme%2520Catechol%2520O-Methyltransferase%2520%2528COMT%2529%253A%2520Efficient%2520Inhibition%2520Despite%2520the%2520Lack%2520of%2520a%2520Nitro%2520Group%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1270%26epage%3D1274%26doi%3D10.1002%2Fcbic.200400084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allemann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tissot, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span> </span><span class="NLM_article-title">Catechol-O-Methyltransferase in Complex with Substituted 3′-Deoxyribose Bisubstrate Inhibitors</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1107/S0907444912001138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1107%2FS0907444912001138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22349227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=253-260&author=M.+Ellermannauthor=C.+Lernerauthor=G.+Burgyauthor=A.+Ehlerauthor=C.+Bissantzauthor=R.+Jakob-Roetneauthor=R.+Pauliniauthor=O.+Allemannauthor=H.+Tissotauthor=D.+Grunsteinauthor=M.+Stihleauthor=F.+Diederichauthor=M.+G.+Rudolph&title=Catechol-O-Methyltransferase+in+Complex+with+Substituted+3%E2%80%B2-Deoxyribose+Bisubstrate+Inhibitors&doi=10.1107%2FS0907444912001138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Lerner, Christian; Burgy, Guillaume; Ehler, Andreas; Bissantz, Caterina; Jakob-Roetne, Roland; Paulini, Ralph; Allemann, Oliver; Tissot, Heloise; Gruenstein, Dan; Stihle, Martine; Diederich, Francois; Rudolph, Markus G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-260</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">High-resoln. structures of catechol-O-methyltransferase with ribose-modified inhibitors and Mg2+ identify the side chain of Glu90 as crucial for hydrogen bonding to the ribose hydroxyl groups.  Glu90 subtly aligns with the 2'-hydroxyl, but not the 3'-hydroxyl, group to increase binding affinity, explaining the obsd. activities of bisubstrate inhibitors with a 3'-desoxyribose moiety.  The biol. activity of catechol neurotransmitters such as dopamine in the synapse is modulated by transporters and enzymes.  Catechol-O-methyltransferase (COMT; EC 2.1.1.6) inactivates neurotransmitters by catalyzing the transfer of a Me group from S-adenosylmethionine to catechols in the presence of Mg2+.  This pathway also inactivates L-DOPA, the std. therapeutic for Parkinson's disease.  Depletion of catechol neurotransmitters in the prefrontal cortex has been linked to schizophrenia.  The inhibition of COMT therefore promises improvements in the treatment of these diseases.  The concept of bisubstrate inhibitors for COMT has been described previously.  Here, ribose-modified bisubstrate inhibitors were studied.  Three high-resoln. crystal structures of COMT in complex with novel ribose-modified bisubstrate inhibitors confirmed the predicted binding mode but displayed subtle alterations at the ribose-binding site.  The high affinity of the inhibitors can be convincingly rationalized from the structures, which document the possibility of removing and/or replacing the ribose 3'-hydroxyl group and provide a framework for further inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocHxOEL-zuzLVg90H21EOLACvtfcHk0liGkI_xBibkYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D&md5=2b1b40fde37e8eae240dd4a1c2c58c4f</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001138%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DAllemann%26aufirst%3DO.%26aulast%3DTissot%26aufirst%3DH.%26aulast%3DGrunstein%26aufirst%3DD.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26atitle%3DCatechol-O-Methyltransferase%2520in%2520Complex%2520with%2520Substituted%25203%25E2%2580%25B2-Deoxyribose%2520Bisubstrate%2520Inhibitors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D253%26epage%3D260%26doi%3D10.1107%2FS0907444912001138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6381</span><span class="refDoi"> DOI: 10.1002/chem.201003648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fchem.201003648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=21538606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6369-6381&author=M.+Ellermannauthor=R.+Pauliniauthor=R.+Jakob-Roetneauthor=C.+Lernerauthor=E.+Borroniauthor=D.+Rothauthor=A.+Ehlerauthor=W.+B.+Schweizerauthor=D.+Schlatterauthor=M.+G.+Rudolphauthor=F.+Diederich&title=Molecular+Recognition+at+the+Active+Site+of+Catechol-O-methyltransferase+%28COMT%29%3A+Adenine+Replacements+in+Bisubstrate+Inhibitors&doi=10.1002%2Fchem.201003648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Paulini, Ralph; Jakob-Roetne, Roland; Lerner, Christian; Borroni, Edilio; Roth, Doris; Ehler, Andreas; Schweizer, W. Bernd; Schlatter, Daniel; Rudolph, Markus G.; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6369-6381, S6369/1-S6369/95</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">L-Dopa, the std. therapeutic for Parkinson's disease, is inactivated by the enzyme catechol-O-methyltransferase (COMT).  COMT catalyzes the transfer of an activated Me group from S-adenosylmethionine (SAM) to its catechol substrates, such as L-dopa, in the presence of magnesium ions.  The mol. recognition properties of the SAM-binding site of COMT have been investigated only sparsely.  Here, we explore this site by structural alterations of the adenine moiety of bisubstrate inhibitors.  The mol. recognition of adenine is of special interest due to the great abundance and importance of this nucleobase in biol. systems.  Novel bisubstrate inhibitors with adenine replacements were developed by structure-based design and synthesized using a nucleosidation protocol introduced by Vorbrueggen and co-workers.  Key interactions of the adenine moiety with COMT were measured with a radiochem. assay.  Several bisubstrate inhibitors, most notably the adenine replacements thiopyridine, purine, N-methyladenine, and 6-methylpurine, displayed nanomolar IC50 values (median inhibitory concn.) for COMT down to 6 nM.  A series of six cocrystal structures of the bisubstrate inhibitors in ternary complexes with COMT and Mg2+ confirm our predicted binding mode of the adenine replacements.  The cocrystal structure of an inhibitor bearing no nucleobase can be regarded as an intermediate along the reaction coordinate of bisubstrate inhibitor binding to COMT.  Our studies show that solvation varies with the type of adenine replacement, whereas among the adenine derivs., the nitrogen atom at position 1 is essential for high affinity, while the exocyclic amino group is most efficiently substituted by a Me group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo1pH4WO4rXLVg90H21EOLACvtfcHk0liGkI_xBibkYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D&md5=2e3849c0801ab409dd4e41b9a5957a8b</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1002%2Fchem.201003648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201003648%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DRoth%26aufirst%3DD.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DMolecular%2520Recognition%2520at%2520the%2520Active%2520Site%2520of%2520Catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Adenine%2520Replacements%2520in%2520Bisubstrate%2520Inhibitors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D6369%26epage%3D6381%26doi%3D10.1002%2Fchem.201003648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><div class="note"><p class="first last">In vivo properties of hydroxypyridones derivatives are discussed where compounds required very high doses to reach meaningful brain exposure:</p></div><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandebo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polsky-Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhearn, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotter, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLoughlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N. A.</span><span> </span><span class="NLM_article-title">Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-<i>O</i>-Methyltransferase Inhibitors and Substrates</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1021/cn200109w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200109w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGru7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=129-140&author=R.+G.+Robinsonauthor=S.+M.+Smithauthor=S.+E.+Wolkenbergauthor=M.+Kandeboauthor=L.+Yaoauthor=C.+R.+Gibsonauthor=S.+T.+Harrisonauthor=S.+Polsky-Fisherauthor=J.+C.+Barrowauthor=P.+J.+Manleyauthor=J.+J.+Mulhearnauthor=K.+K.+Nandaauthor=J.+W.+Schubertauthor=B.+W.+Trotterauthor=Z.+Zhaoauthor=J.+M.+Sandersauthor=R.+F.+Smithauthor=D.+McLoughlinauthor=S.+Sharmaauthor=D.+L.+Hallauthor=T.+L.+Walkerauthor=J.+L.+Kershnerauthor=N.+Bhandariauthor=P.+H.+Hutsonauthor=N.+A.+Sachs&title=Characterization+of+Non-Nitrocatechol+Pan+and+Isoform+Specific+Catechol-O-Methyltransferase+Inhibitors+and+Substrates&doi=10.1021%2Fcn200109w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates</span></div><div class="casAuthors">Robinson, Ronald G.; Smith, Sean M.; Wolkenberg, Scott E.; Kandebo, Monika; Yao, Lihang; Gibson, Christopher R.; Harrison, Scott T.; Polsky-Fisher, Stacey; Barrow, James C.; Manley, Peter J.; Mulhearn, James J.; Nanda, Kausik K.; Schubert, Jeffrey W.; Trotter, B. Wesley; Zhao, Zhijian; Sanders, John M.; Smith, Robert F.; McLoughlin, Debra; Sharma, Sujata; Hall, Dawn L.; Walker, Tiffany L.; Kershner, Jennifer L.; Bhandari, Neetesh; Hutson, Pete H.; Sachs, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-140</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reduced dopamine neurotransmission in the prefrontal cortex has been implicated as causal for the neg. symptoms and cognitive deficit assocd. with schizophrenia; thus, a compd. which selectively enhances dopamine neurotransmission in the prefrontal cortex may have therapeutic potential.  Inhibition of catechol-O-methyltransferase (COMT, EC 2.1.1.6) offers a unique advantage, since this enzyme is the primary mechanism for the elimination of dopamine in cortical areas.  Since membrane bound COMT (MB-COMT) is the predominant isoform in human brain, a high throughput screen (HTS) to identify novel MB-COMT specific inhibitors was completed.  Subsequent optimization led to the identification of novel, non-nitrocatechol COMT inhibitors, some of which interact specifically with MB-COMT.  Compds. were characterized for in vitro efficacy vs. human and rat MB and sol. (S)-COMT.  Select compds. were administered to male Wistar rats, and ex vivo COMT activity, compd. levels in plasma and cerebrospinal fluid (CSF), and CSF dopamine metabolite levels were detd. as measures of preclin. efficacy.  Finally, novel non-nitrocatechol COMT inhibitors displayed less potent uncoupling of the mitochondrial membrane potential (MMP) compared to tolcapone as well as nonhepatotoxic entacapone, thus mitigating the risk of hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbigUdkIqxH7Vg90H21EOLACvtfcHk0liGkI_xBibkYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGru7%252FE&md5=c36c8e4964ce90ba45fe0e1555f6748b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcn200109w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200109w%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DKandebo%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DGibson%26aufirst%3DC.%2BR.%26aulast%3DHarrison%26aufirst%3DS.%2BT.%26aulast%3DPolsky-Fisher%26aufirst%3DS.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DNanda%26aufirst%3DK.%2BK.%26aulast%3DSchubert%26aufirst%3DJ.%2BW.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DR.%2BF.%26aulast%3DMcLoughlin%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%2BL.%26aulast%3DWalker%26aufirst%3DT.%2BL.%26aulast%3DKershner%26aufirst%3DJ.%2BL.%26aulast%3DBhandari%26aufirst%3DN.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DSachs%26aufirst%3DN.%2BA.%26atitle%3DCharacterization%2520of%2520Non-Nitrocatechol%2520Pan%2520and%2520Isoform%2520Specific%2520Catechol-O-Methyltransferase%2520Inhibitors%2520and%2520Substrates%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D129%26epage%3D140%26doi%3D10.1021%2Fcn200109w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span> </span><span class="NLM_article-title">First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of Phenolics</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3655</span><span class="NLM_x">–</span> <span class="NLM_lpage">3681</span><span class="refDoi"> DOI: 10.1002/jps.22568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fjps.22568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=21484808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=3655-3681&author=B.+Wuauthor=K.+Kulkarniauthor=S.+Basuauthor=S.+Zhangauthor=M.+Hu&title=First-Pass+Metabolism+via+UDP-Glucuronosyltransferase%3A+a+Barrier+to+Oral+Bioavailability+of+Phenolics&doi=10.1002%2Fjps.22568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics</span></div><div class="casAuthors">Wu, Baojian; Kulkarni, Kaustubh; Basu, Sumit; Zhang, Shuxing; Hu, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3655-3681</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Glucuronidation mediated by UDP-glucuronosyltransferases (UGTs) is a significant metabolic pathway that facilitates efficient elimination of numerous endobiotics and xenobiotics, including phenolics.  UGT genetic deficiency and polymorphisms or inhibition of glucuronidation by concomitant use of drugs are assocd. with inherited physiol. disorders or drug-induced toxicities.  Moreover, extensive glucuronidation can be a barrier to oral bioavailability as the first-pass glucuronidation (or premature clearance by UGTs) of orally administered agents usually results in the poor oral bioavailability and lack of efficacies.  This review focused on the first-pass glucuronidation of phenolics including natural polyphenols and pharmaceuticals.  The complexity of UGT-mediated metab. of phenolics is highlighted with species-, gender-, organ- and isoform-dependent specificity, as well as functional compensation between UGT1A and 2B subfamily.  In addn., recent advances are discussed with respect to the mechanisms of enzymic actions, including the important properties such as binding pocket size and phosphorylation requirements. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 100:3655-3681, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrChVweDmYyjbVg90H21EOLACvtfcHk0lhRHJH8S99g9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemsrs%253D&md5=b18e570f927808112e9603b3160a02c5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fjps.22568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22568%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DKulkarni%26aufirst%3DK.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DM.%26atitle%3DFirst-Pass%2520Metabolism%2520via%2520UDP-Glucuronosyltransferase%253A%2520a%2520Barrier%2520to%2520Oral%2520Bioavailability%2520of%2520Phenolics%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D3655%26epage%3D3681%26doi%3D10.1002%2Fjps.22568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Barrow, J. C.</span><span> </span><span class="NLM_article-title">Inhibitors of Catechol-O-Methyltransferase</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.2174/187152712800672517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2174%2F187152712800672517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22483290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFekurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=324-332&author=J.+C.+Barrow&title=Inhibitors+of+Catechol-O-Methyltransferase&doi=10.2174%2F187152712800672517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of catechol-O-methyltransferase</span></div><div class="casAuthors">Barrow, James C.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">324-332</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the identification of Catechol-O-Methyltransferase (COMT) by Axelrod in 1957, many inhibitors of this enzyme have been reported.  While COMT inhibition may be beneficial in a no. of disease states, most of the effort over the years has been directed at boosting L-DOPA concns. as adjunct treatment for Parkinson's disease.  This review summarizes the major classes of COMT inhibitors, from early catechol and pyrogallol variants to bisubstrate inhibitors.  The nitrocatechol substructure has proven to be a particularly productive scaffold, resulting in two marketed drugs and several improved drug candidates working their way through clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYoGtMWsRwLVg90H21EOLACvtfcHk0lhRHJH8S99g9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFekurs%253D&md5=ad380403a4e60ee1ae057c3e4622319f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F187152712800672517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152712800672517%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26atitle%3DInhibitors%2520of%2520Catechol-O-Methyltransferase%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D11%26spage%3D324%26epage%3D332%26doi%3D10.2174%2F187152712800672517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Crystal Structure of Catechol <i>O</i>-Methyltransferase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1038/368354a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1038%2F368354a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=8127373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaK2cXksFaqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=354-358&author=J.+Vidgrenauthor=L.+A.+Svenssonauthor=A.+Liljas&title=Crystal+Structure+of+Catechol+O-Methyltransferase&doi=10.1038%2F368354a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of catechol O-methyltransferase</span></div><div class="casAuthors">Vidgren, Jukka; Svensson, L. Anders; Liljas, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6469</span>),
    <span class="NLM_cas:pages">354-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The at. structure of catechol O-methyltransferase (COMT, EC 2.1.1.6) was solved to 2.0 Å resoln., which provides new insights into the mechanism of the Me transfer reaction.  The co-enzyme-binding domain is strikingly similar to that of an S-adenosyl-L-methionine (AdoMet)-dependent DNA methylase, indicating that all AdoMet methylases may have a common structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEyNem_cc5_bVg90H21EOLACvtfcHk0lhRHJH8S99g9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFaqu78%253D&md5=71c7ecae5f4daddfd352d319116d4746</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F368354a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F368354a0%26sid%3Dliteratum%253Aachs%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DL.%2BA.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DCrystal%2520Structure%2520of%2520Catechol%2520O-Methyltransferase%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D354%26epage%3D358%26doi%3D10.1038%2F368354a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal Chemical Properties of Successful Central Nervous System Drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+Chemical+Properties+of+Successful+Central+Nervous+System+Drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eY-CSJ4IpfQA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520Chemical%2520Properties%2520of%2520Successful%2520Central%2520Nervous%2520System%2520Drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">Very polar inhibitors targeting the cofactor pocket, being structural SAM analogs, have been reported:</p></div><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borchardt, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. S.</span><span> </span><span class="NLM_article-title">Potential Inhibitors of S-Adenosylmethionine-Dependent Methyltransferases. 1. Modification of the Amino Acid Portion of S-Adenosylhomocysteine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1021/jm00254a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00254a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaE2MXisFKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=862-868&author=R.+T.+Borchardtauthor=Y.+S.+Wu&title=Potential+Inhibitors+of+S-Adenosylmethionine-Dependent+Methyltransferases.+1.+Modification+of+the+Amino+Acid+Portion+of+S-Adenosylhomocysteine&doi=10.1021%2Fjm00254a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Potential inhibitors of S-adenosylmethionine-dependent methyltransferases.  1.  Modification of the amino acid portion of S-adenosylhomocysteine</span></div><div class="casAuthors">Borchardt, Ronald T.; Wu, Yih Shiong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">862-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Eight analogs of S-adenosyl-L-homocysteine (L-I) [979-92-0] were prepd. by the reaction of the desired S-benzylhomocysteine deriv. with 2',3'-O-isopropylidene-5'-O-p-toluenesulfonyladenosine [5605-63-0] in Na-NH3(liq.) followed by hydrolysis, and their abilities to inhibit methyltransferase was investigated.  The terminal amino and carboxy groups and the S of the homocysteine portion of I are required for max. binding by the enzymes.  The L configuration is required to give max. inhibition, with the exception of the potent inhibition of histamine N-methyltransferase [9029-80-5] by S-adenosyl-D-homocysteine (D-I) [53276-26-9].  The relation of structure to activity and nature of the binding sites was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1wdEbKRPW37Vg90H21EOLACvtfcHk0lhbRKuPR3B-yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXisFKltw%253D%253D&md5=9fa22849dceea9da74edbab1d8921d8c</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm00254a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00254a016%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26aulast%3DWu%26aufirst%3DY.%2BS.%26atitle%3DPotential%2520Inhibitors%2520of%2520S-Adenosylmethionine-Dependent%2520Methyltransferases.%25201.%2520Modification%2520of%2520the%2520Amino%2520Acid%2520Portion%2520of%2520S-Adenosylhomocysteine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1974%26volume%3D17%26spage%3D862%26epage%3D868%26doi%3D10.1021%2Fjm00254a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Borchardt, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. S.</span><span> </span><span class="NLM_article-title">Potential Inhibitors of S-Adenosylmethionine-dependent Methyltransferases. 3. Modifications of the Sugar Portion of S-Adenosylhomocysteine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1021/jm00237a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00237a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaE2MXktVShtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=300-304&author=R.+T.+Borchardtauthor=Y.+S.+Wu&title=Potential+Inhibitors+of+S-Adenosylmethionine-dependent+Methyltransferases.+3.+Modifications+of+the+Sugar+Portion+of+S-Adenosylhomocysteine&doi=10.1021%2Fjm00237a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential inhibitors of S-adenosylmethionine-dependent methyltransferases.  3.  Modifications of the sugar portion of S-adenosylhomocysteine</span></div><div class="casAuthors">Borchardt, Ronald T.; Wu, Yih Shiong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Three deoxy analogs of S-adenosyl-L-homocysteine (I) [979-92-0], prepd. by condensation of the tosylated nucleoside with S-benzyl-L-homocysteine [7689-60-3] were tested for specificity of inhibition of 4 methyltransferases.  Histamine-N-methyltransferase (EC 2.1.1.8) [9029-80-5] and hydroxyindole O-methyltransferase (EC 2.1.1.4) [9029-77-0] show strict specificity for the ribose portion of I.  Phenylethanolamine N-methyltransferase [9037-68-7] and catechol O-methyltransferase (EC 2.1.1.6) [9012-25-3] are less sensitive to changes in the ribose moiety and show inhibition by S-2'-deoxyadenosyl-L-homocysteine [55197-16-5] and S-3'-deoxyadenosyl-L-homocysteine [55197-15-4].  The relation of structure to inhibition and binding of enzymes was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaV0BbluLLc7Vg90H21EOLACvtfcHk0lhbRKuPR3B-yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVShtrc%253D&md5=643ea43723970cb4539ee873a0fe58b8</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm00237a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00237a018%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26aulast%3DWu%26aufirst%3DY.%2BS.%26atitle%3DPotential%2520Inhibitors%2520of%2520S-Adenosylmethionine-dependent%2520Methyltransferases.%25203.%2520Modifications%2520of%2520the%2520Sugar%2520Portion%2520of%2520S-Adenosylhomocysteine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D300%26epage%3D304%26doi%3D10.1021%2Fjm00237a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fuller, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarajan, R.</span><span> </span><span class="NLM_article-title">Inhibition of Methyltransferases by Some New Analogs of <i>S</i>-Adenosylhomocysteine</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1983</span><span class="refDoi"> DOI: 10.1016/0006-2952(78)90018-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2F0006-2952%2878%2990018-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1978&pages=1981-1983&author=R.+W.+Fullerauthor=R.+Nagarajan&title=Inhibition+of+Methyltransferases+by+Some+New+Analogs+of+S-Adenosylhomocysteine&doi=10.1016%2F0006-2952%2878%2990018-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2878%2990018-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252878%252990018-7%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DR.%2BW.%26aulast%3DNagarajan%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Methyltransferases%2520by%2520Some%2520New%2520Analogs%2520of%2520S-Adenosylhomocysteine%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1978%26volume%3D27%26spage%3D1981%26epage%3D1983%26doi%3D10.1016%2F0006-2952%2878%2990018-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span> </span><span class="NLM_article-title">Experiences in Fragment-Based Drug Discovery</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/j.tips.2012.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2Fj.tips.2012.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=22459076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslejsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=224-232&author=C.+W.+Murrayauthor=M.+L.+Verdonkauthor=D.+C.+Rees&title=Experiences+in+Fragment-Based+Drug+Discovery&doi=10.1016%2Fj.tips.2012.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Experiences in fragment-based drug discovery</span></div><div class="casAuthors">Murray, Christopher W.; Verdonk, Marcel L.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">224-232</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) has become established in both industry and academia as an alternative approach to high-throughput screening for the generation of chem. leads for drug targets.  In FBDD, specialised detection methods are used to identify small chem. compds. (fragments) that bind to the drug target, and structural biol. is usually employed to establish their binding mode and to facilitate their optimization.  In this article, we present three recent and successful case histories in FBDD.  We then re-examine the key concepts and challenges of FBDD with particular emphasis on recent literature and our own experience from a substantial no. of FBDD applications.  Our opinion is that careful application of FBDD is living up to its promise of delivering high quality leads with good phys. properties and that in future many drug mols. will be derived from fragment-based approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUzcsuUdmx4bVg90H21EOLACvtfcHk0lhbRKuPR3B-yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslejsLs%253D&md5=c97b6b84a4afeadb87ee7d46e6d2bb91</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DExperiences%2520in%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D224%26epage%3D232%26doi%3D10.1016%2Fj.tips.2012.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzanov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolop, K.</span><span> </span><span class="NLM_article-title">Clinical Efficacy of a RAF Inhibitor Needs Broad Target Blockade in BRAF-Mutant Melanoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1038/nature09454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1038%2Fnature09454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=20823850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=596-599&author=G.+Bollagauthor=P.+Hirthauthor=J.+Tsaiauthor=J.+Zhangauthor=P.+N.+Ibrahimauthor=H.+Choauthor=W.+Spevakauthor=C.+Zhangauthor=Y.+Zhangauthor=G.+Habetsauthor=E.+A.+Burtonauthor=B.+Wongauthor=G.+Tsangauthor=B.+L.+Westauthor=B.+Powellauthor=R.+Shellooeauthor=A.+Marimuthuauthor=H.+Nguyenauthor=K.+Y.+J.+Zhangauthor=D.+R.+Artisauthor=J.+Schlessingerauthor=F.+Suauthor=B.+Higginsauthor=R.+Iyerauthor=K.+D%E2%80%99Andreaauthor=A.+Koehlerauthor=M.+Stummauthor=P.+S.+Linauthor=R.+J.+Leeauthor=J.+Grippoauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+B.+Chapmanauthor=K.+T.+Flahertyauthor=X.+Xuauthor=K.+L.+Nathansonauthor=K.+Nolop&title=Clinical+Efficacy+of+a+RAF+Inhibitor+Needs+Broad+Target+Blockade+in+BRAF-Mutant+Melanoma&doi=10.1038%2Fnature09454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span></div><div class="casAuthors">Bollag, Gideon; Hirth, Peter; Tsai, James; Zhang, Jiazhong; Ibrahim, Prabha N.; Cho, Hanna; Spevak, Wayne; Zhang, Chao; Zhang, Ying; Habets, Gaston; Burton, Elizabeth A.; Wong, Bernice; Tsang, Garson; West, Brian L.; Powell, Ben; Shellooe, Rafe; Marimuthu, Adhirai; Nguyen, Hoa; Zhang, Kam Y. J.; Artis, Dean R.; Schlessinger, Joseph; Su, Fei; Higgins, Brian; Iyer, Raman; D'Andrea, Kurt; Koehler, Astrid; Stumm, Michael; Lin, Paul S.; Lee, Richard J.; Grippo, Joseph; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; Chapman, Paul B.; Flaherty, Keith T.; Xu, Xiaowei; Nathanson, Katherine L.; Nolop, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">7315</span>),
    <span class="NLM_cas:pages">596-599</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">B-RAF is the most frequently mutated protein kinase in human cancers.  The finding that oncogenic mutations in BRAF are common in melanoma, followed by the demonstration that these tumors are dependent on the RAF/MEK/ERK pathway, offered hope that inhibition of B-RAF kinase activity could benefit melanoma patients.  Herein, we describe the structure-guided discovery of PLX4032 (RG7204), a potent inhibitor of oncogenic B-RAF kinase activity.  Preclin. expts. demonstrated that PLX4032 selectively blocked the RAF/MEK/ERK pathway in BRAF mutant cells and caused regression of BRAF mutant xenografts.  Toxicol. studies confirmed a wide safety margin consistent with the high degree of selectivity, enabling Phase 1 clin. trials using a cryst. formulation of PLX4032 (ref. 5).  In a subset of melanoma patients, pathway inhibition was monitored in paired biopsy specimens collected before treatment initiation and following 2 wk of treatment.  This anal. revealed substantial inhibition of ERK phosphorylation, yet clin. evaluation did not show tumor regressions.  At higher drug exposures afforded by a new amorphous drug formulation, greater than 80% inhibition of ERK phosphorylation in the tumors of patients correlated with clin. response.  Indeed, the Phase 1 clin. data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.  These data demonstrate that BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYwlns1EfcLVg90H21EOLACvtfcHk0li5WaJ8nuEViA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK&md5=8a26d0ab41970f39a109ddafff2f17b4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09454%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DF.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DA.%26aulast%3DStumm%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DNolop%26aufirst%3DK.%26atitle%3DClinical%2520Efficacy%2520of%2520a%2520RAF%2520Inhibitor%2520Needs%2520Broad%2520Target%2520Blockade%2520in%2520BRAF-Mutant%2520Melanoma%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D596%26epage%3D599%26doi%3D10.1038%2Fnature09454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><div class="note"><p class="first last">For a comprehensive review on fragment-based approaches see the following:</p></div><span class="NLM_contrib-group">Scott, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abell, C.</span><span> </span><span class="NLM_article-title">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4990</span><span class="NLM_x">–</span> <span class="NLM_lpage">5003</span><span class="refDoi"> DOI: 10.1021/bi3005126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3005126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4990-5003&author=D.+E.+Scottauthor=A.+G.+Coyneauthor=S.+A.+Hudsonauthor=C.+Abell&title=Fragment-Based+Approaches+in+Drug+Discovery+and+Chemical+Biology&doi=10.1021%2Fbi3005126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Scott, Duncan E.; Coyne, Anthony G.; Hudson, Sean A.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4990-5003</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based approaches to finding novel small mols. that bind to proteins are now firmly established in drug discovery and chem. biol.  Initially developed primarily in a few centers in the biotech and pharma industry, this methodol. has now been adopted widely in both the pharmaceutical industry and academia.  After the initial success with kinase targets, the versatility of this approach has now expanded to a broad range of different protein classes.  Herein we describe recent fragment-based approaches to a wide range of target types, including Hsp90, β-secretase, and allosteric sites in human immunodeficiency virus protease and fanesyl pyrophosphate synthase.  The role of fragment-based approaches in an academic research environment is also examd. with an emphasis on neglected diseases such as tuberculosis.  The development of a fragment library, the fragment screening process, and the subsequent fragment hit elaboration will be discussed using examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2ry6mWC83bVg90H21EOLACvtfcHk0li5WaJ8nuEViA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D&md5=39a6f0f741e711fd572e24c95142f55d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3005126%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DHudson%26aufirst%3DS.%2BA.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-Based%2520Approaches%2520in%2520Drug%2520Discovery%2520and%2520Chemical%2520Biology%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D4990%26epage%3D5003%26doi%3D10.1021%2Fbi3005126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huber, W.</span><span> </span><span class="NLM_article-title">A New Strategy for Improved Secondary Screening and Lead Optimization Using High-Resolution SPR Characterization of Compound–Target Interactions</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1002/jmr.744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1002%2Fjmr.744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=15997470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslGhu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=273-281&author=W.+Huber&title=A+New+Strategy+for+Improved+Secondary+Screening+and+Lead+Optimization+Using+High-Resolution+SPR+Characterization+of+Compound%E2%80%93Target+Interactions&doi=10.1002%2Fjmr.744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions</span></div><div class="casAuthors">Huber, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-281</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Biophys. label-free assays such as those based on SPR are essential tools in generating high-quality data on affinity, kinetic, mechanistic and thermodn. aspects of interactions between target proteins and potential drug candidates.  Here we show examples of the integration of SPR with bioinformatic approaches and mutation studies in the early drug discovery process.  We call this combination 'structure-based biophys. anal.'.  Binding sites are identified on target proteins using information that is either extd. from three-dimensional structural anal. (x-ray crystallog. or NMR), or derived from a pharmacore model based on known binders.  The binding site information is used for in silico screening of a large substance library (e.g. available chem. directory), providing virtual hits.  The three-dimensional structure is also used for the design of mutants where the binding site has been impaired.  The wild-type target and the impaired mutant are then immobilized on different spots of the sensor chip and the interactions of compds. with the wild-type and mutant are compared in order to identify selective binders for the binding site of the target protein.  This method can be used as a cost-effective alternative to high-throughput screening methods in cases when detailed binding site information is available.  Here, we present three examples of how this technique can be applied to provide invaluable data during different phases of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUgKw8f-3b7Vg90H21EOLACvtfcHk0li5WaJ8nuEViA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslGhu70%253D&md5=9ab5c7fd7e733fc4d8a4b0c817f82736</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1002%2Fjmr.744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.744%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26atitle%3DA%2520New%2520Strategy%2520for%2520Improved%2520Secondary%2520Screening%2520and%2520Lead%2520Optimization%2520Using%2520High-Resolution%2520SPR%2520Characterization%2520of%2520Compound%25E2%2580%2593Target%2520Interactions%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2005%26volume%3D18%26spage%3D273%26epage%3D281%26doi%3D10.1002%2Fjmr.744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Navratilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Fragment Screening by Surface Plasmon Resonance</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1021/ml900002k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml900002k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1agtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=44-48&author=I.+Navratilovaauthor=A.+L.+Hopkins&title=Fragment+Screening+by+Surface+Plasmon+Resonance&doi=10.1021%2Fml900002k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment Screening by Surface Plasmon Resonance</span></div><div class="casAuthors">Navratilova, Iva; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-48</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery is a validated approach for the discovery of drug candidates.  However, the weak affinity of fragment compds. requires highly sensitive biophys. techniques, such as NMR or x-ray crystallog., to identify hits.  Thus the advantages of screening small fragment libraries are partly offset by the high cost of biophys. analyses.  Here the authors present a method for biosensor-based fragment screening using surface plasmon resonance (SPR).  To reduce the false pos. detection rate the authors present a novel method of data anal. that incorporates multiple referencing with ligand efficiency.  By implementing all necessary steps for assay design, data anal. and interpretation, SPR-based fragment screening has potential to eliminate all nonspecific (false pos.) binders.  Therefore, given the advantages of low protein consumption, rapid assay development and kinetic and thermodn. validation of hits, SPR can be considered as a primary screening technol. for fragment-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2SPJs9bLebVg90H21EOLACvtfcHk0lghSJdBgSJjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1agtbk%253D&md5=05b985a9906da33beb06c710e8c11550</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fml900002k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900002k%26sid%3Dliteratum%253Aachs%26aulast%3DNavratilova%26aufirst%3DI.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DFragment%2520Screening%2520by%2520Surface%2520Plasmon%2520Resonance%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D44%26epage%3D48%26doi%3D10.1021%2Fml900002k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Fragment Library Screening and Lead Characterization Using SPR Biosensors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1735</span><span class="refDoi"> DOI: 10.2174/156802609790102392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.2174%2F156802609790102392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=19929838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFeitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1725-1735&author=U.+H.+Danielson&title=Fragment+Library+Screening+and+Lead+Characterization+Using+SPR+Biosensors&doi=10.2174%2F156802609790102392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment library screening and lead characterization using SPR biosensors</span></div><div class="casAuthors">Danielson, U. Helena</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1725-1735</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The transition from high throughput screening of collections of drug-like compds. to screening of fragment libraries via lower throughput methods with high sensitivity has revolutionized early drug discovery.  It is highlighting the need for sensitive biophys. techniques for interaction anal. rather than high throughput methods.  Biosensors with SPR detection are well suited for this novel scenario.  In less than 20 years the technique has been launched, established and become a highly informative method for a variety of applications in drug discovery.  It is no longer limited to the detection of proteins or other high mol. wt. analytes, but the detection of weakly interacting fragments is now feasible.  This paper discusses the theor. and exptl. limitations for such applications and reviews a no. of successful studies in the area of fragment-based lead discovery that have recently been published.  It can be anticipated that the evolution of this young technique will be significantly influenced by the requirements for efficient fragment-based lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPzUsOfVCNbVg90H21EOLACvtfcHk0lghSJdBgSJjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFeitr0%253D&md5=a4943e5e7e1a893cad27a54febf5beb7</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.2174%2F156802609790102392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609790102392%26sid%3Dliteratum%253Aachs%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DFragment%2520Library%2520Screening%2520and%2520Lead%2520Characterization%2520Using%2520SPR%2520Biosensors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1725%26epage%3D1735%26doi%3D10.2174%2F156802609790102392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Mutations in SAM binding site used for secondary screening were Glu90-Arg, Glu90-Trp, Ser119-Trp, His142-Arg, His142-Lys, and His142-Trp.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">A one-dimensional (1D) <sup>1</sup>H NMR spin lock variation of Carr–Purcell–Meiboom–Gill (CPMG) method was used:</p></div><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Klages, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">NMR-Based Screening: A Powerful Tool in Fragment-Based Drug Discovery</span> <span class="citation_source-journal">Analyst</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1039/B709658P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1039%2FB709658P" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=692-705&author=J.+Klagesauthor=M.+Colesauthor=H.+Kessler&title=NMR-Based+Screening%3A+A+Powerful+Tool+in+Fragment-Based+Drug+Discovery&doi=10.1039%2FB709658P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1039%2FB709658P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB709658P%26sid%3Dliteratum%253Aachs%26aulast%3DKlages%26aufirst%3DJ.%26aulast%3DColes%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DNMR-Based%2520Screening%253A%2520A%2520Powerful%2520Tool%2520in%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DAnalyst%26date%3D2007%26volume%3D132%26spage%3D692%26epage%3D705%26doi%3D10.1039%2FB709658P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meiboom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, D.</span><span> </span><span class="NLM_article-title">Modified Spin-Echo Method for Measuring Nuclear Relaxation Times</span> <span class="citation_source-journal">Rev. Sci. Instrum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1063/1.1716296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1063%2F1.1716296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADyaF3cXosFWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1958&pages=688-691&author=S.+Meiboomauthor=D.+Gill&title=Modified+Spin-Echo+Method+for+Measuring+Nuclear+Relaxation+Times&doi=10.1063%2F1.1716296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Modified spin-echo method for measuring nuclear relaxation times</span></div><div class="casAuthors">Meiboom, S.; Gill, D.</div><div class="citationInfo"><span class="NLM_cas:title">Review of Scientific Instruments</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">688-91</span>CODEN:
                <span class="NLM_cas:coden">RSINAK</span>;
        ISSN:<span class="NLM_cas:issn">0034-6748</span>.
    </div><div class="casAbstract">The Carr-Purcell method for the measurement of long nuclear relaxation times in liquids (cf. CA 48, 8077e) has been further modified.  While the pulse sequence of the modified technique was identical to the original scheme, the necessity of a very accurate adjustment of the 180° pulses was eliminated and the reproducibility was improved.  A schematic diagram of the transmitter gate used in the app. is discussed, and the derivation and principle of the method is explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfTQfkWfruf7Vg90H21EOLACvtfcHk0lghSJdBgSJjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3cXosFWitQ%253D%253D&md5=ecf0073dea1daa97157b5e2b6b62dc73</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1063%2F1.1716296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.1716296%26sid%3Dliteratum%253Aachs%26aulast%3DMeiboom%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DD.%26atitle%3DModified%2520Spin-Echo%2520Method%2520for%2520Measuring%2520Nuclear%2520Relaxation%2520Times%26jtitle%3DRev.%2520Sci.%2520Instrum.%26date%3D1958%26volume%3D29%26spage%3D688%26epage%3D691%26doi%3D10.1063%2F1.1716296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fersht, A. R.</span><span> </span><span class="NLM_article-title">Toward the Rational Design of p53- Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2Fj.chembiol.2009.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=20142040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=46-56&author=N.+Basseauthor=J.+L.+Kaarauthor=G.+Settanniauthor=A.+C.+Joergerauthor=T.+J.+Rutherfordauthor=A.+R.+Fersht&title=Toward+the+Rational+Design+of+p53-+Stabilizing+Drugs%3A+Probing+the+Surface+of+the+Oncogenic+Y220C+Mutant&doi=10.1016%2Fj.chembiol.2009.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant</span></div><div class="casAuthors">Basse, Nicolas; Kaar, Joel L.; Settanni, Giovanni; Joerger, Andreas C.; Rutherford, Trevor J.; Fersht, Alan R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-56</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The p53 cancer mutation Y220C induces formation of a cavity on the protein's surface that can accommodate stabilizing small mols.  We combined fragment screening and mol. dynamics to assess the druggability of p53-Y220C and map ligand interaction sites within the mutational cavity.  Elucidation of the binding mode of fragment hits by crystallog. yielded a clear picture of how a drug might dock in the cavity.  Simulations that solvate the protein with isopropanol found addnl. sites that extend the druggable surface.  Moreover, structural observations and simulation revealed the dynamic landscape of the cavity, which improves our understanding of the impact of the mutation on p53 stability.  This underpins the importance of considering flexibility of the cavity in screening for optimized ligands.  Our findings provide a blueprint for the design of effective drugs that rescue p53-Y220C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJc5HAxcEvgLVg90H21EOLACvtfcHk0lgexxOX9puJ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ns70%253D&md5=9b7ada8df99710cc4f77c75e43b2e617</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DKaar%26aufirst%3DJ.%2BL.%26aulast%3DSettanni%26aufirst%3DG.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DRutherford%26aufirst%3DT.%2BJ.%26aulast%3DFersht%26aufirst%3DA.%2BR.%26atitle%3DToward%2520the%2520Rational%2520Design%2520of%2520p53-%2520Stabilizing%2520Drugs%253A%2520Probing%2520the%2520Surface%2520of%2520the%2520Oncogenic%2520Y220C%2520Mutant%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D46%26epage%3D56%26doi%3D10.1016%2Fj.chembiol.2009.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Enderle, T.; Roth, D.</span><span> </span><span class="NLM_article-title">Method for the Identification of Catechol O-Methyltransferase Modulators</span>. WO/2012/013614 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Enderle&author=D.+Roth&title=Method+for+the+Identification+of+Catechol+O-Methyltransferase+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEnderle%26aufirst%3DT.%26atitle%3DMethod%2520for%2520the%2520Identification%2520of%2520Catechol%2520O-Methyltransferase%2520Modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mortenson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span> </span><span class="NLM_article-title">Assessing the Lipophilicity of Fragments and Early Hits</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span><span class="refDoi"> DOI: 10.1007/s10822-011-9435-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1007%2Fs10822-011-9435-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=21614595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=663-667&author=P.+N.+Mortensonauthor=C.+W.+Murray&title=Assessing+the+Lipophilicity+of+Fragments+and+Early+Hits&doi=10.1007%2Fs10822-011-9435-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the lipophilicity of fragments and early hits</span></div><div class="casAuthors">Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits.  This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small.  Ligand efficiency (LE) considers both the potency and the size of the mol., and enables us to est. whether or not an initial hit is likely to be optimizable to a potent, druglike lead.  While size is a key property that needs to be controlled in a small mol. drug, there are a no. of addnl. properties that should also be considered.  Lipophilicity is amongst the most important of these addnl. properties, and here we present a new efficiency index (LLEAT) that combines lipophilicity, size and potency.  The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists.  Monitoring both LE and LLEAT should help both in the selection of more promising fragment hits, and controlling mol. wt. and lipophilicity during optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnbfcwp30BrVg90H21EOLACvtfcHk0lgexxOX9puJ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL&md5=e6d68046d3d20bd2ea088ce218451c25</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9435-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9435-z%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DAssessing%2520the%2520Lipophilicity%2520of%2520Fragments%2520and%2520Early%2520Hits%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26spage%3D663%26epage%3D667%26doi%3D10.1007%2Fs10822-011-9435-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lanier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellery, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosbeary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadotani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saikatendu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hixon, M. S.</span><span> </span><span class="NLM_article-title">A Fragment-Based Approach to Identifying <i>S</i>-Adenosyl-L-Methionine -Competitive Inhibitors of Catechol <i>O</i>-Methyl Transferase (COMT)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5459</span><span class="NLM_x">–</span> <span class="NLM_lpage">5463</span><span class="refDoi"> DOI: 10.1021/jm500475k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500475k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5459-5463&author=M.+Lanierauthor=G.+Ambrusauthor=D.+C.+Coleauthor=R.+Davenportauthor=J.+Elleryauthor=R.+Fosbearyauthor=A.+J.+Jenningsauthor=A.+Kadotaniauthor=Y.+Kamadaauthor=R.+Kamranauthor=S.-I.+Matsumotoauthor=A.+Mizukamiauthor=S.+Okuboauthor=K.+Okadaauthor=K.+Saikatenduauthor=L.+Walshauthor=H.+Wuauthor=M.+S.+Hixon&title=A+Fragment-Based+Approach+to+Identifying+S-Adenosyl-L-Methionine+-Competitive+Inhibitors+of+Catechol+O-Methyl+Transferase+%28COMT%29&doi=10.1021%2Fjm500475k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm500475k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500475k%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DAmbrus%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DEllery%26aufirst%3DJ.%26aulast%3DFosbeary%26aufirst%3DR.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKadotani%26aufirst%3DA.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DKamran%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DS.-I.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DSaikatendu%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHixon%26aufirst%3DM.%2BS.%26atitle%3DA%2520Fragment-Based%2520Approach%2520to%2520Identifying%2520S-Adenosyl-L-Methionine%2520-Competitive%2520Inhibitors%2520of%2520Catechol%2520O-Methyl%2520Transferase%2520%2528COMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5459%26epage%3D5463%26doi%3D10.1021%2Fjm500475k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">Absolute configuration was confirmed for enantiomers <b>18R</b>/<b>18S</b> and <b>19R</b>/<b>19S</b> and for <b>22</b> and <b>23</b> by enantioselective synthesis of one enantiomer using the corresponding chiral aldehydes or X-ray crystallography. We observed that the <i>R</i> enantiomers have a negative optical rotation (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf" class="ext-link">Supporting Information</a> for data on pyrazolo-pyrazole analogs of compounds <b>15</b> and <b>24</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinman, J. P.</span><span> </span><span class="NLM_article-title">Enzymatic Transfer; Role of and Active Site Residue in Generating Active Site Compaction that Correlates with Catalytic Efficiency</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">17134</span><span class="NLM_x">–</span> <span class="NLM_lpage">17137</span><span class="refDoi"> DOI: 10.1021/ja207467d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja207467d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=17134-17137&author=J.+Zhangauthor=J.+P.+Klinman&title=Enzymatic+Transfer%3B+Role+of+and+Active+Site+Residue+in+Generating+Active+Site+Compaction+that+Correlates+with+Catalytic+Efficiency&doi=10.1021%2Fja207467d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fja207467d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja207467d%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26atitle%3DEnzymatic%2520Transfer%253B%2520Role%2520of%2520and%2520Active%2520Site%2520Residue%2520in%2520Generating%2520Active%2520Site%2520Compaction%2520that%2520Correlates%2520with%2520Catalytic%2520Efficiency%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D17134%26epage%3D17137%26doi%3D10.1021%2Fja207467d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulik, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinman, J. P.</span><span> </span><span class="NLM_article-title">Mediation of Donor-Acceptor Distance in an Enzymatic Methyl Transfer Reaction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">7954</span><span class="NLM_x">–</span> <span class="NLM_lpage">7959</span><span class="refDoi"> DOI: 10.1073/pnas.1506792112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1073%2Fpnas.1506792112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=26080432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSit7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=7954-7959&author=J.+Zhangauthor=H.+J.+Kulikauthor=T.+J.+Martinezauthor=J.+P.+Klinman&title=Mediation+of+Donor-Acceptor+Distance+in+an+Enzymatic+Methyl+Transfer+Reaction&doi=10.1073%2Fpnas.1506792112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Mediation of donor-acceptor distance in an enzymatic methyl transfer reaction</span></div><div class="casAuthors">Zhang, Jianyu; Kulik, Heather J.; Martinez, Todd J.; Klinman, Judith P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7954-7959</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enzymic Me transfer, catalyzed by catechol-O-methyltransferase (COMT), is investigated using binding isotope effects (BIEs), time-resolved fluorescence lifetimes, Stokes shifts, and extended graphics processing unit (GPU)-based quantum mechanics/mol. mechanics (QM/MM) approaches.  The WT enzyme is compared with mutants at Tyr68, a conserved residue that is located behind the reactive sulfur of cofactor.  Small (>1) BIEs are obsd. for an S-adenosylmethionine (AdoMet)-binary and abortive ternary complex contg. 8-hydroxyquinoline, and contrast with previously reported inverse (<1) kinetic isotope effects (KIEs).  Extended GPU-based computational studies of a ternary complex contg. catecholate show a clear trend in ground state structures, from noncanonical bond lengths for WT toward soln. values with mutants.  Structural and dynamical differences that are sensitive to Tyr68 have also been detected using time-resolved Stokes shift measurements and mol. dynamics.  These exptl. and computational results are discussed in the context of active site compaction that requires an ionization of substrate within the enzyme ternary complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUXlL6tcX_srVg90H21EOLACvtfcHk0lj-HxuGUIqkNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSit7rL&md5=f89dc78bd1fc331ac7061eef6c69f899</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1506792112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1506792112%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKulik%26aufirst%3DH.%2BJ.%26aulast%3DMartinez%26aufirst%3DT.%2BJ.%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26atitle%3DMediation%2520of%2520Donor-Acceptor%2520Distance%2520in%2520an%2520Enzymatic%2520Methyl%2520Transfer%2520Reaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D7954%26epage%3D7959%26doi%3D10.1073%2Fpnas.1506792112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span> </span><span class="NLM_article-title">Crystal Structures of the Apo and Holo Form of Rat Catechol-<i>O</i>-Methyltransferase</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1016/j.jsb.2008.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;key=10.1016%2Fj.jsb.2008.11.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2009&pages=133-139&author=E.+Tsujiauthor=K.+Okazakiauthor=M.+Isajiauthor=K.+Takeda&title=Crystal+Structures+of+the+Apo+and+Holo+Form+of+Rat+Catechol-O-Methyltransferase&doi=10.1016%2Fj.jsb.2008.11.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2008.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2008.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DOkazaki%26aufirst%3DK.%26aulast%3DIsaji%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DK.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520Apo%2520and%2520Holo%2520Form%2520of%2520Rat%2520Catechol-O-Methyltransferase%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2009%26volume%3D165%26spage%3D133%26epage%3D139%26doi%3D10.1016%2Fj.jsb.2008.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k03" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k03','PDB','5k03'); return false;">PDB: 5k03</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k05" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k05','PDB','5k05'); return false;">PDB: 5k05</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0l" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0l','PDB','5k0l'); return false;">PDB: 5k0l</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0f" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0f','PDB','5k0f'); return false;">PDB: 5k0f</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0b" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0b','PDB','5k0b'); return false;">PDB: 5k0b</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0c" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0c','PDB','5k0c'); return false;">PDB: 5k0c</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k01" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k01','PDB','5k01'); return false;">PDB: 5k01</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k09" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k09','PDB','5k09'); return false;">PDB: 5k09</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0e" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0e','PDB','5k0e'); return false;">PDB: 5k0e</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0j" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0j','PDB','5k0j'); return false;">PDB: 5k0j</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0n" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0n','PDB','5k0n'); return false;">PDB: 5k0n</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i55"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00927">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_07150"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00927">10.1021/acs.jmedchem.6b00927</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for noncommercial available compounds in <a class="ref internalNav" href="#tbl2">Table 2</a>, pyrazolo-pyrazole analogs, and 4-ethyl analogs, crystallization conditions, X-ray data collection, and experimental details on methods used for fragment screening (SPR, 1D/2D NMR) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf">jm6b00927_si_001.pdf (1.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_002.csv">jm6b00927_si_002.csv (1.39 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k01">5k01</a> (compound <b>2′</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k03">5k03</a> (compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k05">5k05</a> (compound <b>8</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k09">5k09</a> (compound <b>15</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0b">5k0b</a> (compound <b>18</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0c">5k0c</a> (compound <b>20</b> in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0e">5k0e</a> (alternative X-ray of compound <b>20</b>, not shown), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0f">5k0f</a> (<b>22 + 23</b>, cocrystallized as racemate), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0l">5k0l</a> (compound <b>24</b> in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0j">5k0j</a> (alternative X-ray of compound <b>24</b>, not shown), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5k0n">5k0n</a> (<b>24′</b>, pyrazolo-pyrazole analog of <b>24</b> in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00927/suppl_file/jm6b00927_si_001.pdf" class="ext-link">Supporting Information</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00927&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00927" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00927" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67c73867fc5224bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
